Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051239 | 0.00000 | 2.84307 | 169 | 363 | 3248 | regulation of multicellular organismal process |
| GO:0048518 | 0.00000 | 2.39753 | 321 | 546 | 6171 | positive regulation of biological process |
| GO:0006954 | 0.00000 | 4.94746 | 36 | 137 | 691 | inflammatory response |
| GO:0048583 | 0.00000 | 2.53357 | 202 | 391 | 3883 | regulation of response to stimulus |
| GO:0002376 | 0.00000 | 2.67470 | 139 | 295 | 2664 | immune system process |
| GO:0051240 | 0.00000 | 2.96122 | 100 | 239 | 1929 | positive regulation of multicellular organismal process |
| GO:0042221 | 0.00000 | 2.33969 | 215 | 392 | 4136 | response to chemical |
| GO:0006952 | 0.00000 | 3.03379 | 83 | 206 | 1601 | defense response |
| GO:0040011 | 0.00000 | 2.89547 | 95 | 223 | 1817 | locomotion |
| GO:0002682 | 0.00000 | 3.11830 | 77 | 195 | 1473 | regulation of immune system process |
| GO:0065007 | 0.00000 | 2.11427 | 632 | 835 | 12135 | biological regulation |
| GO:0032502 | 0.00000 | 2.11601 | 326 | 517 | 6258 | developmental process |
| GO:0002684 | 0.00000 | 3.49762 | 56 | 159 | 1072 | positive regulation of immune system process |
| GO:0048856 | 0.00000 | 2.12825 | 306 | 493 | 5871 | anatomical structure development |
| GO:0009605 | 0.00000 | 2.57049 | 131 | 273 | 2515 | response to external stimulus |
| GO:0048522 | 0.00000 | 2.14694 | 285 | 468 | 5469 | positive regulation of cellular process |
| GO:0048731 | 0.00000 | 2.20072 | 247 | 423 | 4746 | system development |
| GO:0006928 | 0.00000 | 2.74257 | 105 | 235 | 2014 | movement of cell or subcellular component |
| GO:0032879 | 0.00000 | 2.47290 | 148 | 295 | 2835 | regulation of localization |
| GO:0030154 | 0.00000 | 2.24217 | 220 | 388 | 4218 | cell differentiation |
| GO:0008283 | 0.00000 | 2.74383 | 104 | 233 | 1994 | cell proliferation |
| GO:0009966 | 0.00000 | 2.47265 | 145 | 290 | 2780 | regulation of signal transduction |
| GO:0007275 | 0.00000 | 2.13420 | 279 | 459 | 5362 | multicellular organism development |
| GO:0050896 | 0.00000 | 2.02180 | 496 | 696 | 9531 | response to stimulus |
| GO:0048519 | 0.00000 | 2.12497 | 275 | 452 | 5278 | negative regulation of biological process |
| GO:0016477 | 0.00000 | 3.01196 | 75 | 187 | 1447 | cell migration |
| GO:0042127 | 0.00000 | 2.84938 | 86 | 202 | 1649 | regulation of cell proliferation |
| GO:0048870 | 0.00000 | 2.86886 | 83 | 197 | 1595 | cell motility |
| GO:0051674 | 0.00000 | 2.86886 | 83 | 197 | 1595 | localization of cell |
| GO:0048584 | 0.00000 | 2.54528 | 119 | 250 | 2294 | positive regulation of response to stimulus |
| GO:0048869 | 0.00000 | 2.15213 | 231 | 395 | 4443 | cellular developmental process |
| GO:0050789 | 0.00000 | 2.00346 | 600 | 793 | 11520 | regulation of biological process |
| GO:0006950 | 0.00000 | 2.23701 | 190 | 342 | 3640 | response to stress |
| GO:0031347 | 0.00000 | 4.15212 | 33 | 112 | 640 | regulation of defense response |
| GO:0010646 | 0.00000 | 2.27460 | 174 | 321 | 3338 | regulation of cell communication |
| GO:0023051 | 0.00000 | 2.24510 | 175 | 320 | 3360 | regulation of signaling |
| GO:0007166 | 0.00000 | 2.42056 | 130 | 260 | 2497 | cell surface receptor signaling pathway |
| GO:0048513 | 0.00000 | 2.21681 | 183 | 329 | 3504 | animal organ development |
| GO:0006955 | 0.00000 | 2.74884 | 86 | 197 | 1652 | immune response |
| GO:0001816 | 0.00000 | 3.74810 | 39 | 121 | 755 | cytokine production |
| GO:0070887 | 0.00000 | 2.28024 | 157 | 295 | 3023 | cellular response to chemical stimulus |
| GO:0048523 | 0.00000 | 2.06781 | 244 | 403 | 4687 | negative regulation of cellular process |
| GO:2000026 | 0.00000 | 2.48230 | 114 | 235 | 2184 | regulation of multicellular organismal development |
| GO:0050793 | 0.00000 | 2.32964 | 142 | 273 | 2721 | regulation of developmental process |
| GO:0032501 | 0.00000 | 1.91404 | 429 | 609 | 8233 | multicellular organismal process |
| GO:0032101 | 0.00000 | 3.58045 | 40 | 119 | 770 | regulation of response to external stimulus |
| GO:0001817 | 0.00000 | 3.72564 | 35 | 109 | 679 | regulation of cytokine production |
| GO:0010033 | 0.00000 | 2.19260 | 160 | 291 | 3070 | response to organic substance |
| GO:0035556 | 0.00000 | 2.28087 | 136 | 259 | 2608 | intracellular signal transduction |
| GO:0065008 | 0.00000 | 2.04990 | 211 | 354 | 4051 | regulation of biological quality |
| GO:0045595 | 0.00000 | 2.47982 | 99 | 208 | 1909 | regulation of cell differentiation |
| GO:0051179 | 0.00000 | 1.91738 | 310 | 470 | 5950 | localization |
| GO:0051241 | 0.00000 | 2.77164 | 70 | 164 | 1343 | negative regulation of multicellular organismal process |
| GO:0051094 | 0.00000 | 2.63553 | 80 | 179 | 1540 | positive regulation of developmental process |
| GO:0080134 | 0.00000 | 2.72046 | 70 | 161 | 1337 | regulation of response to stress |
| GO:0050727 | 0.00000 | 4.87711 | 18 | 72 | 354 | regulation of inflammatory response |
| GO:0051270 | 0.00000 | 2.97115 | 54 | 135 | 1028 | regulation of cellular component movement |
| GO:0031349 | 0.00000 | 4.69600 | 19 | 73 | 370 | positive regulation of defense response |
| GO:0034097 | 0.00000 | 2.96976 | 52 | 132 | 1004 | response to cytokine |
| GO:0040012 | 0.00000 | 2.94922 | 53 | 133 | 1018 | regulation of locomotion |
| GO:0001819 | 0.00000 | 4.22129 | 23 | 81 | 449 | positive regulation of cytokine production |
| GO:0050794 | 0.00000 | 1.79459 | 561 | 727 | 10774 | regulation of cellular process |
| GO:0022610 | 0.00000 | 2.67630 | 68 | 156 | 1310 | biological adhesion |
| GO:0007165 | 0.00000 | 1.83991 | 314 | 464 | 6028 | signal transduction |
| GO:0065009 | 0.00000 | 2.18825 | 129 | 240 | 2477 | regulation of molecular function |
| GO:0009653 | 0.00000 | 2.12964 | 143 | 258 | 2744 | anatomical structure morphogenesis |
| GO:0009888 | 0.00000 | 2.33076 | 102 | 203 | 1956 | tissue development |
| GO:0007154 | 0.00000 | 1.81185 | 346 | 499 | 6648 | cell communication |
| GO:0051049 | 0.00000 | 2.32997 | 101 | 202 | 1946 | regulation of transport |
| GO:0009987 | 0.00000 | 1.95071 | 823 | 969 | 15803 | cellular process |
| GO:2000145 | 0.00000 | 2.97087 | 49 | 124 | 939 | regulation of cell motility |
| GO:0030334 | 0.00000 | 3.03016 | 46 | 120 | 892 | regulation of cell migration |
| GO:0023052 | 0.00000 | 1.80715 | 343 | 494 | 6579 | signaling |
| GO:0007155 | 0.00000 | 2.63908 | 68 | 153 | 1298 | cell adhesion |
| GO:0009893 | 0.00000 | 2.00562 | 182 | 306 | 3486 | positive regulation of metabolic process |
| GO:0051171 | 0.00000 | 1.86217 | 266 | 406 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0051246 | 0.00000 | 2.11588 | 140 | 252 | 2687 | regulation of protein metabolic process |
| GO:0051716 | 0.00000 | 1.76805 | 407 | 562 | 7810 | cellular response to stimulus |
| GO:0050900 | 0.00000 | 4.66945 | 18 | 67 | 340 | leukocyte migration |
| GO:0019222 | 0.00000 | 1.81133 | 310 | 455 | 5953 | regulation of metabolic process |
| GO:0001932 | 0.00000 | 2.53206 | 73 | 160 | 1410 | regulation of protein phosphorylation |
| GO:0048585 | 0.00000 | 2.43325 | 82 | 172 | 1576 | negative regulation of response to stimulus |
| GO:0080090 | 0.00000 | 1.83483 | 273 | 412 | 5248 | regulation of primary metabolic process |
| GO:0042325 | 0.00000 | 2.43978 | 80 | 168 | 1533 | regulation of phosphorylation |
| GO:1902531 | 0.00000 | 2.35743 | 89 | 181 | 1710 | regulation of intracellular signal transduction |
| GO:0008219 | 0.00000 | 2.22530 | 108 | 206 | 2065 | cell death |
| GO:0031323 | 0.00000 | 1.81183 | 281 | 419 | 5401 | regulation of cellular metabolic process |
| GO:0008284 | 0.00000 | 2.82175 | 51 | 123 | 972 | positive regulation of cell proliferation |
| GO:0060429 | 0.00000 | 2.63686 | 61 | 139 | 1172 | epithelium development |
| GO:0045597 | 0.00000 | 2.69740 | 57 | 133 | 1097 | positive regulation of cell differentiation |
| GO:0050776 | 0.00000 | 2.89190 | 47 | 117 | 903 | regulation of immune response |
| GO:0051174 | 0.00000 | 2.33456 | 88 | 178 | 1693 | regulation of phosphorus metabolic process |
| GO:0010941 | 0.00000 | 2.33076 | 88 | 177 | 1685 | regulation of cell death |
| GO:0060255 | 0.00000 | 1.79341 | 286 | 422 | 5486 | regulation of macromolecule metabolic process |
| GO:0050778 | 0.00000 | 3.08842 | 39 | 103 | 747 | positive regulation of immune response |
| GO:0019220 | 0.00000 | 2.31920 | 88 | 177 | 1692 | regulation of phosphate metabolic process |
| GO:0071310 | 0.00000 | 2.09893 | 127 | 229 | 2433 | cellular response to organic substance |
| GO:0010604 | 0.00000 | 1.96023 | 167 | 280 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0042592 | 0.00000 | 2.23090 | 98 | 190 | 1887 | homeostatic process |
| GO:0001775 | 0.00000 | 2.64331 | 57 | 131 | 1098 | cell activation |
| GO:0042330 | 0.00000 | 3.34185 | 31 | 89 | 600 | taxis |
| GO:0010647 | 0.00000 | 2.23192 | 97 | 187 | 1854 | positive regulation of cell communication |
| GO:0023014 | 0.00000 | 2.94161 | 42 | 107 | 810 | signal transduction by protein phosphorylation |
| GO:0032268 | 0.00000 | 2.06012 | 130 | 231 | 2494 | regulation of cellular protein metabolic process |
| GO:0006935 | 0.00000 | 3.31464 | 31 | 88 | 597 | chemotaxis |
| GO:0046903 | 0.00000 | 2.51975 | 64 | 140 | 1227 | secretion |
| GO:0000165 | 0.00000 | 2.94630 | 41 | 105 | 793 | MAPK cascade |
| GO:0019221 | 0.00000 | 4.29567 | 18 | 63 | 341 | cytokine-mediated signaling pathway |
| GO:0006468 | 0.00000 | 2.22614 | 95 | 183 | 1815 | protein phosphorylation |
| GO:0009607 | 0.00000 | 2.52055 | 63 | 138 | 1208 | response to biotic stimulus |
| GO:0002699 | 0.00000 | 4.97090 | 13 | 54 | 259 | positive regulation of immune effector process |
| GO:0023056 | 0.00000 | 2.20778 | 97 | 186 | 1860 | positive regulation of signaling |
| GO:0071345 | 0.00000 | 2.78431 | 47 | 114 | 907 | cellular response to cytokine stimulus |
| GO:0051707 | 0.00000 | 2.54112 | 61 | 135 | 1172 | response to other organism |
| GO:0009967 | 0.00000 | 2.34430 | 78 | 160 | 1504 | positive regulation of signal transduction |
| GO:0043207 | 0.00000 | 2.53598 | 61 | 135 | 1174 | response to external biotic stimulus |
| GO:0030155 | 0.00000 | 3.08935 | 36 | 95 | 686 | regulation of cell adhesion |
| GO:0043067 | 0.00000 | 2.32103 | 80 | 162 | 1537 | regulation of programmed cell death |
| GO:0002697 | 0.00000 | 3.80176 | 22 | 70 | 420 | regulation of immune effector process |
| GO:0031399 | 0.00000 | 2.21221 | 92 | 177 | 1760 | regulation of protein modification process |
| GO:0031325 | 0.00000 | 1.90967 | 167 | 274 | 3201 | positive regulation of cellular metabolic process |
| GO:0002252 | 0.00000 | 2.76350 | 46 | 110 | 879 | immune effector process |
| GO:0042981 | 0.00000 | 2.30368 | 79 | 159 | 1516 | regulation of apoptotic process |
| GO:0012501 | 0.00000 | 2.15614 | 99 | 187 | 1908 | programmed cell death |
| GO:0035239 | 0.00000 | 2.73047 | 47 | 112 | 905 | tube morphogenesis |
| GO:0010648 | 0.00000 | 2.40356 | 68 | 143 | 1306 | negative regulation of cell communication |
| GO:0002237 | 0.00000 | 3.94977 | 20 | 65 | 377 | response to molecule of bacterial origin |
| GO:0007159 | 0.00000 | 4.29003 | 17 | 59 | 319 | leukocyte cell-cell adhesion |
| GO:0023057 | 0.00000 | 2.39486 | 68 | 143 | 1310 | negative regulation of signaling |
| GO:0032496 | 0.00000 | 4.03110 | 19 | 63 | 359 | response to lipopolysaccharide |
| GO:0032940 | 0.00000 | 2.54364 | 56 | 124 | 1070 | secretion by cell |
| GO:0045321 | 0.00000 | 2.60825 | 52 | 118 | 994 | leukocyte activation |
| GO:0035295 | 0.00000 | 2.50243 | 58 | 128 | 1122 | tube development |
| GO:0009968 | 0.00000 | 2.46277 | 61 | 132 | 1175 | negative regulation of signal transduction |
| GO:0051173 | 0.00000 | 1.89799 | 159 | 262 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0006915 | 0.00000 | 2.13668 | 97 | 182 | 1867 | apoptotic process |
| GO:0098609 | 0.00000 | 2.91665 | 38 | 95 | 720 | cell-cell adhesion |
| GO:1901700 | 0.00000 | 2.23081 | 83 | 162 | 1589 | response to oxygen-containing compound |
| GO:1903530 | 0.00000 | 2.75414 | 43 | 104 | 831 | regulation of secretion by cell |
| GO:0009617 | 0.00000 | 2.66290 | 47 | 110 | 907 | response to bacterium |
| GO:0043408 | 0.00000 | 2.87422 | 38 | 96 | 737 | regulation of MAPK cascade |
| GO:0033993 | 0.00000 | 2.75655 | 43 | 103 | 822 | response to lipid |
| GO:0002819 | 0.00000 | 5.27730 | 11 | 45 | 205 | regulation of adaptive immune response |
| GO:0051704 | 0.00000 | 1.98483 | 124 | 216 | 2389 | multi-organism process |
| GO:0050790 | 0.00000 | 2.12789 | 94 | 176 | 1807 | regulation of catalytic activity |
| GO:0051046 | 0.00000 | 2.61924 | 47 | 109 | 911 | regulation of secretion |
| GO:0048878 | 0.00000 | 2.39922 | 62 | 130 | 1182 | chemical homeostasis |
| GO:0048646 | 0.00000 | 2.41329 | 60 | 128 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0022407 | 0.00000 | 3.65936 | 21 | 64 | 395 | regulation of cell-cell adhesion |
| GO:1903037 | 0.00000 | 4.26482 | 15 | 53 | 287 | regulation of leukocyte cell-cell adhesion |
| GO:0002822 | 0.00000 | 5.35047 | 10 | 42 | 189 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0022409 | 0.00000 | 4.64733 | 13 | 48 | 242 | positive regulation of cell-cell adhesion |
| GO:0051050 | 0.00000 | 2.43754 | 56 | 121 | 1081 | positive regulation of transport |
| GO:0050865 | 0.00000 | 2.85409 | 36 | 90 | 693 | regulation of cell activation |
| GO:1990266 | 0.00000 | 7.15072 | 6 | 33 | 119 | neutrophil migration |
| GO:0050729 | 0.00000 | 6.33933 | 7 | 36 | 142 | positive regulation of inflammatory response |
| GO:0002521 | 0.00000 | 3.08198 | 30 | 79 | 567 | leukocyte differentiation |
| GO:0022008 | 0.00000 | 2.09067 | 93 | 171 | 1778 | neurogenesis |
| GO:2000147 | 0.00000 | 3.07246 | 29 | 78 | 561 | positive regulation of cell motility |
| GO:0016310 | 0.00000 | 1.98045 | 113 | 197 | 2166 | phosphorylation |
| GO:0048468 | 0.00000 | 1.93162 | 125 | 213 | 2406 | cell development |
| GO:1902533 | 0.00000 | 2.46661 | 52 | 114 | 1005 | positive regulation of intracellular signal transduction |
| GO:0002821 | 0.00000 | 6.05240 | 8 | 36 | 147 | positive regulation of adaptive immune response |
| GO:0060326 | 0.00000 | 4.05454 | 16 | 53 | 299 | cell chemotaxis |
| GO:0022603 | 0.00000 | 2.40069 | 56 | 119 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0051272 | 0.00000 | 3.00019 | 30 | 79 | 580 | positive regulation of cellular component movement |
| GO:0040017 | 0.00000 | 2.96807 | 31 | 80 | 593 | positive regulation of locomotion |
| GO:0002694 | 0.00000 | 2.85873 | 34 | 85 | 652 | regulation of leukocyte activation |
| GO:0002790 | 0.00000 | 2.85873 | 34 | 85 | 652 | peptide secretion |
| GO:0055065 | 0.00000 | 2.83838 | 35 | 86 | 664 | metal ion homeostasis |
| GO:0001934 | 0.00000 | 2.45917 | 52 | 112 | 989 | positive regulation of protein phosphorylation |
| GO:0048699 | 0.00000 | 2.09969 | 87 | 162 | 1672 | generation of neurons |
| GO:0050730 | 0.00000 | 4.30053 | 14 | 49 | 263 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0042327 | 0.00000 | 2.41271 | 54 | 116 | 1043 | positive regulation of phosphorylation |
| GO:0045087 | 0.00000 | 2.58349 | 44 | 100 | 842 | innate immune response |
| GO:0002520 | 0.00000 | 2.39645 | 54 | 114 | 1030 | immune system development |
| GO:0030593 | 0.00000 | 7.59095 | 5 | 29 | 100 | neutrophil chemotaxis |
| GO:0002526 | 0.00000 | 6.61901 | 6 | 32 | 122 | acute inflammatory response |
| GO:0010562 | 0.00000 | 2.33371 | 58 | 120 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 2.33371 | 58 | 120 | 1112 | positive regulation of phosphate metabolic process |
| GO:0051247 | 0.00000 | 2.08294 | 85 | 158 | 1639 | positive regulation of protein metabolic process |
| GO:0043269 | 0.00000 | 2.67583 | 38 | 90 | 732 | regulation of ion transport |
| GO:0002683 | 0.00000 | 3.17791 | 25 | 68 | 473 | negative regulation of immune system process |
| GO:0032270 | 0.00000 | 2.11327 | 80 | 150 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0002824 | 0.00000 | 5.97696 | 7 | 34 | 140 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0046631 | 0.00000 | 5.54966 | 8 | 36 | 157 | alpha-beta T cell activation |
| GO:0007399 | 0.00000 | 1.89465 | 122 | 204 | 2333 | nervous system development |
| GO:0050801 | 0.00000 | 2.56411 | 42 | 96 | 812 | ion homeostasis |
| GO:0030595 | 0.00000 | 4.64928 | 11 | 42 | 211 | leukocyte chemotaxis |
| GO:0031401 | 0.00000 | 2.24498 | 63 | 126 | 1210 | positive regulation of protein modification process |
| GO:0018108 | 0.00000 | 3.74624 | 17 | 53 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0002703 | 0.00000 | 4.22615 | 13 | 46 | 250 | regulation of leukocyte mediated immunity |
| GO:0030335 | 0.00000 | 2.96964 | 28 | 73 | 539 | positive regulation of cell migration |
| GO:0050731 | 0.00000 | 4.82265 | 10 | 40 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0055080 | 0.00000 | 2.63950 | 38 | 89 | 732 | cation homeostasis |
| GO:0006811 | 0.00000 | 2.07795 | 82 | 151 | 1565 | ion transport |
| GO:0002456 | 0.00000 | 5.90824 | 7 | 33 | 137 | T cell mediated immunity |
| GO:0018212 | 0.00000 | 3.70395 | 17 | 53 | 322 | peptidyl-tyrosine modification |
| GO:0030855 | 0.00000 | 2.78440 | 33 | 80 | 626 | epithelial cell differentiation |
| GO:0097529 | 0.00000 | 4.61728 | 11 | 41 | 207 | myeloid leukocyte migration |
| GO:0001944 | 0.00000 | 2.59256 | 39 | 90 | 752 | vasculature development |
| GO:0072358 | 0.00000 | 2.57555 | 40 | 91 | 765 | cardiovascular system development |
| GO:0048534 | 0.00000 | 2.37251 | 51 | 107 | 972 | hematopoietic or lymphoid organ development |
| GO:0030097 | 0.00000 | 2.41166 | 48 | 103 | 921 | hemopoiesis |
| GO:0001568 | 0.00000 | 2.62176 | 37 | 87 | 719 | blood vessel development |
| GO:0048514 | 0.00000 | 2.76273 | 32 | 79 | 622 | blood vessel morphogenesis |
| GO:0098771 | 0.00000 | 2.58156 | 39 | 89 | 746 | inorganic ion homeostasis |
| GO:1901564 | 0.00000 | 1.58228 | 325 | 437 | 6234 | organonitrogen compound metabolic process |
| GO:0002791 | 0.00000 | 2.93465 | 28 | 71 | 529 | regulation of peptide secretion |
| GO:0002705 | 0.00000 | 4.96534 | 9 | 37 | 176 | positive regulation of leukocyte mediated immunity |
| GO:1903039 | 0.00000 | 4.58428 | 11 | 40 | 203 | positive regulation of leukocyte cell-cell adhesion |
| GO:1902107 | 0.00000 | 5.08463 | 9 | 36 | 168 | positive regulation of leukocyte differentiation |
| GO:0002460 | 0.00000 | 3.14471 | 23 | 63 | 441 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032612 | 0.00000 | 6.83965 | 5 | 28 | 104 | interleukin-1 production |
| GO:0070371 | 0.00000 | 3.60380 | 17 | 52 | 323 | ERK1 and ERK2 cascade |
| GO:0006796 | 0.00000 | 1.76581 | 153 | 239 | 2933 | phosphate-containing compound metabolic process |
| GO:1990868 | 0.00000 | 9.05856 | 4 | 23 | 70 | response to chemokine |
| GO:1990869 | 0.00000 | 9.05856 | 4 | 23 | 70 | cellular response to chemokine |
| GO:0002250 | 0.00000 | 2.79822 | 30 | 75 | 583 | adaptive immune response |
| GO:0050663 | 0.00000 | 4.11693 | 13 | 44 | 244 | cytokine secretion |
| GO:0008285 | 0.00000 | 2.63823 | 35 | 83 | 681 | negative regulation of cell proliferation |
| GO:0050863 | 0.00000 | 3.69362 | 16 | 50 | 304 | regulation of T cell activation |
| GO:0032635 | 0.00000 | 5.13481 | 8 | 35 | 162 | interleukin-6 production |
| GO:0032102 | 0.00000 | 3.51845 | 18 | 53 | 336 | negative regulation of response to external stimulus |
| GO:0034341 | 0.00000 | 5.66956 | 7 | 32 | 137 | response to interferon-gamma |
| GO:0032652 | 0.00000 | 7.41708 | 5 | 26 | 91 | regulation of interleukin-1 production |
| GO:0097530 | 0.00000 | 5.43543 | 8 | 33 | 146 | granulocyte migration |
| GO:0072359 | 0.00000 | 2.21338 | 60 | 118 | 1143 | circulatory system development |
| GO:0071396 | 0.00000 | 2.72924 | 32 | 77 | 612 | cellular response to lipid |
| GO:0060548 | 0.00000 | 2.27006 | 55 | 111 | 1049 | negative regulation of cell death |
| GO:0030182 | 0.00000 | 2.05042 | 78 | 143 | 1494 | neuron differentiation |
| GO:0006793 | 0.00000 | 1.74951 | 154 | 239 | 2955 | phosphorus metabolic process |
| GO:0071219 | 0.00000 | 3.71734 | 15 | 48 | 290 | cellular response to molecule of bacterial origin |
| GO:0070098 | 0.00000 | 9.95429 | 3 | 21 | 60 | chemokine-mediated signaling pathway |
| GO:0070555 | 0.00000 | 7.08888 | 5 | 26 | 94 | response to interleukin-1 |
| GO:0032103 | 0.00000 | 3.57952 | 16 | 50 | 312 | positive regulation of response to external stimulus |
| GO:0001525 | 0.00000 | 2.88690 | 27 | 68 | 513 | angiogenesis |
| GO:0071216 | 0.00000 | 3.56575 | 16 | 50 | 313 | cellular response to biotic stimulus |
| GO:0045785 | 0.00000 | 3.15536 | 21 | 59 | 411 | positive regulation of cell adhesion |
| GO:0019882 | 0.00000 | 6.33746 | 6 | 28 | 110 | antigen processing and presentation |
| GO:1902105 | 0.00000 | 3.65623 | 15 | 48 | 294 | regulation of leukocyte differentiation |
| GO:0030001 | 0.00000 | 2.40535 | 44 | 94 | 839 | metal ion transport |
| GO:0002274 | 0.00000 | 4.26758 | 11 | 40 | 215 | myeloid leukocyte activation |
| GO:1903708 | 0.00000 | 4.30611 | 11 | 39 | 208 | positive regulation of hemopoiesis |
| GO:0009306 | 0.00000 | 2.67932 | 32 | 75 | 605 | protein secretion |
| GO:0072507 | 0.00000 | 2.83486 | 27 | 68 | 521 | divalent inorganic cation homeostasis |
| GO:0006812 | 0.00000 | 2.19280 | 57 | 113 | 1101 | cation transport |
| GO:0006875 | 0.00000 | 2.71334 | 30 | 73 | 582 | cellular metal ion homeostasis |
| GO:0070663 | 0.00000 | 4.00386 | 12 | 42 | 238 | regulation of leukocyte proliferation |
| GO:0050708 | 0.00000 | 2.88449 | 26 | 65 | 490 | regulation of protein secretion |
| GO:0006807 | 0.00000 | 1.50425 | 465 | 579 | 8923 | nitrogen compound metabolic process |
| GO:0042110 | 0.00000 | 2.87759 | 26 | 65 | 491 | T cell activation |
| GO:0052547 | 0.00000 | 3.09027 | 21 | 58 | 411 | regulation of peptidase activity |
| GO:0071621 | 0.00000 | 5.72758 | 6 | 29 | 123 | granulocyte chemotaxis |
| GO:0002711 | 0.00000 | 8.30329 | 4 | 22 | 71 | positive regulation of T cell mediated immunity |
| GO:0071222 | 0.00000 | 3.64775 | 15 | 46 | 282 | cellular response to lipopolysaccharide |
| GO:0045089 | 0.00000 | 4.00833 | 12 | 41 | 232 | positive regulation of innate immune response |
| GO:1903531 | 0.00000 | 4.00833 | 12 | 41 | 232 | negative regulation of secretion by cell |
| GO:0031343 | 0.00000 | 6.51233 | 5 | 26 | 100 | positive regulation of cell killing |
| GO:0050707 | 0.00000 | 4.18142 | 11 | 39 | 213 | regulation of cytokine secretion |
| GO:0009719 | 0.00000 | 2.02629 | 73 | 134 | 1409 | response to endogenous stimulus |
| GO:0002443 | 0.00000 | 2.82298 | 26 | 66 | 507 | leukocyte mediated immunity |
| GO:0043410 | 0.00000 | 2.79703 | 27 | 67 | 519 | positive regulation of MAPK cascade |
| GO:1903532 | 0.00000 | 2.90219 | 25 | 63 | 472 | positive regulation of secretion by cell |
| GO:0052548 | 0.00000 | 3.34392 | 18 | 51 | 337 | regulation of endopeptidase activity |
| GO:0043069 | 0.00000 | 2.27438 | 49 | 100 | 939 | negative regulation of programmed cell death |
| GO:0070372 | 0.00000 | 3.48425 | 16 | 48 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0002709 | 0.00000 | 6.71147 | 5 | 25 | 94 | regulation of T cell mediated immunity |
| GO:0050870 | 0.00000 | 4.44098 | 10 | 36 | 187 | positive regulation of T cell activation |
| GO:0045765 | 0.00000 | 3.47063 | 16 | 48 | 307 | regulation of angiogenesis |
| GO:0002573 | 0.00000 | 4.10998 | 11 | 39 | 216 | myeloid leukocyte differentiation |
| GO:1901342 | 0.00000 | 3.29719 | 18 | 51 | 341 | regulation of vasculature development |
| GO:0006810 | 0.00000 | 1.59646 | 229 | 322 | 4398 | transport |
| GO:0002708 | 0.00000 | 5.09735 | 8 | 31 | 144 | positive regulation of lymphocyte mediated immunity |
| GO:0043066 | 0.00000 | 2.26985 | 48 | 98 | 921 | negative regulation of apoptotic process |
| GO:0032675 | 0.00000 | 4.91627 | 8 | 32 | 153 | regulation of interleukin-6 production |
| GO:0045088 | 0.00000 | 3.54153 | 15 | 46 | 289 | regulation of innate immune response |
| GO:0051234 | 0.00000 | 1.58744 | 236 | 330 | 4538 | establishment of localization |
| GO:0051047 | 0.00000 | 2.74737 | 27 | 67 | 527 | positive regulation of secretion |
| GO:0046632 | 0.00000 | 5.88964 | 6 | 27 | 112 | alpha-beta T cell differentiation |
| GO:0048729 | 0.00000 | 2.50220 | 35 | 79 | 677 | tissue morphogenesis |
| GO:0031348 | 0.00000 | 4.01842 | 11 | 39 | 220 | negative regulation of defense response |
| GO:0035296 | 0.00000 | 4.55110 | 9 | 34 | 173 | regulation of tube diameter |
| GO:0050880 | 0.00000 | 4.55110 | 9 | 34 | 173 | regulation of blood vessel size |
| GO:0097746 | 0.00000 | 4.55110 | 9 | 34 | 173 | regulation of blood vessel diameter |
| GO:0030003 | 0.00000 | 2.54495 | 33 | 76 | 641 | cellular cation homeostasis |
| GO:0051048 | 0.00000 | 3.68495 | 14 | 43 | 261 | negative regulation of secretion |
| GO:0035150 | 0.00000 | 4.51838 | 9 | 34 | 174 | regulation of tube size |
| GO:0008152 | 0.00000 | 1.47940 | 546 | 658 | 10485 | metabolic process |
| GO:0072503 | 0.00000 | 2.78417 | 26 | 64 | 497 | cellular divalent inorganic cation homeostasis |
| GO:0019932 | 0.00000 | 2.95408 | 22 | 58 | 427 | second-messenger-mediated signaling |
| GO:0051093 | 0.00000 | 2.14529 | 56 | 108 | 1070 | negative regulation of developmental process |
| GO:0090087 | 0.00000 | 2.39562 | 39 | 84 | 749 | regulation of peptide transport |
| GO:1903706 | 0.00000 | 2.99578 | 21 | 56 | 407 | regulation of hemopoiesis |
| GO:0071704 | 0.00000 | 1.47487 | 521 | 632 | 10008 | organic substance metabolic process |
| GO:0045859 | 0.00000 | 2.49016 | 34 | 77 | 662 | regulation of protein kinase activity |
| GO:0050670 | 0.00000 | 3.90950 | 12 | 39 | 225 | regulation of lymphocyte proliferation |
| GO:0044093 | 0.00000 | 1.97474 | 74 | 133 | 1429 | positive regulation of molecular function |
| GO:0032944 | 0.00000 | 3.86755 | 12 | 39 | 227 | regulation of mononuclear cell proliferation |
| GO:0006873 | 0.00000 | 2.48179 | 34 | 76 | 655 | cellular ion homeostasis |
| GO:0001912 | 0.00000 | 6.75304 | 4 | 23 | 86 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0032611 | 0.00000 | 6.75304 | 4 | 23 | 86 | interleukin-1 beta production |
| GO:0044237 | 0.00000 | 1.46974 | 488 | 597 | 9374 | cellular metabolic process |
| GO:0001818 | 0.00000 | 3.61290 | 13 | 42 | 259 | negative regulation of cytokine production |
| GO:0010942 | 0.00000 | 2.42704 | 36 | 79 | 695 | positive regulation of cell death |
| GO:0051172 | 0.00000 | 1.76071 | 118 | 188 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0044057 | 0.00000 | 2.55217 | 31 | 71 | 596 | regulation of system process |
| GO:0010628 | 0.00000 | 1.81055 | 103 | 169 | 1981 | positive regulation of gene expression |
| GO:0031324 | 0.00000 | 1.72957 | 128 | 199 | 2449 | negative regulation of cellular metabolic process |
| GO:0046634 | 0.00000 | 5.85924 | 5 | 25 | 104 | regulation of alpha-beta T cell activation |
| GO:0060284 | 0.00000 | 2.09291 | 57 | 108 | 1093 | regulation of cell development |
| GO:0003018 | 0.00000 | 4.01256 | 11 | 36 | 203 | vascular process in circulatory system |
| GO:0032651 | 0.00000 | 7.32018 | 4 | 21 | 74 | regulation of interleukin-1 beta production |
| GO:0070661 | 0.00000 | 3.17280 | 17 | 48 | 331 | leukocyte proliferation |
| GO:0006979 | 0.00000 | 2.92613 | 21 | 54 | 400 | response to oxidative stress |
| GO:0009636 | 0.00000 | 3.10811 | 18 | 49 | 344 | response to toxic substance |
| GO:0042092 | 0.00000 | 12.55082 | 2 | 15 | 37 | type 2 immune response |
| GO:0050673 | 0.00000 | 2.84727 | 22 | 56 | 425 | epithelial cell proliferation |
| GO:0032755 | 0.00000 | 5.92095 | 5 | 24 | 99 | positive regulation of interleukin-6 production |
| GO:0001916 | 0.00000 | 9.79113 | 3 | 17 | 49 | positive regulation of T cell mediated cytotoxicity |
| GO:1901701 | 0.00000 | 2.01470 | 63 | 115 | 1206 | cellular response to oxygen-containing compound |
| GO:0009892 | 0.00000 | 1.66312 | 148 | 222 | 2843 | negative regulation of metabolic process |
| GO:0070201 | 0.00000 | 2.32555 | 39 | 81 | 740 | regulation of establishment of protein localization |
| GO:0032602 | 0.00000 | 6.16414 | 5 | 23 | 92 | chemokine production |
| GO:0035710 | 0.00000 | 5.84277 | 5 | 24 | 100 | CD4-positive, alpha-beta T cell activation |
| GO:0071347 | 0.00000 | 6.92708 | 4 | 21 | 77 | cellular response to interleukin-1 |
| GO:0032722 | 0.00000 | 7.96759 | 3 | 19 | 63 | positive regulation of chemokine production |
| GO:0051248 | 0.00000 | 2.07327 | 56 | 105 | 1070 | negative regulation of protein metabolic process |
| GO:0002685 | 0.00000 | 3.92144 | 10 | 35 | 201 | regulation of leukocyte migration |
| GO:0051223 | 0.00000 | 2.33946 | 37 | 78 | 708 | regulation of protein transport |
| GO:0010035 | 0.00000 | 2.65298 | 26 | 61 | 493 | response to inorganic substance |
| GO:0044260 | 0.00000 | 1.46394 | 370 | 468 | 7099 | cellular macromolecule metabolic process |
| GO:0030099 | 0.00000 | 2.85271 | 21 | 53 | 401 | myeloid cell differentiation |
| GO:0072593 | 0.00000 | 3.27479 | 15 | 43 | 288 | reactive oxygen species metabolic process |
| GO:0019725 | 0.00000 | 2.13435 | 48 | 94 | 930 | cellular homeostasis |
| GO:0002706 | 0.00000 | 3.92525 | 10 | 34 | 195 | regulation of lymphocyte mediated immunity |
| GO:0043549 | 0.00000 | 2.30008 | 38 | 79 | 728 | regulation of kinase activity |
| GO:0032642 | 0.00000 | 6.15979 | 5 | 22 | 88 | regulation of chemokine production |
| GO:0009891 | 0.00000 | 1.77027 | 101 | 163 | 1943 | positive regulation of biosynthetic process |
| GO:0032609 | 0.00000 | 5.01488 | 6 | 26 | 122 | interferon-gamma production |
| GO:0031341 | 0.00000 | 4.80947 | 7 | 27 | 131 | regulation of cell killing |
| GO:0072676 | 0.00000 | 5.74633 | 5 | 23 | 97 | lymphocyte migration |
| GO:0051051 | 0.00000 | 2.52761 | 28 | 64 | 540 | negative regulation of transport |
| GO:0044092 | 0.00000 | 2.07426 | 52 | 99 | 1006 | negative regulation of molecular function |
| GO:0046649 | 0.00000 | 2.18501 | 44 | 87 | 841 | lymphocyte activation |
| GO:0070374 | 0.00000 | 3.67932 | 11 | 36 | 218 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002830 | 0.00000 | 30.57409 | 1 | 10 | 16 | positive regulation of type 2 immune response |
| GO:0001906 | 0.00000 | 4.04191 | 9 | 32 | 179 | cell killing |
| GO:0050704 | 0.00000 | 9.50491 | 2 | 16 | 47 | regulation of interleukin-1 secretion |
| GO:0071346 | 0.00000 | 5.14053 | 6 | 25 | 115 | cellular response to interferon-gamma |
| GO:0001914 | 0.00000 | 8.46608 | 3 | 17 | 54 | regulation of T cell mediated cytotoxicity |
| GO:0007167 | 0.00000 | 2.13147 | 46 | 90 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0031328 | 0.00000 | 1.75888 | 99 | 159 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0001913 | 0.00000 | 6.59167 | 4 | 20 | 76 | T cell mediated cytotoxicity |
| GO:0050867 | 0.00000 | 2.64505 | 24 | 57 | 461 | positive regulation of cell activation |
| GO:0002449 | 0.00000 | 2.72580 | 22 | 54 | 425 | lymphocyte mediated immunity |
| GO:0019883 | 0.00000 | 10.22427 | 2 | 15 | 42 | antigen processing and presentation of endogenous antigen |
| GO:0032653 | 0.00000 | 8.24291 | 3 | 17 | 55 | regulation of interleukin-10 production |
| GO:0050701 | 0.00000 | 8.24291 | 3 | 17 | 55 | interleukin-1 secretion |
| GO:0001910 | 0.00000 | 5.22198 | 6 | 24 | 109 | regulation of leukocyte mediated cytotoxicity |
| GO:0032649 | 0.00000 | 5.22198 | 6 | 24 | 109 | regulation of interferon-gamma production |
| GO:0043900 | 0.00000 | 2.80583 | 20 | 51 | 391 | regulation of multi-organism process |
| GO:0060759 | 0.00000 | 4.97403 | 6 | 25 | 118 | regulation of response to cytokine stimulus |
| GO:1901214 | 0.00000 | 2.87109 | 19 | 49 | 368 | regulation of neuron death |
| GO:0043086 | 0.00000 | 2.29406 | 36 | 74 | 682 | negative regulation of catalytic activity |
| GO:0034599 | 0.00000 | 3.26760 | 14 | 40 | 268 | cellular response to oxidative stress |
| GO:0044238 | 0.00000 | 1.42053 | 492 | 591 | 9443 | primary metabolic process |
| GO:0030217 | 0.00000 | 3.25318 | 14 | 40 | 269 | T cell differentiation |
| GO:0051249 | 0.00000 | 2.44869 | 29 | 64 | 555 | regulation of lymphocyte activation |
| GO:0051336 | 0.00000 | 2.04835 | 51 | 96 | 985 | regulation of hydrolase activity |
| GO:0045582 | 0.00000 | 5.56734 | 5 | 22 | 95 | positive regulation of T cell differentiation |
| GO:0002486 | 0.00000 | 12.57551 | 2 | 13 | 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
| GO:0032269 | 0.00000 | 2.03104 | 52 | 97 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0003013 | 0.00000 | 2.53756 | 26 | 59 | 495 | circulatory system process |
| GO:0050777 | 0.00000 | 4.16692 | 8 | 29 | 158 | negative regulation of immune response |
| GO:0002696 | 0.00000 | 2.63412 | 23 | 55 | 446 | positive regulation of leukocyte activation |
| GO:0055082 | 0.00000 | 2.15702 | 42 | 83 | 810 | cellular chemical homeostasis |
| GO:0002475 | 0.00000 | 10.72796 | 2 | 14 | 38 | antigen processing and presentation via MHC class Ib |
| GO:0009887 | 0.00000 | 1.98278 | 57 | 103 | 1090 | animal organ morphogenesis |
| GO:0050728 | 0.00000 | 4.28716 | 8 | 28 | 149 | negative regulation of inflammatory response |
| GO:0008015 | 0.00000 | 2.55208 | 25 | 58 | 484 | blood circulation |
| GO:0090066 | 0.00000 | 2.41845 | 29 | 64 | 561 | regulation of anatomical structure size |
| GO:0002793 | 0.00000 | 2.93531 | 17 | 45 | 331 | positive regulation of peptide secretion |
| GO:0071706 | 0.00000 | 3.97328 | 9 | 30 | 170 | tumor necrosis factor superfamily cytokine production |
| GO:0045944 | 0.00000 | 1.91427 | 64 | 112 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0010605 | 0.00000 | 1.63104 | 135 | 200 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0031326 | 0.00000 | 1.55355 | 181 | 254 | 3470 | regulation of cellular biosynthetic process |
| GO:0043367 | 0.00000 | 6.04999 | 4 | 20 | 81 | CD4-positive, alpha-beta T cell differentiation |
| GO:0002476 | 0.00000 | 11.94620 | 2 | 13 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
| GO:0002484 | 0.00000 | 11.94620 | 2 | 13 | 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway |
| GO:0002483 | 0.00000 | 10.29838 | 2 | 14 | 39 | antigen processing and presentation of endogenous peptide antigen |
| GO:0019885 | 0.00000 | 10.29838 | 2 | 14 | 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I |
| GO:0010468 | 0.00000 | 1.52778 | 201 | 277 | 3860 | regulation of gene expression |
| GO:0009889 | 0.00000 | 1.54622 | 185 | 258 | 3542 | regulation of biosynthetic process |
| GO:0048247 | 0.00000 | 8.18292 | 3 | 16 | 52 | lymphocyte chemotaxis |
| GO:0006749 | 0.00000 | 7.45652 | 3 | 17 | 59 | glutathione metabolic process |
| GO:0032613 | 0.00000 | 7.45652 | 3 | 17 | 59 | interleukin-10 production |
| GO:0002009 | 0.00000 | 2.41335 | 29 | 63 | 553 | morphogenesis of an epithelium |
| GO:1901215 | 0.00000 | 3.32384 | 13 | 37 | 244 | negative regulation of neuron death |
| GO:0070997 | 0.00000 | 2.69312 | 21 | 51 | 405 | neuron death |
| GO:0001667 | 0.00000 | 2.68541 | 21 | 51 | 406 | ameboidal-type cell migration |
| GO:0001959 | 0.00000 | 5.00018 | 6 | 23 | 108 | regulation of cytokine-mediated signaling pathway |
| GO:0045621 | 0.00000 | 5.00018 | 6 | 23 | 108 | positive regulation of lymphocyte differentiation |
| GO:0048666 | 0.00000 | 1.90084 | 64 | 111 | 1222 | neuron development |
| GO:0002428 | 0.00000 | 11.37681 | 2 | 13 | 34 | antigen processing and presentation of peptide antigen via MHC class Ib |
| GO:0071495 | 0.00000 | 1.89904 | 64 | 111 | 1223 | cellular response to endogenous stimulus |
| GO:0030162 | 0.00000 | 2.20390 | 37 | 75 | 716 | regulation of proteolysis |
| GO:0006575 | 0.00000 | 3.86221 | 9 | 30 | 174 | cellular modified amino acid metabolic process |
| GO:0002366 | 0.00000 | 3.15522 | 14 | 39 | 269 | leukocyte activation involved in immune response |
| GO:0048002 | 0.00000 | 6.63506 | 4 | 18 | 68 | antigen processing and presentation of peptide antigen |
| GO:0045766 | 0.00000 | 3.73325 | 10 | 31 | 185 | positive regulation of angiogenesis |
| GO:0006874 | 0.00000 | 2.51394 | 25 | 56 | 473 | cellular calcium ion homeostasis |
| GO:1903555 | 0.00000 | 3.92216 | 9 | 29 | 166 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0050767 | 0.00000 | 2.01495 | 50 | 92 | 956 | regulation of neurogenesis |
| GO:0006953 | 0.00000 | 9.53467 | 2 | 14 | 41 | acute-phase response |
| GO:0051960 | 0.00000 | 1.95294 | 56 | 100 | 1071 | regulation of nervous system development |
| GO:0046635 | 0.00000 | 6.50467 | 4 | 18 | 69 | positive regulation of alpha-beta T cell activation |
| GO:0051338 | 0.00000 | 2.09150 | 43 | 83 | 832 | regulation of transferase activity |
| GO:0043405 | 0.00000 | 3.00543 | 15 | 41 | 295 | regulation of MAP kinase activity |
| GO:0007162 | 0.00000 | 3.05109 | 15 | 40 | 284 | negative regulation of cell adhesion |
| GO:0002253 | 0.00000 | 2.41318 | 27 | 60 | 526 | activation of immune response |
| GO:0002263 | 0.00000 | 3.10071 | 14 | 39 | 273 | cell activation involved in immune response |
| GO:0042088 | 0.00000 | 8.36303 | 3 | 15 | 48 | T-helper 1 type immune response |
| GO:0055074 | 0.00000 | 2.47041 | 25 | 57 | 489 | calcium ion homeostasis |
| GO:0002548 | 0.00000 | 7.55243 | 3 | 16 | 55 | monocyte chemotaxis |
| GO:0010951 | 0.00000 | 3.75713 | 9 | 30 | 178 | negative regulation of endopeptidase activity |
| GO:0043524 | 0.00000 | 3.75713 | 9 | 30 | 178 | negative regulation of neuron apoptotic process |
| GO:0043065 | 0.00000 | 2.26521 | 33 | 68 | 632 | positive regulation of apoptotic process |
| GO:2001141 | 0.00000 | 1.58453 | 146 | 211 | 2801 | regulation of RNA biosynthetic process |
| GO:0010466 | 0.00000 | 3.24709 | 13 | 36 | 242 | negative regulation of peptidase activity |
| GO:0045580 | 0.00000 | 4.06302 | 8 | 27 | 150 | regulation of T cell differentiation |
| GO:0050678 | 0.00000 | 2.74956 | 19 | 46 | 358 | regulation of epithelial cell proliferation |
| GO:0043068 | 0.00000 | 2.24478 | 33 | 68 | 637 | positive regulation of programmed cell death |
| GO:0001909 | 0.00000 | 4.18270 | 7 | 26 | 141 | leukocyte mediated cytotoxicity |
| GO:0030098 | 0.00000 | 2.64375 | 21 | 49 | 395 | lymphocyte differentiation |
| GO:0009611 | 0.00000 | 2.43589 | 26 | 57 | 495 | response to wounding |
| GO:0002695 | 0.00000 | 3.65759 | 9 | 30 | 182 | negative regulation of leukocyte activation |
| GO:0045619 | 0.00000 | 3.65759 | 9 | 30 | 182 | regulation of lymphocyte differentiation |
| GO:0050866 | 0.00000 | 3.47081 | 11 | 32 | 203 | negative regulation of cell activation |
| GO:0007417 | 0.00000 | 2.02423 | 46 | 86 | 888 | central nervous system development |
| GO:0002828 | 0.00000 | 11.59847 | 2 | 12 | 31 | regulation of type 2 immune response |
| GO:0051480 | 0.00000 | 2.68092 | 19 | 47 | 374 | regulation of cytosolic calcium ion concentration |
| GO:1904018 | 0.00000 | 3.45048 | 11 | 32 | 204 | positive regulation of vasculature development |
| GO:0002293 | 0.00000 | 6.52267 | 3 | 17 | 65 | alpha-beta T cell differentiation involved in immune response |
| GO:0010557 | 0.00000 | 1.70501 | 94 | 147 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0002687 | 0.00000 | 4.07581 | 8 | 26 | 144 | positive regulation of leukocyte migration |
| GO:0032680 | 0.00000 | 3.81170 | 9 | 28 | 164 | regulation of tumor necrosis factor production |
| GO:0042493 | 0.00000 | 2.00863 | 47 | 86 | 894 | response to drug |
| GO:0070665 | 0.00000 | 4.04137 | 8 | 26 | 145 | positive regulation of leukocyte proliferation |
| GO:0002287 | 0.00000 | 6.38926 | 3 | 17 | 66 | alpha-beta T cell activation involved in immune response |
| GO:0071900 | 0.00000 | 2.53297 | 22 | 51 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0001562 | 0.00000 | 9.55478 | 2 | 13 | 38 | response to protozoan |
| GO:0006355 | 0.00000 | 1.56691 | 145 | 208 | 2784 | regulation of transcription, DNA-templated |
| GO:0050671 | 0.00000 | 4.16400 | 7 | 25 | 136 | positive regulation of lymphocyte proliferation |
| GO:0045596 | 0.00000 | 2.06637 | 42 | 79 | 799 | negative regulation of cell differentiation |
| GO:0046651 | 0.00000 | 2.85739 | 16 | 41 | 308 | lymphocyte proliferation |
| GO:0050710 | 0.00000 | 6.26119 | 3 | 17 | 67 | negative regulation of cytokine secretion |
| GO:1903506 | 0.00000 | 1.56142 | 145 | 208 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0045893 | 0.00000 | 1.74829 | 80 | 129 | 1536 | positive regulation of transcription, DNA-templated |
| GO:0032640 | 0.00000 | 3.72892 | 9 | 28 | 167 | tumor necrosis factor production |
| GO:0032943 | 0.00000 | 2.83588 | 16 | 41 | 310 | mononuclear cell proliferation |
| GO:0032946 | 0.00000 | 4.08993 | 7 | 25 | 138 | positive regulation of mononuclear cell proliferation |
| GO:0002700 | 0.00000 | 3.94145 | 8 | 26 | 148 | regulation of production of molecular mediator of immune response |
| GO:1903508 | 0.00000 | 1.74299 | 80 | 129 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 0.00000 | 1.74167 | 80 | 129 | 1541 | positive regulation of RNA biosynthetic process |
| GO:0051090 | 0.00000 | 2.57246 | 21 | 48 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0001505 | 0.00000 | 2.62978 | 19 | 46 | 372 | regulation of neurotransmitter levels |
| GO:0034612 | 0.00000 | 3.58011 | 9 | 29 | 179 | response to tumor necrosis factor |
| GO:2000377 | 0.00000 | 3.39956 | 10 | 31 | 200 | regulation of reactive oxygen species metabolic process |
| GO:0034220 | 0.00000 | 1.99428 | 46 | 84 | 878 | ion transmembrane transport |
| GO:0051091 | 0.00000 | 3.10850 | 13 | 35 | 244 | positive regulation of DNA-binding transcription factor activity |
| GO:0002367 | 0.00000 | 4.78364 | 5 | 21 | 102 | cytokine production involved in immune response |
| GO:0043085 | 0.00000 | 1.90083 | 55 | 96 | 1051 | positive regulation of catalytic activity |
| GO:0051222 | 0.00000 | 2.47928 | 23 | 51 | 435 | positive regulation of protein transport |
| GO:0000302 | 0.00000 | 3.37941 | 10 | 31 | 201 | response to reactive oxygen species |
| GO:0050714 | 0.00000 | 2.83912 | 16 | 40 | 302 | positive regulation of protein secretion |
| GO:0042129 | 0.00000 | 3.64964 | 9 | 28 | 170 | regulation of T cell proliferation |
| GO:0048608 | 0.00000 | 2.44576 | 23 | 52 | 449 | reproductive structure development |
| GO:0050706 | 0.00000 | 8.84622 | 2 | 13 | 40 | regulation of interleukin-1 beta secretion |
| GO:0043062 | 0.00000 | 2.78349 | 16 | 41 | 315 | extracellular structure organization |
| GO:0050702 | 0.00000 | 7.79896 | 2 | 14 | 47 | interleukin-1 beta secretion |
| GO:0010556 | 0.00000 | 1.50973 | 172 | 238 | 3311 | regulation of macromolecule biosynthetic process |
| GO:0042832 | 0.00000 | 10.01549 | 2 | 12 | 34 | defense response to protozoan |
| GO:0042326 | 0.00000 | 2.42708 | 24 | 52 | 452 | negative regulation of phosphorylation |
| GO:0098655 | 0.00000 | 2.11939 | 36 | 70 | 690 | cation transmembrane transport |
| GO:0061458 | 0.00000 | 2.42091 | 24 | 52 | 453 | reproductive system development |
| GO:0030198 | 0.00000 | 2.93668 | 14 | 37 | 271 | extracellular matrix organization |
| GO:0032655 | 0.00000 | 6.89730 | 3 | 15 | 55 | regulation of interleukin-12 production |
| GO:0018130 | 0.00000 | 1.49936 | 176 | 241 | 3374 | heterocycle biosynthetic process |
| GO:0042093 | 0.00000 | 6.26463 | 3 | 16 | 63 | T-helper cell differentiation |
| GO:0019538 | 0.00000 | 1.41747 | 278 | 355 | 5344 | protein metabolic process |
| GO:0002292 | 0.00000 | 5.79634 | 4 | 17 | 71 | T cell differentiation involved in immune response |
| GO:0051254 | 0.00000 | 1.69879 | 85 | 134 | 1638 | positive regulation of RNA metabolic process |
| GO:0040013 | 0.00000 | 2.69439 | 17 | 42 | 332 | negative regulation of locomotion |
| GO:0032880 | 0.00000 | 1.88052 | 54 | 94 | 1038 | regulation of protein localization |
| GO:0051252 | 0.00000 | 1.51651 | 159 | 221 | 3049 | regulation of RNA metabolic process |
| GO:0002294 | 0.00000 | 6.13384 | 3 | 16 | 64 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0002763 | 0.00000 | 6.13384 | 3 | 16 | 64 | positive regulation of myeloid leukocyte differentiation |
| GO:0097755 | 0.00000 | 5.69070 | 4 | 17 | 72 | positive regulation of blood vessel diameter |
| GO:0002474 | 0.00000 | 7.35264 | 3 | 14 | 49 | antigen processing and presentation of peptide antigen via MHC class I |
| GO:0046638 | 0.00000 | 7.35264 | 3 | 14 | 49 | positive regulation of alpha-beta T cell differentiation |
| GO:0001933 | 0.00000 | 2.48533 | 21 | 48 | 408 | negative regulation of protein phosphorylation |
| GO:0019438 | 0.00000 | 1.49269 | 176 | 241 | 3386 | aromatic compound biosynthetic process |
| GO:0070838 | 0.00000 | 2.36154 | 25 | 53 | 472 | divalent metal ion transport |
| GO:0010959 | 0.00000 | 2.45602 | 22 | 49 | 421 | regulation of metal ion transport |
| GO:0043523 | 0.00000 | 2.93081 | 14 | 36 | 264 | regulation of neuron apoptotic process |
| GO:0007610 | 0.00000 | 2.06046 | 38 | 72 | 728 | behavior |
| GO:0048871 | 0.00000 | 2.33431 | 25 | 54 | 486 | multicellular organismal homeostasis |
| GO:0042060 | 0.00000 | 2.59179 | 19 | 44 | 360 | wound healing |
| GO:0072677 | 0.00000 | 13.09842 | 1 | 10 | 24 | eosinophil migration |
| GO:1901362 | 0.00000 | 1.48249 | 183 | 248 | 3510 | organic cyclic compound biosynthetic process |
| GO:0032735 | 0.00000 | 9.18003 | 2 | 12 | 36 | positive regulation of interleukin-12 production |
| GO:0045123 | 0.00000 | 6.00838 | 3 | 16 | 65 | cellular extravasation |
| GO:0072511 | 0.00000 | 2.34443 | 25 | 53 | 475 | divalent inorganic cation transport |
| GO:0002825 | 0.00000 | 10.62306 | 2 | 11 | 30 | regulation of T-helper 1 type immune response |
| GO:0033003 | 0.00000 | 7.14807 | 3 | 14 | 50 | regulation of mast cell activation |
| GO:0032774 | 0.00000 | 1.52098 | 151 | 211 | 2896 | RNA biosynthetic process |
| GO:0032963 | 0.00000 | 4.40172 | 6 | 21 | 109 | collagen metabolic process |
| GO:0032615 | 0.00000 | 6.41522 | 3 | 15 | 58 | interleukin-12 production |
| GO:0071674 | 0.00000 | 5.10041 | 4 | 18 | 83 | mononuclear cell migration |
| GO:0043170 | 0.00000 | 1.35794 | 442 | 526 | 8488 | macromolecule metabolic process |
| GO:0060760 | 0.00000 | 6.95456 | 3 | 14 | 51 | positive regulation of response to cytokine stimulus |
| GO:0051128 | 0.00000 | 1.54591 | 133 | 190 | 2558 | regulation of cellular component organization |
| GO:1904951 | 0.00000 | 2.36032 | 24 | 51 | 454 | positive regulation of establishment of protein localization |
| GO:0045935 | 0.00000 | 1.63994 | 95 | 145 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0040007 | 0.00000 | 1.83192 | 57 | 97 | 1097 | growth |
| GO:0050920 | 0.00000 | 3.15486 | 11 | 31 | 213 | regulation of chemotaxis |
| GO:0001890 | 0.00000 | 3.49157 | 9 | 27 | 170 | placenta development |
| GO:0050878 | 0.00000 | 2.60338 | 18 | 42 | 342 | regulation of body fluid levels |
| GO:0034654 | 0.00000 | 1.48499 | 172 | 235 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0009725 | 0.00000 | 2.05992 | 36 | 69 | 697 | response to hormone |
| GO:0050715 | 0.00000 | 3.69527 | 8 | 25 | 150 | positive regulation of cytokine secretion |
| GO:0002673 | 0.00000 | 5.77223 | 3 | 16 | 67 | regulation of acute inflammatory response |
| GO:0030030 | 0.00000 | 1.68569 | 82 | 128 | 1572 | cell projection organization |
| GO:0120036 | 0.00000 | 1.69555 | 79 | 125 | 1526 | plasma membrane bounded cell projection organization |
| GO:0042116 | 0.00000 | 4.73101 | 5 | 19 | 93 | macrophage activation |
| GO:2000116 | 0.00000 | 3.05610 | 12 | 32 | 226 | regulation of cysteine-type endopeptidase activity |
| GO:0007249 | 0.00000 | 3.27239 | 10 | 29 | 193 | I-kappaB kinase/NF-kappaB signaling |
| GO:0048771 | 0.00000 | 3.27239 | 10 | 29 | 193 | tissue remodeling |
| GO:1903038 | 0.00000 | 3.93120 | 7 | 23 | 131 | negative regulation of leukocyte cell-cell adhesion |
| GO:0090130 | 0.00000 | 2.78046 | 15 | 37 | 284 | tissue migration |
| GO:0019229 | 0.00000 | 5.30392 | 4 | 17 | 76 | regulation of vasoconstriction |
| GO:0071356 | 0.00000 | 3.53345 | 8 | 26 | 162 | cellular response to tumor necrosis factor |
| GO:0046637 | 0.00000 | 5.66097 | 4 | 16 | 68 | regulation of alpha-beta T cell differentiation |
| GO:0042098 | 0.00000 | 3.17354 | 11 | 30 | 205 | T cell proliferation |
| GO:0051250 | 0.00000 | 3.63674 | 8 | 25 | 152 | negative regulation of lymphocyte activation |
| GO:0015850 | 0.00000 | 2.96890 | 12 | 33 | 239 | organic hydroxy compound transport |
| GO:0016043 | 0.00000 | 1.38061 | 317 | 393 | 6083 | cellular component organization |
| GO:0043270 | 0.00000 | 2.63534 | 17 | 40 | 322 | positive regulation of ion transport |
| GO:0007267 | 0.00000 | 1.67190 | 83 | 129 | 1596 | cell-cell signaling |
| GO:0032729 | 0.00000 | 5.21528 | 4 | 17 | 77 | positive regulation of interferon-gamma production |
| GO:1902532 | 0.00000 | 2.22015 | 27 | 56 | 527 | negative regulation of intracellular signal transduction |
| GO:0006351 | 0.00000 | 1.50636 | 150 | 208 | 2875 | transcription, DNA-templated |
| GO:0045576 | 0.00000 | 5.55391 | 4 | 16 | 69 | mast cell activation |
| GO:0070427 | 0.00000 | Inf | 0 | 5 | 5 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0002218 | 0.00000 | 3.48192 | 9 | 26 | 164 | activation of innate immune response |
| GO:0009790 | 0.00000 | 1.76323 | 64 | 105 | 1231 | embryo development |
| GO:0098754 | 0.00000 | 7.23584 | 2 | 13 | 46 | detoxification |
| GO:0051962 | 0.00000 | 2.07638 | 34 | 65 | 651 | positive regulation of nervous system development |
| GO:0006937 | 0.00000 | 3.58003 | 8 | 25 | 154 | regulation of muscle contraction |
| GO:0071248 | 0.00000 | 3.58003 | 8 | 25 | 154 | cellular response to metal ion |
| GO:0043491 | 0.00000 | 3.27766 | 10 | 28 | 186 | protein kinase B signaling |
| GO:0097659 | 0.00000 | 1.50123 | 150 | 208 | 2883 | nucleic acid-templated transcription |
| GO:0034765 | 0.00000 | 2.27620 | 25 | 52 | 478 | regulation of ion transmembrane transport |
| GO:0098662 | 0.00000 | 2.10428 | 32 | 62 | 613 | inorganic cation transmembrane transport |
| GO:0002761 | 0.00000 | 3.94039 | 7 | 22 | 125 | regulation of myeloid leukocyte differentiation |
| GO:0042107 | 0.00000 | 3.94039 | 7 | 22 | 125 | cytokine metabolic process |
| GO:0010563 | 0.00000 | 2.17668 | 28 | 57 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00000 | 2.17668 | 28 | 57 | 546 | negative regulation of phosphate metabolic process |
| GO:0050679 | 0.00000 | 3.15603 | 10 | 29 | 199 | positive regulation of epithelial cell proliferation |
| GO:0030336 | 0.00000 | 2.78524 | 14 | 35 | 268 | negative regulation of cell migration |
| GO:0051271 | 0.00000 | 2.61420 | 16 | 39 | 316 | negative regulation of cellular component movement |
| GO:0055076 | 0.00000 | 3.90232 | 7 | 22 | 126 | transition metal ion homeostasis |
| GO:0038061 | 0.00000 | 4.23692 | 6 | 20 | 107 | NIK/NF-kappaB signaling |
| GO:0097756 | 0.00000 | 4.23692 | 6 | 20 | 107 | negative regulation of blood vessel diameter |
| GO:0006357 | 0.00000 | 1.58753 | 104 | 153 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0051186 | 0.00000 | 2.21395 | 27 | 54 | 509 | cofactor metabolic process |
| GO:2000146 | 0.00000 | 2.72532 | 15 | 36 | 281 | negative regulation of cell motility |
| GO:0030856 | 0.00000 | 3.60243 | 8 | 24 | 147 | regulation of epithelial cell differentiation |
| GO:0023061 | 0.00000 | 2.19288 | 27 | 55 | 523 | signal release |
| GO:0043281 | 0.00000 | 3.11904 | 10 | 29 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0090132 | 0.00000 | 2.71412 | 15 | 36 | 282 | epithelium migration |
| GO:0032731 | 0.00000 | 6.82174 | 3 | 13 | 48 | positive regulation of interleukin-1 beta production |
| GO:0001503 | 0.00000 | 2.42793 | 20 | 44 | 381 | ossification |
| GO:0051952 | 0.00000 | 3.99167 | 6 | 21 | 118 | regulation of amine transport |
| GO:0032732 | 0.00000 | 6.12524 | 3 | 14 | 56 | positive regulation of interleukin-1 production |
| GO:0042226 | 0.00000 | 10.18580 | 1 | 10 | 28 | interleukin-6 biosynthetic process |
| GO:0000902 | 0.00000 | 1.78159 | 57 | 95 | 1100 | cell morphogenesis |
| GO:0045637 | 0.00000 | 3.00062 | 11 | 30 | 215 | regulation of myeloid cell differentiation |
| GO:0007188 | 0.00000 | 3.06515 | 11 | 29 | 204 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0002718 | 0.00000 | 4.81301 | 4 | 17 | 82 | regulation of cytokine production involved in immune response |
| GO:0019219 | 0.00000 | 1.45347 | 175 | 234 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:1903522 | 0.00000 | 2.86246 | 12 | 32 | 239 | regulation of blood circulation |
| GO:0042310 | 0.00000 | 4.26789 | 5 | 19 | 101 | vasoconstriction |
| GO:1901222 | 0.00000 | 4.26789 | 5 | 19 | 101 | regulation of NIK/NF-kappaB signaling |
| GO:0002792 | 0.00000 | 3.36975 | 8 | 25 | 162 | negative regulation of peptide secretion |
| GO:0042089 | 0.00000 | 3.87139 | 6 | 21 | 121 | cytokine biosynthetic process |
| GO:0071702 | 0.00000 | 1.51163 | 130 | 183 | 2505 | organic substance transport |
| GO:0050709 | 0.00000 | 3.46092 | 8 | 24 | 152 | negative regulation of protein secretion |
| GO:0051346 | 0.00000 | 2.34384 | 21 | 45 | 402 | negative regulation of hydrolase activity |
| GO:0007260 | 0.00000 | 4.98774 | 4 | 16 | 75 | tyrosine phosphorylation of STAT protein |
| GO:0071887 | 0.00000 | 3.68846 | 7 | 22 | 132 | leukocyte apoptotic process |
| GO:0015837 | 0.00000 | 3.83288 | 6 | 21 | 122 | amine transport |
| GO:0007204 | 0.00000 | 2.51308 | 17 | 39 | 327 | positive regulation of cytosolic calcium ion concentration |
| GO:0050711 | 0.00000 | 21.34845 | 1 | 7 | 13 | negative regulation of interleukin-1 secretion |
| GO:0060322 | 0.00000 | 1.98470 | 36 | 66 | 688 | head development |
| GO:0006464 | 0.00000 | 1.44025 | 180 | 239 | 3453 | cellular protein modification process |
| GO:0036211 | 0.00000 | 1.44025 | 180 | 239 | 3453 | protein modification process |
| GO:0002224 | 0.00000 | 4.16590 | 5 | 19 | 103 | toll-like receptor signaling pathway |
| GO:0031175 | 0.00000 | 1.76860 | 56 | 93 | 1083 | neuron projection development |
| GO:2000112 | 0.00000 | 1.45161 | 168 | 225 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:0007420 | 0.00000 | 2.02504 | 33 | 62 | 634 | brain development |
| GO:0022408 | 0.00000 | 3.11816 | 10 | 27 | 187 | negative regulation of cell-cell adhesion |
| GO:0010631 | 0.00000 | 2.64736 | 15 | 35 | 280 | epithelial cell migration |
| GO:0003006 | 0.00000 | 1.90482 | 41 | 73 | 791 | developmental process involved in reproduction |
| GO:0007187 | 0.00000 | 2.83989 | 12 | 31 | 233 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0030278 | 0.00000 | 2.83989 | 12 | 31 | 233 | regulation of ossification |
| GO:0032692 | 0.00000 | 9.16639 | 2 | 10 | 30 | negative regulation of interleukin-1 production |
| GO:0051402 | 0.00000 | 2.59663 | 15 | 36 | 293 | neuron apoptotic process |
| GO:0051251 | 0.00000 | 2.33634 | 21 | 44 | 394 | positive regulation of lymphocyte activation |
| GO:0034762 | 0.00000 | 2.08084 | 30 | 57 | 568 | regulation of transmembrane transport |
| GO:0032753 | 0.00000 | 10.99300 | 1 | 9 | 24 | positive regulation of interleukin-4 production |
| GO:0032989 | 0.00000 | 1.71561 | 63 | 101 | 1211 | cellular component morphogenesis |
| GO:0008217 | 0.00000 | 3.00894 | 10 | 28 | 200 | regulation of blood pressure |
| GO:2001023 | 0.00000 | 3.87871 | 6 | 20 | 115 | regulation of response to drug |
| GO:0010876 | 0.00000 | 2.37806 | 19 | 42 | 370 | lipid localization |
| GO:0002064 | 0.00000 | 2.75494 | 13 | 32 | 247 | epithelial cell development |
| GO:0032637 | 0.00000 | 5.10585 | 4 | 15 | 69 | interleukin-8 production |
| GO:0001961 | 0.00000 | 6.67365 | 2 | 12 | 45 | positive regulation of cytokine-mediated signaling pathway |
| GO:0098660 | 0.00000 | 1.98462 | 34 | 63 | 656 | inorganic ion transmembrane transport |
| GO:0019752 | 0.00000 | 1.82570 | 47 | 80 | 902 | carboxylic acid metabolic process |
| GO:0009914 | 0.00000 | 2.35618 | 19 | 42 | 373 | hormone transport |
| GO:0043412 | 0.00000 | 1.41875 | 189 | 248 | 3634 | macromolecule modification |
| GO:0032656 | 0.00000 | 13.31618 | 1 | 8 | 19 | regulation of interleukin-13 production |
| GO:0071363 | 0.00000 | 2.02742 | 31 | 59 | 602 | cellular response to growth factor stimulus |
| GO:0048589 | 0.00000 | 1.88521 | 41 | 72 | 787 | developmental growth |
| GO:0032736 | 0.00000 | 18.29784 | 1 | 7 | 14 | positive regulation of interleukin-13 production |
| GO:0010720 | 0.00000 | 1.97435 | 34 | 63 | 659 | positive regulation of cell development |
| GO:0006925 | 0.00000 | 10.30547 | 1 | 9 | 25 | inflammatory cell apoptotic process |
| GO:0055069 | 0.00000 | 10.30547 | 1 | 9 | 25 | zinc ion homeostasis |
| GO:0045861 | 0.00000 | 2.40208 | 18 | 40 | 349 | negative regulation of proteolysis |
| GO:1904062 | 0.00000 | 2.40208 | 18 | 40 | 349 | regulation of cation transmembrane transport |
| GO:0048732 | 0.00000 | 2.18109 | 24 | 49 | 467 | gland development |
| GO:0040008 | 0.00000 | 1.92714 | 37 | 67 | 717 | regulation of growth |
| GO:0032720 | 0.00000 | 5.35812 | 3 | 14 | 62 | negative regulation of tumor necrosis factor production |
| GO:0030316 | 0.00000 | 3.93096 | 6 | 19 | 108 | osteoclast differentiation |
| GO:0097190 | 0.00000 | 2.01600 | 32 | 59 | 605 | apoptotic signaling pathway |
| GO:0006366 | 0.00000 | 1.53636 | 107 | 153 | 2049 | transcription by RNA polymerase II |
| GO:0031400 | 0.00000 | 2.05491 | 29 | 56 | 564 | negative regulation of protein modification process |
| GO:0042509 | 0.00000 | 4.92305 | 4 | 15 | 71 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0002758 | 0.00000 | 3.46667 | 7 | 22 | 139 | innate immune response-activating signal transduction |
| GO:0007423 | 0.00000 | 2.01222 | 32 | 59 | 606 | sensory organ development |
| GO:0044267 | 0.00000 | 1.37733 | 238 | 301 | 4569 | cellular protein metabolic process |
| GO:0014070 | 0.00000 | 1.90916 | 38 | 68 | 734 | response to organic cyclic compound |
| GO:0045639 | 0.00000 | 4.08993 | 5 | 18 | 99 | positive regulation of myeloid cell differentiation |
| GO:2000241 | 0.00000 | 3.13908 | 9 | 25 | 172 | regulation of reproductive process |
| GO:0046879 | 0.00000 | 2.34852 | 19 | 41 | 365 | hormone secretion |
| GO:0050868 | 0.00000 | 3.72132 | 6 | 20 | 119 | negative regulation of T cell activation |
| GO:0042035 | 0.00000 | 3.88711 | 6 | 19 | 109 | regulation of cytokine biosynthetic process |
| GO:1903556 | 0.00000 | 5.24854 | 3 | 14 | 63 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0031098 | 0.00000 | 2.54237 | 15 | 35 | 290 | stress-activated protein kinase signaling cascade |
| GO:0042531 | 0.00000 | 5.68297 | 3 | 13 | 55 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0001776 | 0.00000 | 3.84421 | 6 | 19 | 110 | leukocyte homeostasis |
| GO:0048245 | 0.00000 | 12.20594 | 1 | 8 | 20 | eosinophil chemotaxis |
| GO:0021700 | 0.00000 | 2.44904 | 17 | 37 | 317 | developmental maturation |
| GO:2000514 | 0.00000 | 5.14333 | 3 | 14 | 64 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0002369 | 0.00000 | 6.95677 | 2 | 11 | 40 | T cell cytokine production |
| GO:0006692 | 0.00000 | 6.95677 | 2 | 11 | 40 | prostanoid metabolic process |
| GO:0006693 | 0.00000 | 6.95677 | 2 | 11 | 40 | prostaglandin metabolic process |
| GO:0071840 | 0.00000 | 1.33320 | 326 | 395 | 6266 | cellular component organization or biogenesis |
| GO:0035456 | 0.00000 | 5.55056 | 3 | 13 | 56 | response to interferon-beta |
| GO:0045414 | 0.00000 | 16.00988 | 1 | 7 | 15 | regulation of interleukin-8 biosynthetic process |
| GO:0010038 | 0.00000 | 2.58793 | 14 | 33 | 269 | response to metal ion |
| GO:0051590 | 0.00000 | 6.11668 | 3 | 12 | 48 | positive regulation of neurotransmitter transport |
| GO:0051403 | 0.00000 | 2.63129 | 13 | 32 | 257 | stress-activated MAPK cascade |
| GO:0043542 | 0.00000 | 2.91611 | 10 | 27 | 198 | endothelial cell migration |
| GO:0048469 | 0.00000 | 2.91611 | 10 | 27 | 198 | cell maturation |
| GO:0070848 | 0.00000 | 1.97882 | 32 | 59 | 615 | response to growth factor |
| GO:0051897 | 0.00000 | 3.94332 | 5 | 18 | 102 | positive regulation of protein kinase B signaling |
| GO:0006813 | 0.00001 | 2.71878 | 12 | 30 | 234 | potassium ion transport |
| GO:0045860 | 0.00001 | 2.18035 | 23 | 46 | 438 | positive regulation of protein kinase activity |
| GO:0045408 | 0.00001 | 9.15958 | 1 | 9 | 27 | regulation of interleukin-6 biosynthetic process |
| GO:0030900 | 0.00001 | 2.26578 | 20 | 42 | 386 | forebrain development |
| GO:0045664 | 0.00001 | 1.85373 | 40 | 70 | 776 | regulation of neuron differentiation |
| GO:0002286 | 0.00001 | 3.72102 | 6 | 19 | 113 | T cell activation involved in immune response |
| GO:0032693 | 0.00001 | 11.26651 | 1 | 8 | 21 | negative regulation of interleukin-10 production |
| GO:0034103 | 0.00001 | 4.32582 | 4 | 16 | 84 | regulation of tissue remodeling |
| GO:0120039 | 0.00001 | 1.90543 | 36 | 64 | 691 | plasma membrane bounded cell projection morphogenesis |
| GO:0010632 | 0.00001 | 2.73411 | 12 | 29 | 225 | regulation of epithelial cell migration |
| GO:0042136 | 0.00001 | 3.85127 | 5 | 18 | 104 | neurotransmitter biosynthetic process |
| GO:0015711 | 0.00001 | 2.20196 | 22 | 44 | 415 | organic anion transport |
| GO:0050769 | 0.00001 | 1.99068 | 30 | 56 | 580 | positive regulation of neurogenesis |
| GO:0098659 | 0.00001 | 4.26293 | 4 | 16 | 85 | inorganic cation import across plasma membrane |
| GO:0099587 | 0.00001 | 4.26293 | 4 | 16 | 85 | inorganic ion import across plasma membrane |
| GO:0010594 | 0.00001 | 3.16466 | 8 | 23 | 157 | regulation of endothelial cell migration |
| GO:1903523 | 0.00001 | 6.50735 | 2 | 11 | 42 | negative regulation of blood circulation |
| GO:0007409 | 0.00001 | 2.11411 | 24 | 48 | 470 | axonogenesis |
| GO:0007169 | 0.00001 | 2.01461 | 29 | 54 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0022414 | 0.00001 | 1.60043 | 77 | 115 | 1471 | reproductive process |
| GO:0048858 | 0.00001 | 1.88991 | 36 | 64 | 696 | cell projection morphogenesis |
| GO:0002507 | 0.00001 | 8.67711 | 1 | 9 | 28 | tolerance induction |
| GO:0000003 | 0.00001 | 1.59917 | 77 | 115 | 1472 | reproduction |
| GO:0002544 | 0.00001 | 14.23036 | 1 | 7 | 16 | chronic inflammatory response |
| GO:0042228 | 0.00001 | 14.23036 | 1 | 7 | 16 | interleukin-8 biosynthetic process |
| GO:0090257 | 0.00001 | 2.65313 | 12 | 30 | 239 | regulation of muscle system process |
| GO:0002831 | 0.00001 | 3.24362 | 8 | 22 | 147 | regulation of response to biotic stimulus |
| GO:0046942 | 0.00001 | 2.43600 | 16 | 35 | 301 | carboxylic acid transport |
| GO:0002221 | 0.00001 | 3.33497 | 7 | 21 | 137 | pattern recognition receptor signaling pathway |
| GO:0098739 | 0.00001 | 3.60544 | 6 | 19 | 116 | import across plasma membrane |
| GO:0015849 | 0.00001 | 2.42677 | 16 | 35 | 302 | organic acid transport |
| GO:0046883 | 0.00001 | 2.42677 | 16 | 35 | 302 | regulation of hormone secretion |
| GO:0002285 | 0.00001 | 2.87346 | 10 | 26 | 193 | lymphocyte activation involved in immune response |
| GO:0048872 | 0.00001 | 2.38946 | 16 | 36 | 315 | homeostasis of number of cells |
| GO:0032616 | 0.00001 | 10.46128 | 1 | 8 | 22 | interleukin-13 production |
| GO:0045624 | 0.00001 | 10.46128 | 1 | 8 | 22 | positive regulation of T-helper cell differentiation |
| GO:0050770 | 0.00001 | 2.80053 | 11 | 27 | 205 | regulation of axonogenesis |
| GO:0097191 | 0.00001 | 2.67894 | 12 | 29 | 229 | extrinsic apoptotic signaling pathway |
| GO:0008544 | 0.00001 | 2.34710 | 17 | 37 | 329 | epidermis development |
| GO:0006469 | 0.00001 | 2.85623 | 10 | 26 | 194 | negative regulation of protein kinase activity |
| GO:0000904 | 0.00001 | 1.81025 | 42 | 71 | 804 | cell morphogenesis involved in differentiation |
| GO:0033674 | 0.00001 | 2.08389 | 25 | 48 | 476 | positive regulation of kinase activity |
| GO:0045776 | 0.00001 | 5.07724 | 3 | 13 | 60 | negative regulation of blood pressure |
| GO:0046850 | 0.00001 | 5.07724 | 3 | 13 | 60 | regulation of bone remodeling |
| GO:0018193 | 0.00001 | 1.67281 | 59 | 93 | 1137 | peptidyl-amino acid modification |
| GO:0051092 | 0.00001 | 3.40981 | 7 | 20 | 128 | positive regulation of NF-kappaB transcription factor activity |
| GO:0002764 | 0.00001 | 2.09870 | 24 | 47 | 463 | immune response-regulating signaling pathway |
| GO:0030574 | 0.00001 | 7.04914 | 2 | 10 | 36 | collagen catabolic process |
| GO:0030318 | 0.00001 | 8.24287 | 2 | 9 | 29 | melanocyte differentiation |
| GO:0051259 | 0.00001 | 1.93289 | 32 | 58 | 617 | protein complex oligomerization |
| GO:0002757 | 0.00001 | 2.11441 | 23 | 46 | 450 | immune response-activating signal transduction |
| GO:0006816 | 0.00001 | 2.15468 | 22 | 44 | 423 | calcium ion transport |
| GO:0022612 | 0.00001 | 3.16716 | 8 | 22 | 150 | gland morphogenesis |
| GO:0034614 | 0.00001 | 3.16716 | 8 | 22 | 150 | cellular response to reactive oxygen species |
| GO:0032990 | 0.00001 | 1.85751 | 37 | 65 | 718 | cell part morphogenesis |
| GO:2001234 | 0.00001 | 2.65217 | 12 | 29 | 231 | negative regulation of apoptotic signaling pathway |
| GO:0043588 | 0.00001 | 2.42907 | 15 | 34 | 293 | skin development |
| GO:0043436 | 0.00001 | 1.73979 | 49 | 80 | 941 | oxoacid metabolic process |
| GO:0001960 | 0.00001 | 5.50401 | 3 | 12 | 52 | negative regulation of cytokine-mediated signaling pathway |
| GO:0061564 | 0.00001 | 2.03830 | 26 | 50 | 506 | axon development |
| GO:0042102 | 0.00001 | 3.85947 | 5 | 17 | 98 | positive regulation of T cell proliferation |
| GO:0048812 | 0.00001 | 1.87967 | 35 | 62 | 677 | neuron projection morphogenesis |
| GO:0055085 | 0.00001 | 1.63031 | 66 | 101 | 1266 | transmembrane transport |
| GO:0019722 | 0.00001 | 2.73848 | 11 | 27 | 209 | calcium-mediated signaling |
| GO:0061138 | 0.00001 | 2.67896 | 12 | 28 | 221 | morphogenesis of a branching epithelium |
| GO:2000379 | 0.00001 | 3.63883 | 6 | 18 | 109 | positive regulation of reactive oxygen species metabolic process |
| GO:0009615 | 0.00001 | 2.48608 | 14 | 32 | 270 | response to virus |
| GO:1903557 | 0.00001 | 3.81223 | 5 | 17 | 99 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0051347 | 0.00001 | 1.97965 | 29 | 53 | 551 | positive regulation of transferase activity |
| GO:0002675 | 0.00001 | 6.78776 | 2 | 10 | 37 | positive regulation of acute inflammatory response |
| GO:0032633 | 0.00001 | 6.78776 | 2 | 10 | 37 | interleukin-4 production |
| GO:0046640 | 0.00001 | 6.78776 | 2 | 10 | 37 | regulation of alpha-beta T cell proliferation |
| GO:0002720 | 0.00001 | 5.36952 | 3 | 12 | 53 | positive regulation of cytokine production involved in immune response |
| GO:0070423 | 0.00001 | 18.28346 | 1 | 6 | 12 | nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070431 | 0.00001 | 18.28346 | 1 | 6 | 12 | nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:2001233 | 0.00001 | 2.15007 | 22 | 43 | 414 | regulation of apoptotic signaling pathway |
| GO:0044070 | 0.00001 | 3.46202 | 6 | 19 | 120 | regulation of anion transport |
| GO:0006898 | 0.00001 | 2.66503 | 12 | 28 | 222 | receptor-mediated endocytosis |
| GO:0048638 | 0.00001 | 2.16961 | 21 | 42 | 401 | regulation of developmental growth |
| GO:0032673 | 0.00001 | 7.85000 | 2 | 9 | 30 | regulation of interleukin-4 production |
| GO:0043372 | 0.00001 | 7.85000 | 2 | 9 | 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0010469 | 0.00001 | 3.31719 | 7 | 20 | 131 | regulation of signaling receptor activity |
| GO:0098542 | 0.00001 | 1.87598 | 35 | 61 | 667 | defense response to other organism |
| GO:0006836 | 0.00001 | 2.39169 | 15 | 34 | 297 | neurotransmitter transport |
| GO:0002437 | 0.00001 | 4.86957 | 3 | 13 | 62 | inflammatory response to antigenic stimulus |
| GO:0001649 | 0.00002 | 2.77304 | 10 | 26 | 199 | osteoblast differentiation |
| GO:0002702 | 0.00002 | 3.76613 | 5 | 17 | 100 | positive regulation of production of molecular mediator of immune response |
| GO:0042063 | 0.00002 | 2.32200 | 17 | 36 | 323 | gliogenesis |
| GO:0051130 | 0.00002 | 1.61425 | 67 | 102 | 1290 | positive regulation of cellular component organization |
| GO:0019233 | 0.00002 | 3.17008 | 7 | 21 | 143 | sensory perception of pain |
| GO:0043030 | 0.00002 | 5.24144 | 3 | 12 | 54 | regulation of macrophage activation |
| GO:0001558 | 0.00002 | 2.10936 | 22 | 44 | 431 | regulation of cell growth |
| GO:0072210 | 0.00002 | 6.54504 | 2 | 10 | 38 | metanephric nephron development |
| GO:0032677 | 0.00002 | 4.77196 | 3 | 13 | 63 | regulation of interleukin-8 production |
| GO:0071241 | 0.00002 | 2.62409 | 12 | 28 | 225 | cellular response to inorganic substance |
| GO:0032757 | 0.00002 | 5.76260 | 2 | 11 | 46 | positive regulation of interleukin-8 production |
| GO:0051896 | 0.00002 | 3.04740 | 8 | 22 | 155 | regulation of protein kinase B signaling |
| GO:0006882 | 0.00002 | 9.15279 | 1 | 8 | 24 | cellular zinc ion homeostasis |
| GO:0051588 | 0.00002 | 2.87319 | 9 | 24 | 178 | regulation of neurotransmitter transport |
| GO:0050718 | 0.00002 | 7.49284 | 2 | 9 | 31 | positive regulation of interleukin-1 beta secretion |
| GO:0060712 | 0.00002 | 11.64196 | 1 | 7 | 18 | spongiotrophoblast layer development |
| GO:2000696 | 0.00002 | 11.64196 | 1 | 7 | 18 | regulation of epithelial cell differentiation involved in kidney development |
| GO:0046849 | 0.00002 | 3.67718 | 5 | 17 | 102 | bone remodeling |
| GO:0060562 | 0.00002 | 2.17994 | 20 | 40 | 380 | epithelial tube morphogenesis |
| GO:0048066 | 0.00002 | 5.11931 | 3 | 12 | 55 | developmental pigmentation |
| GO:0006942 | 0.00002 | 4.05206 | 4 | 15 | 83 | regulation of striated muscle contraction |
| GO:0050931 | 0.00002 | 6.31906 | 2 | 10 | 39 | pigment cell differentiation |
| GO:0001763 | 0.00002 | 2.53800 | 13 | 29 | 240 | morphogenesis of a branching structure |
| GO:0042108 | 0.00002 | 4.28416 | 4 | 14 | 74 | positive regulation of cytokine biosynthetic process |
| GO:1901224 | 0.00002 | 4.28416 | 4 | 14 | 74 | positive regulation of NIK/NF-kappaB signaling |
| GO:0035872 | 0.00002 | 15.67082 | 1 | 6 | 13 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0060761 | 0.00003 | 5.00273 | 3 | 12 | 56 | negative regulation of response to cytokine stimulus |
| GO:0150076 | 0.00003 | 4.58800 | 3 | 13 | 65 | neuroinflammatory response |
| GO:0071705 | 0.00003 | 1.46504 | 111 | 153 | 2133 | nitrogen compound transport |
| GO:0001516 | 0.00003 | 8.61400 | 1 | 8 | 25 | prostaglandin biosynthetic process |
| GO:0014048 | 0.00003 | 8.61400 | 1 | 8 | 25 | regulation of glutamate secretion |
| GO:0046457 | 0.00003 | 8.61400 | 1 | 8 | 25 | prostanoid biosynthetic process |
| GO:2001057 | 0.00003 | 3.99315 | 4 | 15 | 84 | reactive nitrogen species metabolic process |
| GO:0097237 | 0.00003 | 2.88308 | 9 | 23 | 170 | cellular response to toxic substance |
| GO:0048598 | 0.00003 | 1.86438 | 33 | 58 | 637 | embryonic morphogenesis |
| GO:0032620 | 0.00003 | 6.10815 | 2 | 10 | 40 | interleukin-17 production |
| GO:0046456 | 0.00003 | 6.10815 | 2 | 10 | 40 | icosanoid biosynthetic process |
| GO:0046633 | 0.00003 | 6.10815 | 2 | 10 | 40 | alpha-beta T cell proliferation |
| GO:0050764 | 0.00003 | 3.55134 | 5 | 17 | 105 | regulation of phagocytosis |
| GO:0046916 | 0.00003 | 3.72163 | 5 | 16 | 95 | cellular transition metal ion homeostasis |
| GO:0006082 | 0.00003 | 1.68474 | 50 | 80 | 968 | organic acid metabolic process |
| GO:0015893 | 0.00003 | 2.64951 | 11 | 26 | 207 | drug transport |
| GO:2000181 | 0.00003 | 3.37783 | 6 | 18 | 116 | negative regulation of blood vessel morphogenesis |
| GO:0044271 | 0.00003 | 1.34774 | 208 | 261 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0043406 | 0.00003 | 2.58110 | 11 | 27 | 220 | positive regulation of MAP kinase activity |
| GO:2001236 | 0.00003 | 2.91506 | 8 | 22 | 161 | regulation of extrinsic apoptotic signaling pathway |
| GO:0006809 | 0.00003 | 4.14558 | 4 | 14 | 76 | nitric oxide biosynthetic process |
| GO:0032660 | 0.00003 | 6.86781 | 2 | 9 | 33 | regulation of interleukin-17 production |
| GO:0017001 | 0.00003 | 5.30694 | 3 | 11 | 49 | antibiotic catabolic process |
| GO:0007507 | 0.00003 | 1.85699 | 33 | 57 | 628 | heart development |
| GO:0015718 | 0.00003 | 2.99710 | 8 | 21 | 150 | monocarboxylic acid transport |
| GO:0090287 | 0.00004 | 2.38607 | 14 | 31 | 271 | regulation of cellular response to growth factor stimulus |
| GO:1904950 | 0.00004 | 2.62031 | 11 | 26 | 209 | negative regulation of establishment of protein localization |
| GO:2000027 | 0.00004 | 2.62031 | 11 | 26 | 209 | regulation of animal organ morphogenesis |
| GO:0090025 | 0.00004 | 8.13507 | 1 | 8 | 26 | regulation of monocyte chemotaxis |
| GO:0010817 | 0.00004 | 1.91309 | 29 | 52 | 557 | regulation of hormone levels |
| GO:0072678 | 0.00004 | 4.78479 | 3 | 12 | 58 | T cell migration |
| GO:0033002 | 0.00004 | 2.50841 | 12 | 28 | 234 | muscle cell proliferation |
| GO:0019935 | 0.00004 | 2.60595 | 11 | 26 | 210 | cyclic-nucleotide-mediated signaling |
| GO:0001936 | 0.00004 | 3.17746 | 7 | 19 | 129 | regulation of endothelial cell proliferation |
| GO:0002604 | 0.00004 | 22.83742 | 0 | 5 | 9 | regulation of dendritic cell antigen processing and presentation |
| GO:0032650 | 0.00004 | 22.83742 | 0 | 5 | 9 | regulation of interleukin-1 alpha production |
| GO:0048660 | 0.00004 | 2.87345 | 8 | 22 | 163 | regulation of smooth muscle cell proliferation |
| GO:0031663 | 0.00004 | 5.17063 | 3 | 11 | 50 | lipopolysaccharide-mediated signaling pathway |
| GO:0043370 | 0.00004 | 5.17063 | 3 | 11 | 50 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0045428 | 0.00004 | 4.33715 | 4 | 13 | 68 | regulation of nitric oxide biosynthetic process |
| GO:2000106 | 0.00004 | 3.43379 | 6 | 17 | 108 | regulation of leukocyte apoptotic process |
| GO:0031589 | 0.00004 | 2.19777 | 18 | 36 | 339 | cell-substrate adhesion |
| GO:0061041 | 0.00004 | 3.04166 | 7 | 20 | 141 | regulation of wound healing |
| GO:0050716 | 0.00004 | 6.59280 | 2 | 9 | 34 | positive regulation of interleukin-1 secretion |
| GO:0032760 | 0.00004 | 3.58498 | 5 | 16 | 98 | positive regulation of tumor necrosis factor production |
| GO:0070664 | 0.00005 | 3.77366 | 5 | 15 | 88 | negative regulation of leukocyte proliferation |
| GO:0015844 | 0.00005 | 3.39631 | 6 | 17 | 109 | monoamine transport |
| GO:0021953 | 0.00005 | 2.51534 | 12 | 27 | 225 | central nervous system neuron differentiation |
| GO:0043122 | 0.00005 | 2.83300 | 9 | 22 | 165 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0008016 | 0.00005 | 2.75115 | 9 | 23 | 177 | regulation of heart contraction |
| GO:0006936 | 0.00005 | 2.30028 | 15 | 32 | 289 | muscle contraction |
| GO:0048568 | 0.00005 | 1.95481 | 26 | 47 | 493 | embryonic organ development |
| GO:0070542 | 0.00005 | 5.04113 | 3 | 11 | 51 | response to fatty acid |
| GO:0032890 | 0.00005 | 3.95370 | 4 | 14 | 79 | regulation of organic acid transport |
| GO:0051937 | 0.00005 | 3.72250 | 5 | 15 | 89 | catecholamine transport |
| GO:1905954 | 0.00005 | 3.72250 | 5 | 15 | 89 | positive regulation of lipid localization |
| GO:0033673 | 0.00005 | 2.55004 | 11 | 26 | 214 | negative regulation of kinase activity |
| GO:0001935 | 0.00005 | 2.99192 | 7 | 20 | 143 | endothelial cell proliferation |
| GO:0072073 | 0.00005 | 2.99192 | 7 | 20 | 143 | kidney epithelium development |
| GO:0071695 | 0.00005 | 2.66402 | 10 | 24 | 190 | anatomical structure maturation |
| GO:0046717 | 0.00005 | 3.21313 | 6 | 18 | 121 | acid secretion |
| GO:0006869 | 0.00006 | 2.19360 | 17 | 35 | 330 | lipid transport |
| GO:0042391 | 0.00006 | 2.01200 | 23 | 43 | 439 | regulation of membrane potential |
| GO:0032733 | 0.00006 | 6.33894 | 2 | 9 | 35 | positive regulation of interleukin-10 production |
| GO:1990748 | 0.00006 | 6.33894 | 2 | 9 | 35 | cellular detoxification |
| GO:0019933 | 0.00006 | 2.71563 | 9 | 23 | 179 | cAMP-mediated signaling |
| GO:0071804 | 0.00006 | 2.64795 | 10 | 24 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.00006 | 2.64795 | 10 | 24 | 191 | potassium ion transmembrane transport |
| GO:0046209 | 0.00006 | 3.89362 | 4 | 14 | 80 | nitric oxide metabolic process |
| GO:0002688 | 0.00006 | 3.32375 | 6 | 17 | 111 | regulation of leukocyte chemotaxis |
| GO:0001666 | 0.00006 | 2.57413 | 11 | 25 | 204 | response to hypoxia |
| GO:0051224 | 0.00006 | 2.57413 | 11 | 25 | 204 | negative regulation of protein transport |
| GO:0048659 | 0.00006 | 2.77441 | 9 | 22 | 168 | smooth muscle cell proliferation |
| GO:0043032 | 0.00006 | 7.32090 | 1 | 8 | 28 | positive regulation of macrophage activation |
| GO:0048667 | 0.00007 | 1.81955 | 33 | 56 | 628 | cell morphogenesis involved in neuron differentiation |
| GO:0001655 | 0.00007 | 2.14745 | 18 | 36 | 346 | urogenital system development |
| GO:0072283 | 0.00007 | 12.18731 | 1 | 6 | 15 | metanephric renal vesicle morphogenesis |
| GO:0032787 | 0.00007 | 1.86395 | 30 | 52 | 570 | monocarboxylic acid metabolic process |
| GO:0050433 | 0.00007 | 4.11226 | 4 | 13 | 71 | regulation of catecholamine secretion |
| GO:0002698 | 0.00007 | 3.03861 | 7 | 19 | 134 | negative regulation of immune effector process |
| GO:0050818 | 0.00007 | 3.83533 | 4 | 14 | 81 | regulation of coagulation |
| GO:0036293 | 0.00007 | 2.45283 | 12 | 27 | 230 | response to decreased oxygen levels |
| GO:0042311 | 0.00007 | 6.10389 | 2 | 9 | 36 | vasodilation |
| GO:2000516 | 0.00007 | 6.10389 | 2 | 9 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0015800 | 0.00007 | 4.40120 | 3 | 12 | 62 | acidic amino acid transport |
| GO:0055078 | 0.00007 | 4.80064 | 3 | 11 | 53 | sodium ion homeostasis |
| GO:0061900 | 0.00007 | 4.80064 | 3 | 11 | 53 | glial cell activation |
| GO:2000177 | 0.00008 | 3.25420 | 6 | 17 | 113 | regulation of neural precursor cell proliferation |
| GO:0070391 | 0.00008 | 18.26910 | 1 | 5 | 10 | response to lipoteichoic acid |
| GO:0071223 | 0.00008 | 18.26910 | 1 | 5 | 10 | cellular response to lipoteichoic acid |
| GO:0042133 | 0.00008 | 2.89716 | 8 | 20 | 147 | neurotransmitter metabolic process |
| GO:0032872 | 0.00008 | 2.42867 | 12 | 27 | 232 | regulation of stress-activated MAPK cascade |
| GO:0007411 | 0.00008 | 2.38005 | 13 | 28 | 245 | axon guidance |
| GO:0061351 | 0.00008 | 2.64725 | 10 | 23 | 183 | neural precursor cell proliferation |
| GO:0001774 | 0.00009 | 5.23436 | 2 | 10 | 45 | microglial cell activation |
| GO:0002269 | 0.00009 | 5.23436 | 2 | 10 | 45 | leukocyte activation involved in inflammatory response |
| GO:0014009 | 0.00009 | 4.68878 | 3 | 11 | 54 | glial cell proliferation |
| GO:0097485 | 0.00009 | 2.36902 | 13 | 28 | 246 | neuron projection guidance |
| GO:0033028 | 0.00009 | 5.88563 | 2 | 9 | 37 | myeloid cell apoptotic process |
| GO:0097028 | 0.00009 | 5.88563 | 2 | 9 | 37 | dendritic cell differentiation |
| GO:0070302 | 0.00009 | 2.40499 | 12 | 27 | 234 | regulation of stress-activated protein kinase signaling cascade |
| GO:0002606 | 0.00010 | 36.51286 | 0 | 4 | 6 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0002826 | 0.00010 | 36.51286 | 0 | 4 | 6 | negative regulation of T-helper 1 type immune response |
| GO:0034112 | 0.00010 | 36.51286 | 0 | 4 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0035633 | 0.00010 | 36.51286 | 0 | 4 | 6 | maintenance of permeability of blood-brain barrier |
| GO:0071224 | 0.00010 | 36.51286 | 0 | 4 | 6 | cellular response to peptidoglycan |
| GO:0050432 | 0.00011 | 3.90948 | 4 | 13 | 74 | catecholamine secretion |
| GO:0002040 | 0.00011 | 3.15516 | 6 | 17 | 116 | sprouting angiogenesis |
| GO:0044249 | 0.00011 | 1.29444 | 257 | 310 | 4938 | cellular biosynthetic process |
| GO:0033005 | 0.00011 | 6.65476 | 2 | 8 | 30 | positive regulation of mast cell activation |
| GO:0042744 | 0.00011 | 6.65476 | 2 | 8 | 30 | hydrogen peroxide catabolic process |
| GO:0021537 | 0.00011 | 2.33654 | 13 | 28 | 249 | telencephalon development |
| GO:0022898 | 0.00011 | 2.29604 | 14 | 29 | 262 | regulation of transmembrane transporter activity |
| GO:0006636 | 0.00011 | 5.68241 | 2 | 9 | 38 | unsaturated fatty acid biosynthetic process |
| GO:0045622 | 0.00011 | 5.68241 | 2 | 9 | 38 | regulation of T-helper cell differentiation |
| GO:0061061 | 0.00011 | 1.74010 | 37 | 60 | 701 | muscle structure development |
| GO:0060627 | 0.00012 | 1.83015 | 30 | 51 | 568 | regulation of vesicle-mediated transport |
| GO:1901343 | 0.00012 | 3.00769 | 7 | 18 | 128 | negative regulation of vasculature development |
| GO:0072001 | 0.00012 | 2.18821 | 16 | 32 | 302 | renal system development |
| GO:0002886 | 0.00012 | 4.15151 | 3 | 12 | 65 | regulation of myeloid leukocyte mediated immunity |
| GO:1903793 | 0.00012 | 4.15151 | 3 | 12 | 65 | positive regulation of anion transport |
| GO:0002275 | 0.00012 | 3.61860 | 4 | 14 | 85 | myeloid cell activation involved in immune response |
| GO:1900407 | 0.00012 | 3.61860 | 4 | 14 | 85 | regulation of cellular response to oxidative stress |
| GO:0002827 | 0.00012 | 8.00203 | 1 | 7 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0035743 | 0.00012 | 8.00203 | 1 | 7 | 23 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0071276 | 0.00012 | 8.00203 | 1 | 7 | 23 | cellular response to cadmium ion |
| GO:0009058 | 0.00012 | 1.28820 | 267 | 320 | 5125 | biosynthetic process |
| GO:0072089 | 0.00012 | 2.88714 | 7 | 19 | 140 | stem cell proliferation |
| GO:0007178 | 0.00012 | 2.07281 | 19 | 36 | 357 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0042743 | 0.00013 | 4.47999 | 3 | 11 | 56 | hydrogen peroxide metabolic process |
| GO:0030279 | 0.00013 | 3.39971 | 5 | 15 | 96 | negative regulation of ossification |
| GO:0002262 | 0.00013 | 2.62932 | 9 | 22 | 176 | myeloid cell homeostasis |
| GO:0016049 | 0.00013 | 1.86918 | 27 | 47 | 513 | cell growth |
| GO:0002468 | 0.00013 | 15.22356 | 1 | 5 | 11 | dendritic cell antigen processing and presentation |
| GO:0002579 | 0.00013 | 15.22356 | 1 | 5 | 11 | positive regulation of antigen processing and presentation |
| GO:0032610 | 0.00013 | 15.22356 | 1 | 5 | 11 | interleukin-1 alpha production |
| GO:0045416 | 0.00013 | 15.22356 | 1 | 5 | 11 | positive regulation of interleukin-8 biosynthetic process |
| GO:0060693 | 0.00013 | 15.22356 | 1 | 5 | 11 | regulation of branching involved in salivary gland morphogenesis |
| GO:0002440 | 0.00014 | 2.08602 | 18 | 35 | 345 | production of molecular mediator of immune response |
| GO:0043901 | 0.00014 | 2.68306 | 9 | 21 | 165 | negative regulation of multi-organism process |
| GO:0006826 | 0.00014 | 5.49275 | 2 | 9 | 39 | iron ion transport |
| GO:0019371 | 0.00014 | Inf | 0 | 3 | 3 | cyclooxygenase pathway |
| GO:0032690 | 0.00014 | Inf | 0 | 3 | 3 | negative regulation of interleukin-1 alpha production |
| GO:0051466 | 0.00014 | Inf | 0 | 3 | 3 | positive regulation of corticotropin-releasing hormone secretion |
| GO:0070428 | 0.00014 | Inf | 0 | 3 | 3 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:1902214 | 0.00014 | Inf | 0 | 3 | 3 | regulation of interleukin-4-mediated signaling pathway |
| GO:0010574 | 0.00014 | 6.36513 | 2 | 8 | 31 | regulation of vascular endothelial growth factor production |
| GO:0045932 | 0.00014 | 6.36513 | 2 | 8 | 31 | negative regulation of muscle contraction |
| GO:0071902 | 0.00014 | 2.22284 | 15 | 30 | 279 | positive regulation of protein serine/threonine kinase activity |
| GO:0045667 | 0.00015 | 2.83994 | 7 | 19 | 142 | regulation of osteoblast differentiation |
| GO:1901576 | 0.00015 | 1.28554 | 262 | 314 | 5031 | organic substance biosynthetic process |
| GO:0000188 | 0.00015 | 9.97053 | 1 | 6 | 17 | inactivation of MAPK activity |
| GO:0045064 | 0.00015 | 9.97053 | 1 | 6 | 17 | T-helper 2 cell differentiation |
| GO:0044706 | 0.00015 | 2.53548 | 10 | 23 | 190 | multi-multicellular organism process |
| GO:0043303 | 0.00015 | 4.82046 | 3 | 10 | 48 | mast cell degranulation |
| GO:1903115 | 0.00015 | 4.82046 | 3 | 10 | 48 | regulation of actin filament-based movement |
| GO:0072091 | 0.00015 | 3.51914 | 5 | 14 | 87 | regulation of stem cell proliferation |
| GO:2000179 | 0.00016 | 4.00018 | 3 | 12 | 67 | positive regulation of neural precursor cell proliferation |
| GO:0030193 | 0.00016 | 3.72571 | 4 | 13 | 77 | regulation of blood coagulation |
| GO:2001237 | 0.00016 | 3.31749 | 5 | 15 | 98 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0098869 | 0.00016 | 7.53098 | 1 | 7 | 24 | cellular oxidant detoxification |
| GO:0001659 | 0.00016 | 2.57872 | 9 | 22 | 179 | temperature homeostasis |
| GO:0034105 | 0.00017 | 5.31532 | 2 | 9 | 40 | positive regulation of tissue remodeling |
| GO:0051187 | 0.00017 | 4.28896 | 3 | 11 | 58 | cofactor catabolic process |
| GO:0070482 | 0.00017 | 2.19607 | 15 | 30 | 282 | response to oxygen levels |
| GO:0006820 | 0.00018 | 1.81646 | 29 | 49 | 549 | anion transport |
| GO:2001257 | 0.00018 | 2.62795 | 9 | 21 | 168 | regulation of cation channel activity |
| GO:0007596 | 0.00018 | 2.70432 | 8 | 20 | 156 | blood coagulation |
| GO:0002279 | 0.00018 | 4.69665 | 3 | 10 | 49 | mast cell activation involved in immune response |
| GO:0002448 | 0.00018 | 4.69665 | 3 | 10 | 49 | mast cell mediated immunity |
| GO:0032941 | 0.00018 | 4.69665 | 3 | 10 | 49 | secretion by tissue |
| GO:0051955 | 0.00018 | 4.69665 | 3 | 10 | 49 | regulation of amino acid transport |
| GO:1900046 | 0.00018 | 3.66823 | 4 | 13 | 78 | regulation of hemostasis |
| GO:0006690 | 0.00018 | 3.12561 | 6 | 16 | 110 | icosanoid metabolic process |
| GO:0003012 | 0.00018 | 1.98436 | 20 | 38 | 392 | muscle system process |
| GO:0060560 | 0.00019 | 2.21900 | 14 | 29 | 270 | developmental growth involved in morphogenesis |
| GO:1905952 | 0.00020 | 2.77194 | 8 | 19 | 145 | regulation of lipid localization |
| GO:0000041 | 0.00020 | 3.42498 | 5 | 14 | 89 | transition metal ion transport |
| GO:0014015 | 0.00020 | 3.42498 | 5 | 14 | 89 | positive regulation of gliogenesis |
| GO:0031960 | 0.00020 | 3.42498 | 5 | 14 | 89 | response to corticosteroid |
| GO:0045165 | 0.00020 | 2.17858 | 15 | 30 | 284 | cell fate commitment |
| GO:0006508 | 0.00021 | 1.45256 | 86 | 119 | 1657 | proteolysis |
| GO:0038034 | 0.00021 | 3.61248 | 4 | 13 | 79 | signal transduction in absence of ligand |
| GO:0097192 | 0.00021 | 3.61248 | 4 | 13 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0043407 | 0.00021 | 3.85947 | 4 | 12 | 69 | negative regulation of MAP kinase activity |
| GO:0055117 | 0.00021 | 3.85947 | 4 | 12 | 69 | regulation of cardiac muscle contraction |
| GO:0032700 | 0.00021 | 9.13924 | 1 | 6 | 18 | negative regulation of interleukin-17 production |
| GO:0072077 | 0.00021 | 9.13924 | 1 | 6 | 18 | renal vesicle morphogenesis |
| GO:0032409 | 0.00021 | 2.20054 | 14 | 29 | 272 | regulation of transporter activity |
| GO:0051924 | 0.00021 | 2.20054 | 14 | 29 | 272 | regulation of calcium ion transport |
| GO:0060485 | 0.00021 | 2.20054 | 14 | 29 | 272 | mesenchyme development |
| GO:0001956 | 0.00021 | 7.11227 | 1 | 7 | 25 | positive regulation of neurotransmitter secretion |
| GO:0010575 | 0.00021 | 7.11227 | 1 | 7 | 25 | positive regulation of vascular endothelial growth factor production |
| GO:0046688 | 0.00021 | 7.11227 | 1 | 7 | 25 | response to copper ion |
| GO:0007599 | 0.00022 | 2.66489 | 8 | 20 | 158 | hemostasis |
| GO:0045124 | 0.00022 | 4.57902 | 3 | 10 | 50 | regulation of bone resorption |
| GO:0046189 | 0.00022 | 4.57902 | 3 | 10 | 50 | phenol-containing compound biosynthetic process |
| GO:0071675 | 0.00022 | 4.57902 | 3 | 10 | 50 | regulation of mononuclear cell migration |
| GO:0001781 | 0.00022 | 13.04817 | 1 | 5 | 12 | neutrophil apoptotic process |
| GO:0001973 | 0.00022 | 13.04817 | 1 | 5 | 12 | adenosine receptor signaling pathway |
| GO:0003337 | 0.00022 | 13.04817 | 1 | 5 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0032754 | 0.00022 | 13.04817 | 1 | 5 | 12 | positive regulation of interleukin-5 production |
| GO:0035588 | 0.00022 | 13.04817 | 1 | 5 | 12 | G protein-coupled purinergic receptor signaling pathway |
| GO:0098657 | 0.00022 | 1.62448 | 45 | 70 | 872 | import into cell |
| GO:1903524 | 0.00022 | 3.37976 | 5 | 14 | 90 | positive regulation of blood circulation |
| GO:0001892 | 0.00023 | 3.06021 | 6 | 16 | 112 | embryonic placenta development |
| GO:0006939 | 0.00023 | 3.06021 | 6 | 16 | 112 | smooth muscle contraction |
| GO:0008630 | 0.00023 | 3.06021 | 6 | 16 | 112 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0016525 | 0.00023 | 3.06021 | 6 | 16 | 112 | negative regulation of angiogenesis |
| GO:0009635 | 0.00023 | 24.34080 | 0 | 4 | 7 | response to herbicide |
| GO:0045630 | 0.00023 | 24.34080 | 0 | 4 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:2000698 | 0.00023 | 24.34080 | 0 | 4 | 7 | positive regulation of epithelial cell differentiation involved in kidney development |
| GO:0110110 | 0.00023 | 3.20133 | 5 | 15 | 101 | positive regulation of animal organ morphogenesis |
| GO:0010573 | 0.00023 | 5.85539 | 2 | 8 | 33 | vascular endothelial growth factor production |
| GO:2000108 | 0.00023 | 5.85539 | 2 | 8 | 33 | positive regulation of leukocyte apoptotic process |
| GO:0032874 | 0.00023 | 2.57503 | 9 | 21 | 171 | positive regulation of stress-activated MAPK cascade |
| GO:0043409 | 0.00023 | 2.57503 | 9 | 21 | 171 | negative regulation of MAPK cascade |
| GO:0033036 | 0.00023 | 1.34446 | 151 | 192 | 2901 | macromolecule localization |
| GO:0050817 | 0.00023 | 2.64559 | 8 | 20 | 159 | coagulation |
| GO:0043154 | 0.00024 | 3.55840 | 4 | 13 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0045744 | 0.00024 | 4.11352 | 3 | 11 | 60 | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0045862 | 0.00024 | 2.06474 | 17 | 33 | 328 | positive regulation of proteolysis |
| GO:0032147 | 0.00025 | 2.25119 | 13 | 27 | 248 | activation of protein kinase activity |
| GO:0015672 | 0.00025 | 1.88123 | 24 | 42 | 455 | monovalent inorganic cation transport |
| GO:0001938 | 0.00025 | 3.33572 | 5 | 14 | 91 | positive regulation of endothelial cell proliferation |
| GO:0070304 | 0.00025 | 2.55786 | 9 | 21 | 172 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0046427 | 0.00025 | 3.16439 | 5 | 15 | 102 | positive regulation of JAK-STAT cascade |
| GO:0046636 | 0.00026 | 4.99273 | 2 | 9 | 42 | negative regulation of alpha-beta T cell activation |
| GO:1902622 | 0.00026 | 4.99273 | 2 | 9 | 42 | regulation of neutrophil migration |
| GO:0042058 | 0.00028 | 4.03107 | 3 | 11 | 61 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0043534 | 0.00028 | 2.99749 | 6 | 16 | 114 | blood vessel endothelial cell migration |
| GO:0030183 | 0.00028 | 2.68616 | 8 | 19 | 149 | B cell differentiation |
| GO:0051767 | 0.00028 | 6.73763 | 1 | 7 | 26 | nitric-oxide synthase biosynthetic process |
| GO:0051769 | 0.00028 | 6.73763 | 1 | 7 | 26 | regulation of nitric-oxide synthase biosynthetic process |
| GO:1903426 | 0.00028 | 3.12828 | 5 | 15 | 103 | regulation of reactive oxygen species biosynthetic process |
| GO:0014047 | 0.00029 | 5.62992 | 2 | 8 | 34 | glutamate secretion |
| GO:0033032 | 0.00029 | 5.62992 | 2 | 8 | 34 | regulation of myeloid cell apoptotic process |
| GO:0002643 | 0.00030 | 8.43583 | 1 | 6 | 19 | regulation of tolerance induction |
| GO:0060231 | 0.00030 | 8.43583 | 1 | 6 | 19 | mesenchymal to epithelial transition |
| GO:0010712 | 0.00030 | 4.36058 | 3 | 10 | 52 | regulation of collagen metabolic process |
| GO:1901570 | 0.00030 | 4.36058 | 3 | 10 | 52 | fatty acid derivative biosynthetic process |
| GO:0014013 | 0.00030 | 2.66553 | 8 | 19 | 150 | regulation of gliogenesis |
| GO:0000187 | 0.00031 | 2.96707 | 6 | 16 | 115 | activation of MAPK activity |
| GO:0019730 | 0.00031 | 2.96707 | 6 | 16 | 115 | antimicrobial humoral response |
| GO:0030072 | 0.00031 | 2.14692 | 14 | 29 | 278 | peptide hormone secretion |
| GO:0045807 | 0.00032 | 2.50769 | 9 | 21 | 175 | positive regulation of endocytosis |
| GO:0030858 | 0.00032 | 3.95185 | 3 | 11 | 62 | positive regulation of epithelial cell differentiation |
| GO:0009913 | 0.00032 | 2.33737 | 11 | 24 | 213 | epidermal cell differentiation |
| GO:0045666 | 0.00033 | 1.85377 | 24 | 42 | 461 | positive regulation of neuron differentiation |
| GO:0046394 | 0.00034 | 1.97602 | 19 | 35 | 362 | carboxylic acid biosynthetic process |
| GO:0002517 | 0.00034 | 11.41663 | 1 | 5 | 13 | T cell tolerance induction |
| GO:0031652 | 0.00034 | 11.41663 | 1 | 5 | 13 | positive regulation of heat generation |
| GO:0032494 | 0.00034 | 11.41663 | 1 | 5 | 13 | response to peptidoglycan |
| GO:0045906 | 0.00034 | 11.41663 | 1 | 5 | 13 | negative regulation of vasoconstriction |
| GO:0033554 | 0.00035 | 1.41982 | 92 | 124 | 1763 | cellular response to stress |
| GO:1902882 | 0.00035 | 3.21019 | 5 | 14 | 94 | regulation of response to oxidative stress |
| GO:0002701 | 0.00035 | 5.42116 | 2 | 8 | 35 | negative regulation of production of molecular mediator of immune response |
| GO:0009954 | 0.00035 | 5.42116 | 2 | 8 | 35 | proximal/distal pattern formation |
| GO:0034122 | 0.00035 | 5.42116 | 2 | 8 | 35 | negative regulation of toll-like receptor signaling pathway |
| GO:0043304 | 0.00035 | 5.42116 | 2 | 8 | 35 | regulation of mast cell degranulation |
| GO:0015833 | 0.00035 | 1.41548 | 94 | 126 | 1797 | peptide transport |
| GO:0048662 | 0.00036 | 4.25898 | 3 | 10 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:0071715 | 0.00036 | 4.25898 | 3 | 10 | 53 | icosanoid transport |
| GO:1901571 | 0.00036 | 4.25898 | 3 | 10 | 53 | fatty acid derivative transport |
| GO:0016053 | 0.00036 | 1.96990 | 19 | 35 | 363 | organic acid biosynthetic process |
| GO:0003085 | 0.00036 | 6.40046 | 1 | 7 | 27 | negative regulation of systemic arterial blood pressure |
| GO:0045332 | 0.00036 | 6.40046 | 1 | 7 | 27 | phospholipid translocation |
| GO:0045780 | 0.00036 | 6.40046 | 1 | 7 | 27 | positive regulation of bone resorption |
| GO:0046852 | 0.00036 | 6.40046 | 1 | 7 | 27 | positive regulation of bone remodeling |
| GO:0048305 | 0.00036 | 6.40046 | 1 | 7 | 27 | immunoglobulin secretion |
| GO:0050901 | 0.00036 | 6.40046 | 1 | 7 | 27 | leukocyte tethering or rolling |
| GO:0051354 | 0.00036 | 6.40046 | 1 | 7 | 27 | negative regulation of oxidoreductase activity |
| GO:0032412 | 0.00036 | 2.19108 | 13 | 27 | 254 | regulation of ion transmembrane transporter activity |
| GO:0002637 | 0.00036 | 3.60574 | 4 | 12 | 73 | regulation of immunoglobulin production |
| GO:0045670 | 0.00036 | 3.60574 | 4 | 12 | 73 | regulation of osteoclast differentiation |
| GO:0098742 | 0.00037 | 2.36420 | 11 | 23 | 202 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:1901698 | 0.00037 | 1.56183 | 51 | 76 | 982 | response to nitrogen compound |
| GO:0034121 | 0.00037 | 3.87567 | 3 | 11 | 63 | regulation of toll-like receptor signaling pathway |
| GO:0043616 | 0.00037 | 4.70700 | 2 | 9 | 44 | keratinocyte proliferation |
| GO:0042886 | 0.00038 | 1.41066 | 95 | 127 | 1817 | amide transport |
| GO:0009056 | 0.00038 | 1.37015 | 118 | 153 | 2257 | catabolic process |
| GO:0032945 | 0.00039 | 3.35732 | 4 | 13 | 84 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.00039 | 3.35732 | 4 | 13 | 84 | negative regulation of lymphocyte proliferation |
| GO:1904894 | 0.00039 | 3.02474 | 6 | 15 | 106 | positive regulation of STAT cascade |
| GO:0043583 | 0.00039 | 2.21663 | 13 | 26 | 242 | ear development |
| GO:0007173 | 0.00039 | 3.17041 | 5 | 14 | 95 | epidermal growth factor receptor signaling pathway |
| GO:0031344 | 0.00040 | 1.62954 | 41 | 63 | 781 | regulation of cell projection organization |
| GO:0048545 | 0.00040 | 2.30053 | 11 | 24 | 216 | response to steroid hormone |
| GO:0002577 | 0.00041 | 7.83292 | 1 | 6 | 20 | regulation of antigen processing and presentation |
| GO:0072087 | 0.00041 | 7.83292 | 1 | 6 | 20 | renal vesicle development |
| GO:0051345 | 0.00041 | 1.79049 | 27 | 45 | 510 | positive regulation of hydrolase activity |
| GO:0002532 | 0.00042 | 3.54742 | 4 | 12 | 74 | production of molecular mediator involved in inflammatory response |
| GO:0045453 | 0.00042 | 3.54742 | 4 | 12 | 74 | bone resorption |
| GO:2000648 | 0.00042 | 4.16199 | 3 | 10 | 54 | positive regulation of stem cell proliferation |
| GO:0007160 | 0.00042 | 2.33786 | 11 | 23 | 204 | cell-matrix adhesion |
| GO:0007189 | 0.00043 | 2.76249 | 7 | 17 | 130 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0003339 | 0.00043 | 18.25477 | 0 | 4 | 8 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0031394 | 0.00043 | 18.25477 | 0 | 4 | 8 | positive regulation of prostaglandin biosynthetic process |
| GO:0071578 | 0.00043 | 18.25477 | 0 | 4 | 8 | zinc ion import across plasma membrane |
| GO:0002861 | 0.00043 | 5.22731 | 2 | 8 | 36 | regulation of inflammatory response to antigenic stimulus |
| GO:0002920 | 0.00043 | 5.22731 | 2 | 8 | 36 | regulation of humoral immune response |
| GO:0033006 | 0.00043 | 5.22731 | 2 | 8 | 36 | regulation of mast cell activation involved in immune response |
| GO:0051384 | 0.00044 | 3.31054 | 4 | 13 | 85 | response to glucocorticoid |
| GO:0032965 | 0.00044 | 4.57604 | 2 | 9 | 45 | regulation of collagen biosynthetic process |
| GO:0007389 | 0.00045 | 1.82272 | 24 | 42 | 468 | pattern specification process |
| GO:0009059 | 0.00045 | 1.28049 | 215 | 259 | 4121 | macromolecule biosynthetic process |
| GO:0034204 | 0.00046 | 6.09540 | 1 | 7 | 28 | lipid translocation |
| GO:0060445 | 0.00046 | 6.09540 | 1 | 7 | 28 | branching involved in salivary gland morphogenesis |
| GO:0010634 | 0.00047 | 2.64496 | 7 | 18 | 143 | positive regulation of epithelial cell migration |
| GO:0061097 | 0.00047 | 3.49095 | 4 | 12 | 75 | regulation of protein tyrosine kinase activity |
| GO:0001894 | 0.00048 | 2.22308 | 12 | 25 | 232 | tissue homeostasis |
| GO:0002042 | 0.00049 | 4.06932 | 3 | 10 | 55 | cell migration involved in sprouting angiogenesis |
| GO:0055072 | 0.00049 | 3.26504 | 4 | 13 | 86 | iron ion homeostasis |
| GO:0002444 | 0.00049 | 3.09373 | 5 | 14 | 97 | myeloid leukocyte mediated immunity |
| GO:0051348 | 0.00051 | 2.17592 | 13 | 26 | 246 | negative regulation of transferase activity |
| GO:0019184 | 0.00051 | 10.14766 | 1 | 5 | 14 | nonribosomal peptide biosynthetic process |
| GO:0035815 | 0.00051 | 10.14766 | 1 | 5 | 14 | positive regulation of renal sodium excretion |
| GO:0010243 | 0.00052 | 1.57539 | 46 | 69 | 883 | response to organonitrogen compound |
| GO:0003382 | 0.00053 | 4.45216 | 2 | 9 | 46 | epithelial cell morphogenesis |
| GO:0035458 | 0.00053 | 4.45216 | 2 | 9 | 46 | cellular response to interferon-beta |
| GO:0002717 | 0.00053 | 5.04683 | 2 | 8 | 37 | positive regulation of natural killer cell mediated immunity |
| GO:0035850 | 0.00053 | 5.04683 | 2 | 8 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0045954 | 0.00053 | 5.04683 | 2 | 8 | 37 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0061756 | 0.00053 | 5.04683 | 2 | 8 | 37 | leukocyte adhesion to vascular endothelial cell |
| GO:0010769 | 0.00054 | 1.96347 | 18 | 33 | 343 | regulation of cell morphogenesis involved in differentiation |
| GO:0015691 | 0.00054 | 54.72637 | 0 | 3 | 4 | cadmium ion transport |
| GO:0043396 | 0.00054 | 54.72637 | 0 | 3 | 4 | corticotropin-releasing hormone secretion |
| GO:0043397 | 0.00054 | 54.72637 | 0 | 3 | 4 | regulation of corticotropin-releasing hormone secretion |
| GO:0043435 | 0.00054 | 54.72637 | 0 | 3 | 4 | response to corticotropin-releasing hormone |
| GO:0050923 | 0.00054 | 54.72637 | 0 | 3 | 4 | regulation of negative chemotaxis |
| GO:0070574 | 0.00054 | 54.72637 | 0 | 3 | 4 | cadmium ion transmembrane transport |
| GO:0071376 | 0.00054 | 54.72637 | 0 | 3 | 4 | cellular response to corticotropin-releasing hormone stimulus |
| GO:0019430 | 0.00054 | 7.31039 | 1 | 6 | 21 | removal of superoxide radicals |
| GO:0034694 | 0.00054 | 7.31039 | 1 | 6 | 21 | response to prostaglandin |
| GO:0051023 | 0.00054 | 7.31039 | 1 | 6 | 21 | regulation of immunoglobulin secretion |
| GO:1903409 | 0.00055 | 2.79676 | 6 | 16 | 121 | reactive oxygen species biosynthetic process |
| GO:2000117 | 0.00055 | 3.22077 | 5 | 13 | 87 | negative regulation of cysteine-type endopeptidase activity |
| GO:0003015 | 0.00055 | 2.24162 | 12 | 24 | 221 | heart process |
| GO:0046928 | 0.00056 | 2.69067 | 7 | 17 | 133 | regulation of neurotransmitter secretion |
| GO:1901568 | 0.00056 | 2.69067 | 7 | 17 | 133 | fatty acid derivative metabolic process |
| GO:0032623 | 0.00056 | 3.66377 | 3 | 11 | 66 | interleukin-2 production |
| GO:1901184 | 0.00056 | 3.66377 | 3 | 11 | 66 | regulation of ERBB signaling pathway |
| GO:0007588 | 0.00056 | 3.98067 | 3 | 10 | 56 | excretion |
| GO:0044281 | 0.00058 | 1.40174 | 91 | 122 | 1753 | small molecule metabolic process |
| GO:1903707 | 0.00059 | 2.51120 | 8 | 19 | 158 | negative regulation of hemopoiesis |
| GO:0006835 | 0.00060 | 3.38323 | 4 | 12 | 77 | dicarboxylic acid transport |
| GO:0050766 | 0.00060 | 3.38323 | 4 | 12 | 77 | positive regulation of phagocytosis |
| GO:0002820 | 0.00062 | 4.33480 | 2 | 9 | 47 | negative regulation of adaptive immune response |
| GO:0045429 | 0.00062 | 4.33480 | 2 | 9 | 47 | positive regulation of nitric oxide biosynthetic process |
| GO:0045581 | 0.00062 | 4.33480 | 2 | 9 | 47 | negative regulation of T cell differentiation |
| GO:0045907 | 0.00062 | 4.33480 | 2 | 9 | 47 | positive regulation of vasoconstriction |
| GO:0048880 | 0.00063 | 1.86616 | 21 | 37 | 403 | sensory system development |
| GO:0046006 | 0.00064 | 4.87838 | 2 | 8 | 38 | regulation of activated T cell proliferation |
| GO:1904645 | 0.00064 | 4.87838 | 2 | 8 | 38 | response to amyloid-beta |
| GO:2000403 | 0.00064 | 4.87838 | 2 | 8 | 38 | positive regulation of lymphocyte migration |
| GO:0071901 | 0.00064 | 2.86655 | 6 | 15 | 111 | negative regulation of protein serine/threonine kinase activity |
| GO:0006801 | 0.00064 | 3.59818 | 3 | 11 | 67 | superoxide metabolic process |
| GO:0006940 | 0.00064 | 3.59818 | 3 | 11 | 67 | regulation of smooth muscle contraction |
| GO:0042551 | 0.00065 | 3.89580 | 3 | 10 | 57 | neuron maturation |
| GO:0051961 | 0.00066 | 1.91793 | 19 | 34 | 361 | negative regulation of nervous system development |
| GO:0072330 | 0.00066 | 2.09767 | 14 | 27 | 264 | monocarboxylic acid biosynthetic process |
| GO:0048839 | 0.00068 | 2.25009 | 11 | 23 | 211 | inner ear development |
| GO:0060047 | 0.00068 | 2.25009 | 11 | 23 | 211 | heart contraction |
| GO:0001656 | 0.00069 | 3.13573 | 5 | 13 | 89 | metanephros development |
| GO:0097193 | 0.00069 | 2.03133 | 15 | 29 | 292 | intrinsic apoptotic signaling pathway |
| GO:0022604 | 0.00070 | 1.74074 | 27 | 45 | 523 | regulation of cell morphogenesis |
| GO:0031644 | 0.00071 | 2.40197 | 9 | 20 | 173 | regulation of neurological system process |
| GO:0001780 | 0.00072 | 6.85318 | 1 | 6 | 22 | neutrophil homeostasis |
| GO:0015874 | 0.00072 | 6.85318 | 1 | 6 | 22 | norepinephrine transport |
| GO:0032196 | 0.00072 | 6.85318 | 1 | 6 | 22 | transposition |
| GO:0032691 | 0.00072 | 6.85318 | 1 | 6 | 22 | negative regulation of interleukin-1 beta production |
| GO:0045063 | 0.00072 | 6.85318 | 1 | 6 | 22 | T-helper 1 cell differentiation |
| GO:0046641 | 0.00072 | 6.85318 | 1 | 6 | 22 | positive regulation of alpha-beta T cell proliferation |
| GO:0072273 | 0.00072 | 6.85318 | 1 | 6 | 22 | metanephric nephron morphogenesis |
| GO:0050905 | 0.00072 | 2.62248 | 7 | 17 | 136 | neuromuscular process |
| GO:2001056 | 0.00072 | 2.62248 | 7 | 17 | 136 | positive regulation of cysteine-type endopeptidase activity |
| GO:1903305 | 0.00072 | 2.33933 | 10 | 21 | 186 | regulation of regulated secretory pathway |
| GO:0002438 | 0.00072 | 5.56486 | 2 | 7 | 30 | acute inflammatory response to antigenic stimulus |
| GO:0002724 | 0.00072 | 5.56486 | 2 | 7 | 30 | regulation of T cell cytokine production |
| GO:0042533 | 0.00072 | 5.56486 | 2 | 7 | 30 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.00072 | 5.56486 | 2 | 7 | 30 | regulation of tumor necrosis factor biosynthetic process |
| GO:0044062 | 0.00072 | 5.56486 | 2 | 7 | 30 | regulation of excretion |
| GO:0061082 | 0.00072 | 5.56486 | 2 | 7 | 30 | myeloid leukocyte cytokine production |
| GO:0030857 | 0.00073 | 4.22346 | 3 | 9 | 48 | negative regulation of epithelial cell differentiation |
| GO:0032892 | 0.00073 | 4.22346 | 3 | 9 | 48 | positive regulation of organic acid transport |
| GO:1904407 | 0.00073 | 4.22346 | 3 | 9 | 48 | positive regulation of nitric oxide metabolic process |
| GO:0010935 | 0.00074 | 9.13248 | 1 | 5 | 15 | regulation of macrophage cytokine production |
| GO:0031650 | 0.00074 | 9.13248 | 1 | 5 | 15 | regulation of heat generation |
| GO:0035587 | 0.00074 | 9.13248 | 1 | 5 | 15 | purinergic receptor signaling pathway |
| GO:0045760 | 0.00074 | 9.13248 | 1 | 5 | 15 | positive regulation of action potential |
| GO:0048070 | 0.00074 | 9.13248 | 1 | 5 | 15 | regulation of developmental pigmentation |
| GO:0071280 | 0.00074 | 9.13248 | 1 | 5 | 15 | cellular response to copper ion |
| GO:0031622 | 0.00075 | 14.60315 | 0 | 4 | 9 | positive regulation of fever generation |
| GO:0050713 | 0.00075 | 14.60315 | 0 | 4 | 9 | negative regulation of interleukin-1 beta secretion |
| GO:0098900 | 0.00075 | 3.81446 | 3 | 10 | 58 | regulation of action potential |
| GO:0048663 | 0.00076 | 3.28194 | 4 | 12 | 79 | neuron fate commitment |
| GO:0030431 | 0.00077 | 4.72080 | 2 | 8 | 39 | sleep |
| GO:0031640 | 0.00077 | 4.72080 | 2 | 8 | 39 | killing of cells of other organism |
| GO:0044364 | 0.00077 | 4.72080 | 2 | 8 | 39 | disruption of cells of other organism |
| GO:0045927 | 0.00077 | 1.98830 | 16 | 30 | 308 | positive regulation of growth |
| GO:0008585 | 0.00077 | 2.80779 | 6 | 15 | 113 | female gonad development |
| GO:0010952 | 0.00080 | 2.44051 | 8 | 19 | 162 | positive regulation of peptidase activity |
| GO:0001822 | 0.00080 | 2.03801 | 15 | 28 | 281 | kidney development |
| GO:1902106 | 0.00082 | 2.91729 | 5 | 14 | 102 | negative regulation of leukocyte differentiation |
| GO:0008406 | 0.00082 | 2.21445 | 11 | 23 | 214 | gonad development |
| GO:0030888 | 0.00083 | 3.47379 | 4 | 11 | 69 | regulation of B cell proliferation |
| GO:2000107 | 0.00083 | 3.47379 | 4 | 11 | 69 | negative regulation of leukocyte apoptotic process |
| GO:0048864 | 0.00085 | 3.05504 | 5 | 13 | 91 | stem cell development |
| GO:0045682 | 0.00086 | 3.23352 | 4 | 12 | 80 | regulation of epidermis development |
| GO:0050852 | 0.00086 | 2.66902 | 7 | 16 | 126 | T cell receptor signaling pathway |
| GO:0048863 | 0.00086 | 2.16401 | 12 | 24 | 228 | stem cell differentiation |
| GO:0001755 | 0.00086 | 3.73645 | 3 | 10 | 59 | neural crest cell migration |
| GO:0015872 | 0.00086 | 3.73645 | 3 | 10 | 59 | dopamine transport |
| GO:2000401 | 0.00086 | 3.73645 | 3 | 10 | 59 | regulation of lymphocyte migration |
| GO:0007254 | 0.00089 | 2.24685 | 11 | 22 | 202 | JNK cascade |
| GO:0019884 | 0.00089 | 5.33274 | 2 | 7 | 31 | antigen processing and presentation of exogenous antigen |
| GO:0033081 | 0.00089 | 5.33274 | 2 | 7 | 31 | regulation of T cell differentiation in thymus |
| GO:2000515 | 0.00089 | 5.33274 | 2 | 7 | 31 | negative regulation of CD4-positive, alpha-beta T cell activation |
| GO:0048520 | 0.00092 | 4.57306 | 2 | 8 | 40 | positive regulation of behavior |
| GO:0070207 | 0.00092 | 4.57306 | 2 | 8 | 40 | protein homotrimerization |
| GO:0098801 | 0.00092 | 4.57306 | 2 | 8 | 40 | regulation of renal system process |
| GO:0043576 | 0.00093 | 6.44976 | 1 | 6 | 23 | regulation of respiratory gaseous exchange |
| GO:0071450 | 0.00093 | 6.44976 | 1 | 6 | 23 | cellular response to oxygen radical |
| GO:0071451 | 0.00093 | 6.44976 | 1 | 6 | 23 | cellular response to superoxide |
| GO:0046887 | 0.00093 | 2.40663 | 9 | 19 | 164 | positive regulation of hormone secretion |
| GO:0061387 | 0.00094 | 2.64486 | 7 | 16 | 127 | regulation of extent of cell growth |
| GO:0042130 | 0.00094 | 3.41476 | 4 | 11 | 70 | negative regulation of T cell proliferation |
| GO:0050890 | 0.00095 | 1.93631 | 17 | 31 | 326 | cognition |
| GO:2000243 | 0.00096 | 3.18652 | 4 | 12 | 81 | positive regulation of reproductive process |
| GO:0009890 | 0.00098 | 1.41090 | 79 | 106 | 1509 | negative regulation of biosynthetic process |
| GO:0009792 | 0.00099 | 1.55408 | 44 | 65 | 841 | embryo development ending in birth or egg hatching |
| GO:0033209 | 0.00099 | 3.66155 | 3 | 10 | 60 | tumor necrosis factor-mediated signaling pathway |
| GO:0045824 | 0.00099 | 3.66155 | 3 | 10 | 60 | negative regulation of innate immune response |
| GO:0010596 | 0.00099 | 4.01707 | 3 | 9 | 50 | negative regulation of endothelial cell migration |
| GO:0071622 | 0.00099 | 4.01707 | 3 | 9 | 50 | regulation of granulocyte chemotaxis |
| GO:0001657 | 0.00100 | 2.85220 | 5 | 14 | 104 | ureteric bud development |
| GO:0072163 | 0.00100 | 2.85220 | 5 | 14 | 104 | mesonephric epithelium development |
| GO:0072164 | 0.00100 | 2.85220 | 5 | 14 | 104 | mesonephric tubule development |
| GO:0046425 | 0.00100 | 2.39004 | 9 | 19 | 165 | regulation of JAK-STAT cascade |
| GO:0050921 | 0.00100 | 2.53674 | 7 | 17 | 140 | positive regulation of chemotaxis |
| GO:0017157 | 0.00101 | 2.10011 | 13 | 25 | 244 | regulation of exocytosis |
| GO:0071560 | 0.00101 | 2.22196 | 11 | 22 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:0030282 | 0.00102 | 2.72402 | 6 | 15 | 116 | bone mineralization |
| GO:0046545 | 0.00102 | 2.72402 | 6 | 15 | 116 | development of primary female sexual characteristics |
| GO:1901360 | 0.00102 | 1.23758 | 271 | 316 | 5208 | organic cyclic compound metabolic process |
| GO:0002281 | 0.00103 | 8.30187 | 1 | 5 | 16 | macrophage activation involved in immune response |
| GO:0006825 | 0.00103 | 8.30187 | 1 | 5 | 16 | copper ion transport |
| GO:0016322 | 0.00103 | 8.30187 | 1 | 5 | 16 | neuron remodeling |
| GO:0032230 | 0.00103 | 8.30187 | 1 | 5 | 16 | positive regulation of synaptic transmission, GABAergic |
| GO:0051709 | 0.00103 | 8.30187 | 1 | 5 | 16 | regulation of killing of cells of other organism |
| GO:0032870 | 0.00104 | 1.71527 | 27 | 44 | 518 | cellular response to hormone stimulus |
| GO:0051817 | 0.00104 | 2.97840 | 5 | 13 | 93 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0010950 | 0.00105 | 2.44791 | 8 | 18 | 153 | positive regulation of endopeptidase activity |
| GO:0061045 | 0.00106 | 3.35769 | 4 | 11 | 71 | negative regulation of wound healing |
| GO:0045137 | 0.00106 | 2.16863 | 11 | 23 | 218 | development of primary sexual characteristics |
| GO:1903034 | 0.00109 | 2.31070 | 9 | 20 | 179 | regulation of response to wounding |
| GO:1903672 | 0.00109 | 4.43428 | 2 | 8 | 41 | positive regulation of sprouting angiogenesis |
| GO:0032689 | 0.00109 | 5.11920 | 2 | 7 | 32 | negative regulation of interferon-gamma production |
| GO:0045672 | 0.00109 | 5.11920 | 2 | 7 | 32 | positive regulation of osteoclast differentiation |
| GO:0038127 | 0.00109 | 2.82073 | 5 | 14 | 105 | ERBB signaling pathway |
| GO:0009410 | 0.00110 | 2.12201 | 12 | 24 | 232 | response to xenobiotic stimulus |
| GO:1903307 | 0.00113 | 3.58959 | 3 | 10 | 61 | positive regulation of regulated secretory pathway |
| GO:1903428 | 0.00113 | 3.58959 | 3 | 10 | 61 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0050819 | 0.00115 | 3.92125 | 3 | 9 | 51 | negative regulation of coagulation |
| GO:0061844 | 0.00116 | 2.94149 | 5 | 13 | 94 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0002693 | 0.00118 | 6.09116 | 1 | 6 | 24 | positive regulation of cellular extravasation |
| GO:0030728 | 0.00118 | 6.09116 | 1 | 6 | 24 | ovulation |
| GO:0035813 | 0.00118 | 6.09116 | 1 | 6 | 24 | regulation of renal sodium excretion |
| GO:0002420 | 0.00119 | 12.16874 | 1 | 4 | 10 | natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0002858 | 0.00119 | 12.16874 | 1 | 4 | 10 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0031620 | 0.00119 | 12.16874 | 1 | 4 | 10 | regulation of fever generation |
| GO:0032621 | 0.00119 | 12.16874 | 1 | 4 | 10 | interleukin-18 production |
| GO:0033029 | 0.00119 | 12.16874 | 1 | 4 | 10 | regulation of neutrophil apoptotic process |
| GO:0052803 | 0.00119 | 12.16874 | 1 | 4 | 10 | imidazole-containing compound metabolic process |
| GO:0060907 | 0.00119 | 12.16874 | 1 | 4 | 10 | positive regulation of macrophage cytokine production |
| GO:1904468 | 0.00119 | 12.16874 | 1 | 4 | 10 | negative regulation of tumor necrosis factor secretion |
| GO:2001280 | 0.00119 | 12.16874 | 1 | 4 | 10 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0008277 | 0.00120 | 2.57490 | 7 | 16 | 130 | regulation of G protein-coupled receptor signaling pathway |
| GO:0046330 | 0.00127 | 2.47600 | 7 | 17 | 143 | positive regulation of JNK cascade |
| GO:0050804 | 0.00127 | 1.61319 | 34 | 53 | 661 | modulation of chemical synaptic transmission |
| GO:0002823 | 0.00128 | 4.30367 | 2 | 8 | 42 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0010883 | 0.00128 | 4.30367 | 2 | 8 | 42 | regulation of lipid storage |
| GO:0032768 | 0.00128 | 4.30367 | 2 | 8 | 42 | regulation of monooxygenase activity |
| GO:0001922 | 0.00130 | 27.36194 | 0 | 3 | 5 | B-1 B cell homeostasis |
| GO:0002678 | 0.00130 | 27.36194 | 0 | 3 | 5 | positive regulation of chronic inflammatory response |
| GO:0006548 | 0.00130 | 27.36194 | 0 | 3 | 5 | histidine catabolic process |
| GO:0031632 | 0.00130 | 27.36194 | 0 | 3 | 5 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0035771 | 0.00130 | 27.36194 | 0 | 3 | 5 | interleukin-4-mediated signaling pathway |
| GO:0045341 | 0.00130 | 27.36194 | 0 | 3 | 5 | MHC class I biosynthetic process |
| GO:0045343 | 0.00130 | 27.36194 | 0 | 3 | 5 | regulation of MHC class I biosynthetic process |
| GO:0045345 | 0.00130 | 27.36194 | 0 | 3 | 5 | positive regulation of MHC class I biosynthetic process |
| GO:0045636 | 0.00130 | 27.36194 | 0 | 3 | 5 | positive regulation of melanocyte differentiation |
| GO:0070424 | 0.00130 | 27.36194 | 0 | 3 | 5 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070432 | 0.00130 | 27.36194 | 0 | 3 | 5 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0070460 | 0.00130 | 27.36194 | 0 | 3 | 5 | thyroid-stimulating hormone secretion |
| GO:0099502 | 0.00130 | 27.36194 | 0 | 3 | 5 | calcium-dependent activation of synaptic vesicle fusion |
| GO:1903969 | 0.00130 | 27.36194 | 0 | 3 | 5 | regulation of response to macrophage colony-stimulating factor |
| GO:1903972 | 0.00130 | 27.36194 | 0 | 3 | 5 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:2000697 | 0.00130 | 27.36194 | 0 | 3 | 5 | negative regulation of epithelial cell differentiation involved in kidney development |
| GO:0071559 | 0.00130 | 2.17377 | 11 | 22 | 208 | response to transforming growth factor beta |
| GO:0015696 | 0.00131 | 2.55240 | 7 | 16 | 131 | ammonium transport |
| GO:0099177 | 0.00131 | 1.61047 | 34 | 53 | 662 | regulation of trans-synaptic signaling |
| GO:0001823 | 0.00132 | 2.75981 | 6 | 14 | 107 | mesonephros development |
| GO:0002691 | 0.00132 | 4.92208 | 2 | 7 | 33 | regulation of cellular extravasation |
| GO:0034142 | 0.00132 | 4.92208 | 2 | 7 | 33 | toll-like receptor 4 signaling pathway |
| GO:1904467 | 0.00132 | 4.92208 | 2 | 7 | 33 | regulation of tumor necrosis factor secretion |
| GO:0043280 | 0.00132 | 2.64508 | 6 | 15 | 119 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0120035 | 0.00133 | 1.56137 | 40 | 60 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0007259 | 0.00133 | 2.26760 | 9 | 20 | 182 | JAK-STAT cascade |
| GO:0016331 | 0.00133 | 2.26760 | 9 | 20 | 182 | morphogenesis of embryonic epithelium |
| GO:0008361 | 0.00139 | 2.16205 | 11 | 22 | 209 | regulation of cell size |
| GO:0002922 | 0.00139 | 7.60970 | 1 | 5 | 17 | positive regulation of humoral immune response |
| GO:0010934 | 0.00139 | 7.60970 | 1 | 5 | 17 | macrophage cytokine production |
| GO:0044406 | 0.00139 | 7.60970 | 1 | 5 | 17 | adhesion of symbiont to host |
| GO:0045410 | 0.00139 | 7.60970 | 1 | 5 | 17 | positive regulation of interleukin-6 biosynthetic process |
| GO:0090195 | 0.00139 | 7.60970 | 1 | 5 | 17 | chemokine secretion |
| GO:0009894 | 0.00139 | 1.54064 | 43 | 63 | 821 | regulation of catabolic process |
| GO:1904892 | 0.00142 | 2.31037 | 9 | 19 | 170 | regulation of STAT cascade |
| GO:0010975 | 0.00144 | 1.63529 | 31 | 49 | 603 | regulation of neuron projection development |
| GO:0035725 | 0.00144 | 2.73033 | 6 | 14 | 108 | sodium ion transmembrane transport |
| GO:0010830 | 0.00146 | 3.45382 | 3 | 10 | 63 | regulation of myotube differentiation |
| GO:0032970 | 0.00147 | 1.80233 | 20 | 35 | 393 | regulation of actin filament-based process |
| GO:0014032 | 0.00147 | 3.01136 | 4 | 12 | 85 | neural crest cell development |
| GO:0014910 | 0.00147 | 3.01136 | 4 | 12 | 85 | regulation of smooth muscle cell migration |
| GO:0051341 | 0.00147 | 3.01136 | 4 | 12 | 85 | regulation of oxidoreductase activity |
| GO:0002478 | 0.00149 | 5.77031 | 1 | 6 | 25 | antigen processing and presentation of exogenous peptide antigen |
| GO:0010640 | 0.00149 | 5.77031 | 1 | 6 | 25 | regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0085029 | 0.00149 | 5.77031 | 1 | 6 | 25 | extracellular matrix assembly |
| GO:0150077 | 0.00149 | 5.77031 | 1 | 6 | 25 | regulation of neuroinflammatory response |
| GO:0006919 | 0.00150 | 3.19737 | 4 | 11 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:1903201 | 0.00150 | 3.19737 | 4 | 11 | 74 | regulation of oxidative stress-induced cell death |
| GO:1901031 | 0.00151 | 4.18052 | 2 | 8 | 43 | regulation of response to reactive oxygen species |
| GO:0030100 | 0.00151 | 1.94465 | 15 | 28 | 293 | regulation of endocytosis |
| GO:0043009 | 0.00152 | 1.53435 | 43 | 63 | 824 | chordate embryonic development |
| GO:1901361 | 0.00152 | 1.68941 | 27 | 43 | 513 | organic cyclic compound catabolic process |
| GO:0043271 | 0.00153 | 2.29506 | 9 | 19 | 171 | negative regulation of ion transport |
| GO:0010595 | 0.00155 | 2.83605 | 5 | 13 | 97 | positive regulation of endothelial cell migration |
| GO:0045444 | 0.00156 | 2.06194 | 12 | 24 | 238 | fat cell differentiation |
| GO:0030029 | 0.00158 | 1.56102 | 39 | 58 | 746 | actin filament-based process |
| GO:0018958 | 0.00158 | 2.70147 | 6 | 14 | 109 | phenol-containing compound metabolic process |
| GO:0010558 | 0.00159 | 1.40302 | 74 | 99 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:0072006 | 0.00159 | 2.41808 | 8 | 17 | 146 | nephron development |
| GO:0008045 | 0.00159 | 4.73957 | 2 | 7 | 34 | motor neuron axon guidance |
| GO:0070588 | 0.00160 | 1.96356 | 15 | 27 | 280 | calcium ion transmembrane transport |
| GO:0050768 | 0.00161 | 1.86576 | 18 | 31 | 337 | negative regulation of neurogenesis |
| GO:0007269 | 0.00163 | 2.22606 | 10 | 20 | 185 | neurotransmitter secretion |
| GO:0015908 | 0.00163 | 2.97053 | 4 | 12 | 86 | fatty acid transport |
| GO:0007566 | 0.00165 | 3.38971 | 3 | 10 | 64 | embryo implantation |
| GO:0070373 | 0.00167 | 3.14726 | 4 | 11 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0006725 | 0.00170 | 1.22809 | 261 | 303 | 5012 | cellular aromatic compound metabolic process |
| GO:0070227 | 0.00170 | 2.80256 | 5 | 13 | 98 | lymphocyte apoptotic process |
| GO:0046660 | 0.00171 | 2.39937 | 8 | 17 | 147 | female sex differentiation |
| GO:0099643 | 0.00173 | 2.21255 | 10 | 20 | 186 | signal release from synapse |
| GO:0031214 | 0.00174 | 2.32650 | 8 | 18 | 160 | biomineral tissue development |
| GO:0035821 | 0.00174 | 2.32650 | 8 | 18 | 160 | modification of morphology or physiology of other organism |
| GO:1903169 | 0.00174 | 2.32650 | 8 | 18 | 160 | regulation of calcium ion transmembrane transport |
| GO:0007585 | 0.00175 | 3.65933 | 3 | 9 | 54 | respiratory gaseous exchange |
| GO:0032964 | 0.00175 | 3.65933 | 3 | 9 | 54 | collagen biosynthetic process |
| GO:0045687 | 0.00175 | 3.65933 | 3 | 9 | 54 | positive regulation of glial cell differentiation |
| GO:0050922 | 0.00175 | 3.65933 | 3 | 9 | 54 | negative regulation of chemotaxis |
| GO:2000351 | 0.00175 | 3.65933 | 3 | 9 | 54 | regulation of endothelial cell apoptotic process |
| GO:0043124 | 0.00176 | 4.06421 | 2 | 8 | 44 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0050919 | 0.00176 | 4.06421 | 2 | 8 | 44 | negative chemotaxis |
| GO:0051253 | 0.00177 | 1.42043 | 66 | 90 | 1269 | negative regulation of RNA metabolic process |
| GO:0051260 | 0.00180 | 1.79520 | 20 | 34 | 383 | protein homooligomerization |
| GO:0002423 | 0.00180 | 10.42988 | 1 | 4 | 11 | natural killer cell mediated immune response to tumor cell |
| GO:0002664 | 0.00180 | 10.42988 | 1 | 4 | 11 | regulation of T cell tolerance induction |
| GO:0002676 | 0.00180 | 10.42988 | 1 | 4 | 11 | regulation of chronic inflammatory response |
| GO:0002855 | 0.00180 | 10.42988 | 1 | 4 | 11 | regulation of natural killer cell mediated immune response to tumor cell |
| GO:0017085 | 0.00180 | 10.42988 | 1 | 4 | 11 | response to insecticide |
| GO:0021559 | 0.00180 | 10.42988 | 1 | 4 | 11 | trigeminal nerve development |
| GO:0031392 | 0.00180 | 10.42988 | 1 | 4 | 11 | regulation of prostaglandin biosynthetic process |
| GO:0032490 | 0.00180 | 10.42988 | 1 | 4 | 11 | detection of molecule of bacterial origin |
| GO:2000343 | 0.00180 | 10.42988 | 1 | 4 | 11 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0002690 | 0.00180 | 2.93079 | 5 | 12 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0051607 | 0.00181 | 2.07210 | 12 | 23 | 227 | defense response to virus |
| GO:0031327 | 0.00184 | 1.38864 | 77 | 102 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0002031 | 0.00184 | 7.02402 | 1 | 5 | 18 | G protein-coupled receptor internalization |
| GO:0007252 | 0.00184 | 7.02402 | 1 | 5 | 18 | I-kappaB phosphorylation |
| GO:0010801 | 0.00184 | 7.02402 | 1 | 5 | 18 | negative regulation of peptidyl-threonine phosphorylation |
| GO:0032674 | 0.00184 | 7.02402 | 1 | 5 | 18 | regulation of interleukin-5 production |
| GO:0043252 | 0.00184 | 7.02402 | 1 | 5 | 18 | sodium-independent organic anion transport |
| GO:0000303 | 0.00185 | 5.48155 | 1 | 6 | 26 | response to superoxide |
| GO:0007263 | 0.00185 | 5.48155 | 1 | 6 | 26 | nitric oxide mediated signal transduction |
| GO:0009713 | 0.00185 | 5.48155 | 1 | 6 | 26 | catechol-containing compound biosynthetic process |
| GO:0035812 | 0.00185 | 5.48155 | 1 | 6 | 26 | renal sodium excretion |
| GO:0042104 | 0.00185 | 5.48155 | 1 | 6 | 26 | positive regulation of activated T cell proliferation |
| GO:0042423 | 0.00185 | 5.48155 | 1 | 6 | 26 | catecholamine biosynthetic process |
| GO:0097696 | 0.00185 | 2.19920 | 10 | 20 | 187 | STAT cascade |
| GO:0051153 | 0.00185 | 2.54665 | 6 | 15 | 123 | regulation of striated muscle cell differentiation |
| GO:0045921 | 0.00187 | 2.76984 | 5 | 13 | 99 | positive regulation of exocytosis |
| GO:0048639 | 0.00188 | 2.10526 | 11 | 22 | 214 | positive regulation of developmental growth |
| GO:1901652 | 0.00188 | 1.78999 | 20 | 34 | 384 | response to peptide |
| GO:0008637 | 0.00188 | 2.64552 | 6 | 14 | 111 | apoptotic mitochondrial changes |
| GO:0032228 | 0.00190 | 4.57009 | 2 | 7 | 35 | regulation of synaptic transmission, GABAergic |
| GO:0046686 | 0.00190 | 4.57009 | 2 | 7 | 35 | response to cadmium ion |
| GO:1990774 | 0.00190 | 4.57009 | 2 | 7 | 35 | tumor necrosis factor secretion |
| GO:0046328 | 0.00197 | 2.18601 | 10 | 20 | 188 | regulation of JNK cascade |
| GO:0150063 | 0.00198 | 1.76719 | 21 | 35 | 400 | visual system development |
| GO:0033077 | 0.00199 | 2.89210 | 5 | 12 | 88 | T cell differentiation in thymus |
| GO:0044344 | 0.00199 | 2.89210 | 5 | 12 | 88 | cellular response to fibroblast growth factor stimulus |
| GO:0045058 | 0.00200 | 3.57962 | 3 | 9 | 55 | T cell selection |
| GO:0050732 | 0.00200 | 3.57962 | 3 | 9 | 55 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0033138 | 0.00201 | 2.52317 | 6 | 15 | 124 | positive regulation of peptidyl-serine phosphorylation |
| GO:0044703 | 0.00203 | 1.46072 | 54 | 75 | 1028 | multi-organism reproductive process |
| GO:0002534 | 0.00204 | 3.95418 | 2 | 8 | 45 | cytokine production involved in inflammatory response |
| GO:0002888 | 0.00204 | 3.95418 | 2 | 8 | 45 | positive regulation of myeloid leukocyte mediated immunity |
| GO:0014046 | 0.00204 | 3.95418 | 2 | 8 | 45 | dopamine secretion |
| GO:0014059 | 0.00204 | 3.95418 | 2 | 8 | 45 | regulation of dopamine secretion |
| GO:0043123 | 0.00205 | 2.61841 | 6 | 14 | 112 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:1905330 | 0.00205 | 2.61841 | 6 | 14 | 112 | regulation of morphogenesis of an epithelium |
| GO:0048762 | 0.00211 | 2.08337 | 11 | 22 | 216 | mesenchymal cell differentiation |
| GO:0009628 | 0.00213 | 1.45752 | 54 | 75 | 1030 | response to abiotic stimulus |
| GO:0010721 | 0.00213 | 1.77453 | 20 | 34 | 387 | negative regulation of cell development |
| GO:0001701 | 0.00217 | 1.64429 | 28 | 44 | 538 | in utero embryonic development |
| GO:0045926 | 0.00218 | 1.97265 | 13 | 25 | 258 | negative regulation of growth |
| GO:1904035 | 0.00220 | 2.85441 | 5 | 12 | 89 | regulation of epithelial cell apoptotic process |
| GO:0001952 | 0.00223 | 2.59184 | 6 | 14 | 113 | regulation of cell-matrix adhesion |
| GO:1904019 | 0.00223 | 2.59184 | 6 | 14 | 113 | epithelial cell apoptotic process |
| GO:0034641 | 0.00224 | 1.21316 | 289 | 331 | 5547 | cellular nitrogen compound metabolic process |
| GO:0051953 | 0.00226 | 4.41230 | 2 | 7 | 36 | negative regulation of amine transport |
| GO:0071398 | 0.00226 | 4.41230 | 2 | 7 | 36 | cellular response to fatty acid |
| GO:0000305 | 0.00227 | 5.22028 | 1 | 6 | 27 | response to oxygen radical |
| GO:0003338 | 0.00227 | 5.22028 | 1 | 6 | 27 | metanephros morphogenesis |
| GO:0044342 | 0.00227 | 5.22028 | 1 | 6 | 27 | type B pancreatic cell proliferation |
| GO:0045061 | 0.00227 | 5.22028 | 1 | 6 | 27 | thymic T cell selection |
| GO:0060713 | 0.00227 | 5.22028 | 1 | 6 | 27 | labyrinthine layer morphogenesis |
| GO:0061099 | 0.00227 | 5.22028 | 1 | 6 | 27 | negative regulation of protein tyrosine kinase activity |
| GO:0045620 | 0.00227 | 3.50330 | 3 | 9 | 56 | negative regulation of lymphocyte differentiation |
| GO:1900449 | 0.00227 | 3.50330 | 3 | 9 | 56 | regulation of glutamate receptor signaling pathway |
| GO:0017144 | 0.00230 | 1.54393 | 38 | 56 | 727 | drug metabolic process |
| GO:0060688 | 0.00234 | 3.21086 | 3 | 10 | 67 | regulation of morphogenesis of a branching structure |
| GO:0010799 | 0.00236 | 3.84995 | 2 | 8 | 46 | regulation of peptidyl-threonine phosphorylation |
| GO:0050798 | 0.00236 | 3.84995 | 2 | 8 | 46 | activated T cell proliferation |
| GO:1902667 | 0.00236 | 3.84995 | 2 | 8 | 46 | regulation of axon guidance |
| GO:0007548 | 0.00239 | 1.90268 | 15 | 27 | 288 | sex differentiation |
| GO:0002726 | 0.00240 | 6.52201 | 1 | 5 | 19 | positive regulation of T cell cytokine production |
| GO:0010528 | 0.00240 | 6.52201 | 1 | 5 | 19 | regulation of transposition |
| GO:0010529 | 0.00240 | 6.52201 | 1 | 5 | 19 | negative regulation of transposition |
| GO:0030502 | 0.00240 | 6.52201 | 1 | 5 | 19 | negative regulation of bone mineralization |
| GO:0032634 | 0.00240 | 6.52201 | 1 | 5 | 19 | interleukin-5 production |
| GO:0051818 | 0.00240 | 6.52201 | 1 | 5 | 19 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0051883 | 0.00240 | 6.52201 | 1 | 5 | 19 | killing of cells in other organism involved in symbiotic interaction |
| GO:0061081 | 0.00240 | 6.52201 | 1 | 5 | 19 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
| GO:0072189 | 0.00240 | 6.52201 | 1 | 5 | 19 | ureter development |
| GO:0090026 | 0.00240 | 6.52201 | 1 | 5 | 19 | positive regulation of monocyte chemotaxis |
| GO:0014031 | 0.00242 | 2.81769 | 5 | 12 | 90 | mesenchymal cell development |
| GO:0071774 | 0.00242 | 2.81769 | 5 | 12 | 90 | response to fibroblast growth factor |
| GO:0030216 | 0.00242 | 2.38551 | 7 | 16 | 139 | keratinocyte differentiation |
| GO:0042113 | 0.00243 | 1.74291 | 21 | 35 | 405 | B cell activation |
| GO:0080135 | 0.00246 | 1.56549 | 35 | 52 | 666 | regulation of cellular response to stress |
| GO:0010273 | 0.00250 | 18.24046 | 0 | 3 | 6 | detoxification of copper ion |
| GO:0010572 | 0.00250 | 18.24046 | 0 | 3 | 6 | positive regulation of platelet activation |
| GO:0021960 | 0.00250 | 18.24046 | 0 | 3 | 6 | anterior commissure morphogenesis |
| GO:0043305 | 0.00250 | 18.24046 | 0 | 3 | 6 | negative regulation of mast cell degranulation |
| GO:0052805 | 0.00250 | 18.24046 | 0 | 3 | 6 | imidazole-containing compound catabolic process |
| GO:0060708 | 0.00250 | 18.24046 | 0 | 3 | 6 | spongiotrophoblast differentiation |
| GO:0071895 | 0.00250 | 18.24046 | 0 | 3 | 6 | odontoblast differentiation |
| GO:0090027 | 0.00250 | 18.24046 | 0 | 3 | 6 | negative regulation of monocyte chemotaxis |
| GO:0097647 | 0.00250 | 18.24046 | 0 | 3 | 6 | amylin receptor signaling pathway |
| GO:1903935 | 0.00250 | 18.24046 | 0 | 3 | 6 | response to sodium arsenite |
| GO:1990169 | 0.00250 | 18.24046 | 0 | 3 | 6 | stress response to copper ion |
| GO:2000321 | 0.00250 | 18.24046 | 0 | 3 | 6 | positive regulation of T-helper 17 cell differentiation |
| GO:2000427 | 0.00250 | 18.24046 | 0 | 3 | 6 | positive regulation of apoptotic cell clearance |
| GO:2000659 | 0.00250 | 18.24046 | 0 | 3 | 6 | regulation of interleukin-1-mediated signaling pathway |
| GO:1901615 | 0.00251 | 1.67284 | 25 | 40 | 481 | organic hydroxy compound metabolic process |
| GO:0099536 | 0.00251 | 1.48837 | 46 | 65 | 874 | synaptic signaling |
| GO:0045071 | 0.00258 | 3.43016 | 3 | 9 | 57 | negative regulation of viral genome replication |
| GO:0072577 | 0.00258 | 3.43016 | 3 | 9 | 57 | endothelial cell apoptotic process |
| GO:0006750 | 0.00259 | 9.12573 | 1 | 4 | 12 | glutathione biosynthetic process |
| GO:0033004 | 0.00259 | 9.12573 | 1 | 4 | 12 | negative regulation of mast cell activation |
| GO:0045625 | 0.00259 | 9.12573 | 1 | 4 | 12 | regulation of T-helper 1 cell differentiation |
| GO:0051024 | 0.00259 | 9.12573 | 1 | 4 | 12 | positive regulation of immunoglobulin secretion |
| GO:0009308 | 0.00266 | 2.78189 | 5 | 12 | 91 | amine metabolic process |
| GO:0021954 | 0.00266 | 2.78189 | 5 | 12 | 91 | central nervous system neuron development |
| GO:0001782 | 0.00266 | 4.26503 | 2 | 7 | 37 | B cell homeostasis |
| GO:0002753 | 0.00266 | 4.26503 | 2 | 7 | 37 | cytoplasmic pattern recognition receptor signaling pathway |
| GO:0007435 | 0.00266 | 4.26503 | 2 | 7 | 37 | salivary gland morphogenesis |
| GO:0048665 | 0.00266 | 4.26503 | 2 | 7 | 37 | neuron fate specification |
| GO:0001970 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of activation of membrane attack complex |
| GO:0003404 | 0.00271 | Inf | 0 | 2 | 2 | optic vesicle morphogenesis |
| GO:0015939 | 0.00271 | Inf | 0 | 2 | 2 | pantothenate metabolic process |
| GO:0016107 | 0.00271 | Inf | 0 | 2 | 2 | sesquiterpenoid catabolic process |
| GO:0016487 | 0.00271 | Inf | 0 | 2 | 2 | farnesol metabolic process |
| GO:0016488 | 0.00271 | Inf | 0 | 2 | 2 | farnesol catabolic process |
| GO:0021622 | 0.00271 | Inf | 0 | 2 | 2 | oculomotor nerve morphogenesis |
| GO:0021623 | 0.00271 | Inf | 0 | 2 | 2 | oculomotor nerve formation |
| GO:0021784 | 0.00271 | Inf | 0 | 2 | 2 | postganglionic parasympathetic fiber development |
| GO:0021985 | 0.00271 | Inf | 0 | 2 | 2 | neurohypophysis development |
| GO:0032639 | 0.00271 | Inf | 0 | 2 | 2 | TRAIL production |
| GO:0032679 | 0.00271 | Inf | 0 | 2 | 2 | regulation of TRAIL production |
| GO:0032759 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of TRAIL production |
| GO:0034775 | 0.00271 | Inf | 0 | 2 | 2 | glutathione transmembrane transport |
| GO:0035443 | 0.00271 | Inf | 0 | 2 | 2 | tripeptide transmembrane transport |
| GO:0035846 | 0.00271 | Inf | 0 | 2 | 2 | oviduct epithelium development |
| GO:0035847 | 0.00271 | Inf | 0 | 2 | 2 | uterine epithelium development |
| GO:0038041 | 0.00271 | Inf | 0 | 2 | 2 | cross-receptor inhibition within G protein-coupled receptor heterodimer |
| GO:0045105 | 0.00271 | Inf | 0 | 2 | 2 | intermediate filament polymerization or depolymerization |
| GO:0045751 | 0.00271 | Inf | 0 | 2 | 2 | negative regulation of Toll signaling pathway |
| GO:0050712 | 0.00271 | Inf | 0 | 2 | 2 | negative regulation of interleukin-1 alpha secretion |
| GO:0050902 | 0.00271 | Inf | 0 | 2 | 2 | leukocyte adhesive activation |
| GO:0052551 | 0.00271 | Inf | 0 | 2 | 2 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction |
| GO:0052565 | 0.00271 | Inf | 0 | 2 | 2 | response to defense-related host nitric oxide production |
| GO:0055073 | 0.00271 | Inf | 0 | 2 | 2 | cadmium ion homeostasis |
| GO:0060370 | 0.00271 | Inf | 0 | 2 | 2 | susceptibility to T cell mediated cytotoxicity |
| GO:0070104 | 0.00271 | Inf | 0 | 2 | 2 | negative regulation of interleukin-6-mediated signaling pathway |
| GO:0070426 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070434 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0071105 | 0.00271 | Inf | 0 | 2 | 2 | response to interleukin-11 |
| GO:0072272 | 0.00271 | Inf | 0 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0099039 | 0.00271 | Inf | 0 | 2 | 2 | sphingolipid translocation |
| GO:0100001 | 0.00271 | Inf | 0 | 2 | 2 | regulation of skeletal muscle contraction by action potential |
| GO:1901329 | 0.00271 | Inf | 0 | 2 | 2 | regulation of odontoblast differentiation |
| GO:1902216 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of interleukin-4-mediated signaling pathway |
| GO:2000295 | 0.00271 | Inf | 0 | 2 | 2 | regulation of hydrogen peroxide catabolic process |
| GO:2000768 | 0.00271 | Inf | 0 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
| GO:0001504 | 0.00272 | 3.75106 | 2 | 8 | 47 | neurotransmitter uptake |
| GO:0002639 | 0.00272 | 3.75106 | 2 | 8 | 47 | positive regulation of immunoglobulin production |
| GO:2001239 | 0.00272 | 3.75106 | 2 | 8 | 47 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0048511 | 0.00276 | 1.88080 | 15 | 27 | 291 | rhythmic process |
| GO:0001945 | 0.00277 | 4.98277 | 1 | 6 | 28 | lymph vessel development |
| GO:0021952 | 0.00277 | 4.98277 | 1 | 6 | 28 | central nervous system projection neuron axonogenesis |
| GO:0045822 | 0.00277 | 4.98277 | 1 | 6 | 28 | negative regulation of heart contraction |
| GO:0051957 | 0.00277 | 4.98277 | 1 | 6 | 28 | positive regulation of amino acid transport |
| GO:0072539 | 0.00277 | 4.98277 | 1 | 6 | 28 | T-helper 17 cell differentiation |
| GO:0016042 | 0.00284 | 1.85261 | 16 | 28 | 306 | lipid catabolic process |
| GO:0030308 | 0.00285 | 2.11005 | 10 | 20 | 194 | negative regulation of cell growth |
| GO:0061326 | 0.00291 | 2.61706 | 5 | 13 | 104 | renal tubule development |
| GO:0014033 | 0.00291 | 2.74699 | 5 | 12 | 92 | neural crest cell differentiation |
| GO:0014909 | 0.00291 | 2.74699 | 5 | 12 | 92 | smooth muscle cell migration |
| GO:0032663 | 0.00291 | 3.36000 | 3 | 9 | 58 | regulation of interleukin-2 production |
| GO:0070231 | 0.00291 | 3.36000 | 3 | 9 | 58 | T cell apoptotic process |
| GO:0010633 | 0.00293 | 3.10174 | 4 | 10 | 69 | negative regulation of epithelial cell migration |
| GO:0021536 | 0.00293 | 3.10174 | 4 | 10 | 69 | diencephalon development |
| GO:0032370 | 0.00293 | 3.10174 | 4 | 10 | 69 | positive regulation of lipid transport |
| GO:0043299 | 0.00293 | 3.10174 | 4 | 10 | 69 | leukocyte degranulation |
| GO:1903670 | 0.00293 | 3.10174 | 4 | 10 | 69 | regulation of sprouting angiogenesis |
| GO:0010629 | 0.00294 | 1.33430 | 93 | 119 | 1783 | negative regulation of gene expression |
| GO:0035690 | 0.00295 | 1.75112 | 20 | 33 | 380 | cellular response to drug |
| GO:0042692 | 0.00296 | 1.73457 | 21 | 34 | 395 | muscle cell differentiation |
| GO:0099537 | 0.00304 | 1.47937 | 45 | 64 | 865 | trans-synaptic signaling |
| GO:0051235 | 0.00305 | 1.82082 | 17 | 29 | 322 | maintenance of location |
| GO:0001946 | 0.00306 | 6.08693 | 1 | 5 | 20 | lymphangiogenesis |
| GO:0002755 | 0.00306 | 6.08693 | 1 | 5 | 20 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0010039 | 0.00306 | 6.08693 | 1 | 5 | 20 | response to iron ion |
| GO:0043011 | 0.00306 | 6.08693 | 1 | 5 | 20 | myeloid dendritic cell differentiation |
| GO:0045649 | 0.00306 | 6.08693 | 1 | 5 | 20 | regulation of macrophage differentiation |
| GO:0045986 | 0.00306 | 6.08693 | 1 | 5 | 20 | negative regulation of smooth muscle contraction |
| GO:0046697 | 0.00306 | 6.08693 | 1 | 5 | 20 | decidualization |
| GO:0050966 | 0.00306 | 6.08693 | 1 | 5 | 20 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0051195 | 0.00306 | 6.08693 | 1 | 5 | 20 | negative regulation of cofactor metabolic process |
| GO:0002714 | 0.00311 | 3.65712 | 3 | 8 | 48 | positive regulation of B cell mediated immunity |
| GO:0002891 | 0.00311 | 3.65712 | 3 | 8 | 48 | positive regulation of immunoglobulin mediated immune response |
| GO:0007157 | 0.00311 | 3.65712 | 3 | 8 | 48 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0022602 | 0.00311 | 3.65712 | 3 | 8 | 48 | ovulation cycle process |
| GO:0048483 | 0.00311 | 3.65712 | 3 | 8 | 48 | autonomic nervous system development |
| GO:0061005 | 0.00311 | 3.65712 | 3 | 8 | 48 | cell differentiation involved in kidney development |
| GO:0044106 | 0.00312 | 2.87671 | 4 | 11 | 81 | cellular amine metabolic process |
| GO:0051968 | 0.00312 | 4.12726 | 2 | 7 | 38 | positive regulation of synaptic transmission, glutamatergic |
| GO:0043266 | 0.00317 | 2.58849 | 5 | 13 | 105 | regulation of potassium ion transport |
| GO:0043473 | 0.00317 | 2.58849 | 5 | 13 | 105 | pigmentation |
| GO:0009895 | 0.00318 | 1.85941 | 15 | 27 | 294 | negative regulation of catabolic process |
| GO:0043506 | 0.00319 | 2.71296 | 5 | 12 | 93 | regulation of JUN kinase activity |
| GO:0045445 | 0.00319 | 2.71296 | 5 | 12 | 93 | myoblast differentiation |
| GO:0001654 | 0.00321 | 1.72485 | 21 | 34 | 397 | eye development |
| GO:0003341 | 0.00326 | 3.04990 | 4 | 10 | 70 | cilium movement |
| GO:0019915 | 0.00326 | 3.04990 | 4 | 10 | 70 | lipid storage |
| GO:0060711 | 0.00328 | 3.29265 | 3 | 9 | 59 | labyrinthine layer development |
| GO:0046483 | 0.00329 | 1.21172 | 257 | 296 | 4940 | heterocycle metabolic process |
| GO:0002230 | 0.00334 | 4.76591 | 2 | 6 | 29 | positive regulation of defense response to virus by host |
| GO:0051899 | 0.00344 | 2.83606 | 4 | 11 | 82 | membrane depolarization |
| GO:0072088 | 0.00344 | 2.83606 | 4 | 11 | 82 | nephron epithelium morphogenesis |
| GO:0014812 | 0.00344 | 2.56054 | 6 | 13 | 106 | muscle cell migration |
| GO:0048661 | 0.00344 | 2.56054 | 6 | 13 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0006814 | 0.00346 | 2.02920 | 11 | 21 | 211 | sodium ion transport |
| GO:0010810 | 0.00346 | 2.02920 | 11 | 21 | 211 | regulation of cell-substrate adhesion |
| GO:0002065 | 0.00346 | 2.29181 | 8 | 16 | 144 | columnar/cuboidal epithelial cell differentiation |
| GO:0030195 | 0.00355 | 3.56776 | 3 | 8 | 49 | negative regulation of blood coagulation |
| GO:0043300 | 0.00355 | 3.56776 | 3 | 8 | 49 | regulation of leukocyte degranulation |
| GO:0006959 | 0.00357 | 1.76064 | 18 | 31 | 355 | humoral immune response |
| GO:0001660 | 0.00359 | 8.11139 | 1 | 4 | 13 | fever generation |
| GO:0002674 | 0.00359 | 8.11139 | 1 | 4 | 13 | negative regulation of acute inflammatory response |
| GO:0006857 | 0.00359 | 8.11139 | 1 | 4 | 13 | oligopeptide transport |
| GO:0035810 | 0.00359 | 8.11139 | 1 | 4 | 13 | positive regulation of urine volume |
| GO:0045628 | 0.00359 | 8.11139 | 1 | 4 | 13 | regulation of T-helper 2 cell differentiation |
| GO:0046642 | 0.00359 | 8.11139 | 1 | 4 | 13 | negative regulation of alpha-beta T cell proliferation |
| GO:0060340 | 0.00359 | 8.11139 | 1 | 4 | 13 | positive regulation of type I interferon-mediated signaling pathway |
| GO:0060670 | 0.00359 | 8.11139 | 1 | 4 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0070255 | 0.00359 | 8.11139 | 1 | 4 | 13 | regulation of mucus secretion |
| GO:2001279 | 0.00359 | 8.11139 | 1 | 4 | 13 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0003073 | 0.00360 | 2.44307 | 6 | 14 | 119 | regulation of systemic arterial blood pressure |
| GO:0034645 | 0.00362 | 1.22627 | 210 | 245 | 4022 | cellular macromolecule biosynthetic process |
| GO:0060251 | 0.00363 | 3.99810 | 2 | 7 | 39 | regulation of glial cell proliferation |
| GO:0060337 | 0.00363 | 3.99810 | 2 | 7 | 39 | type I interferon signaling pathway |
| GO:0071357 | 0.00363 | 3.99810 | 2 | 7 | 39 | cellular response to type I interferon |
| GO:1902692 | 0.00363 | 3.99810 | 2 | 7 | 39 | regulation of neuroblast proliferation |
| GO:2001024 | 0.00363 | 3.99810 | 2 | 7 | 39 | negative regulation of response to drug |
| GO:0022607 | 0.00365 | 1.26325 | 146 | 177 | 2807 | cellular component assembly |
| GO:0007268 | 0.00367 | 1.47022 | 45 | 63 | 856 | chemical synaptic transmission |
| GO:0098916 | 0.00367 | 1.47022 | 45 | 63 | 856 | anterograde trans-synaptic signaling |
| GO:0006941 | 0.00368 | 2.21108 | 8 | 17 | 158 | striated muscle contraction |
| GO:0001836 | 0.00369 | 3.22794 | 3 | 9 | 60 | release of cytochrome c from mitochondria |
| GO:0090183 | 0.00369 | 3.22794 | 3 | 9 | 60 | regulation of kidney development |
| GO:0001508 | 0.00369 | 2.34978 | 7 | 15 | 132 | action potential |
| GO:0001764 | 0.00373 | 2.10016 | 10 | 19 | 185 | neuron migration |
| GO:0003014 | 0.00374 | 2.53319 | 6 | 13 | 107 | renal system process |
| GO:0043487 | 0.00374 | 2.53319 | 6 | 13 | 107 | regulation of RNA stability |
| GO:0072028 | 0.00378 | 2.79655 | 4 | 11 | 83 | nephron morphogenesis |
| GO:0015031 | 0.00383 | 1.32636 | 91 | 116 | 1746 | protein transport |
| GO:0015732 | 0.00384 | 5.70624 | 1 | 5 | 21 | prostaglandin transport |
| GO:0031290 | 0.00384 | 5.70624 | 1 | 5 | 21 | retinal ganglion cell axon guidance |
| GO:0036303 | 0.00384 | 5.70624 | 1 | 5 | 21 | lymph vessel morphogenesis |
| GO:0042535 | 0.00384 | 5.70624 | 1 | 5 | 21 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0051770 | 0.00384 | 5.70624 | 1 | 5 | 21 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0090050 | 0.00384 | 5.70624 | 1 | 5 | 21 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:0016999 | 0.00396 | 2.32976 | 7 | 15 | 133 | antibiotic metabolic process |
| GO:0010803 | 0.00399 | 4.56712 | 2 | 6 | 30 | regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0031645 | 0.00399 | 4.56712 | 2 | 6 | 30 | negative regulation of neurological system process |
| GO:0034110 | 0.00399 | 4.56712 | 2 | 6 | 30 | regulation of homotypic cell-cell adhesion |
| GO:0044319 | 0.00399 | 4.56712 | 2 | 6 | 30 | wound healing, spreading of cells |
| GO:0090505 | 0.00399 | 4.56712 | 2 | 6 | 30 | epiboly involved in wound healing |
| GO:0044403 | 0.00401 | 1.76312 | 18 | 30 | 343 | symbiont process |
| GO:0045055 | 0.00403 | 1.90039 | 13 | 24 | 256 | regulated exocytosis |
| GO:1900047 | 0.00404 | 3.48265 | 3 | 8 | 50 | negative regulation of hemostasis |
| GO:0016070 | 0.00407 | 1.22889 | 196 | 230 | 3761 | RNA metabolic process |
| GO:0090276 | 0.00409 | 1.96093 | 12 | 22 | 228 | regulation of peptide hormone secretion |
| GO:0045600 | 0.00413 | 3.16572 | 3 | 9 | 61 | positive regulation of fat cell differentiation |
| GO:0048286 | 0.00413 | 3.16572 | 3 | 9 | 61 | lung alveolus development |
| GO:0010467 | 0.00414 | 1.20736 | 251 | 288 | 4814 | gene expression |
| GO:0050795 | 0.00415 | 2.61571 | 5 | 12 | 96 | regulation of behavior |
| GO:0006629 | 0.00417 | 1.37930 | 66 | 87 | 1258 | lipid metabolic process |
| GO:0007565 | 0.00418 | 2.17995 | 8 | 17 | 160 | female pregnancy |
| GO:0042542 | 0.00419 | 2.39718 | 6 | 14 | 121 | response to hydrogen peroxide |
| GO:0002686 | 0.00421 | 3.87677 | 2 | 7 | 40 | negative regulation of leukocyte migration |
| GO:0030225 | 0.00421 | 3.87677 | 2 | 7 | 40 | macrophage differentiation |
| GO:0042398 | 0.00421 | 3.87677 | 2 | 7 | 40 | cellular modified amino acid biosynthetic process |
| GO:0086004 | 0.00421 | 3.87677 | 2 | 7 | 40 | regulation of cardiac muscle cell contraction |
| GO:1903053 | 0.00421 | 3.87677 | 2 | 7 | 40 | regulation of extracellular matrix organization |
| GO:0002860 | 0.00421 | 13.67973 | 0 | 3 | 7 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
| GO:0003025 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of systemic arterial blood pressure by baroreceptor feedback |
| GO:0003330 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of extracellular matrix constituent secretion |
| GO:0006145 | 0.00421 | 13.67973 | 0 | 3 | 7 | purine nucleobase catabolic process |
| GO:0006547 | 0.00421 | 13.67973 | 0 | 3 | 7 | histidine metabolic process |
| GO:0010626 | 0.00421 | 13.67973 | 0 | 3 | 7 | negative regulation of Schwann cell proliferation |
| GO:0010727 | 0.00421 | 13.67973 | 0 | 3 | 7 | negative regulation of hydrogen peroxide metabolic process |
| GO:0015677 | 0.00421 | 13.67973 | 0 | 3 | 7 | copper ion import |
| GO:0035754 | 0.00421 | 13.67973 | 0 | 3 | 7 | B cell chemotaxis |
| GO:0045634 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of melanocyte differentiation |
| GO:0050861 | 0.00421 | 13.67973 | 0 | 3 | 7 | positive regulation of B cell receptor signaling pathway |
| GO:0050942 | 0.00421 | 13.67973 | 0 | 3 | 7 | positive regulation of pigment cell differentiation |
| GO:0051970 | 0.00421 | 13.67973 | 0 | 3 | 7 | negative regulation of transmission of nerve impulse |
| GO:0061074 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of neural retina development |
| GO:0061517 | 0.00421 | 13.67973 | 0 | 3 | 7 | macrophage proliferation |
| GO:0061518 | 0.00421 | 13.67973 | 0 | 3 | 7 | microglial cell proliferation |
| GO:0070995 | 0.00421 | 13.67973 | 0 | 3 | 7 | NADPH oxidation |
| GO:0071608 | 0.00421 | 13.67973 | 0 | 3 | 7 | macrophage inflammatory protein-1 alpha production |
| GO:0071676 | 0.00421 | 13.67973 | 0 | 3 | 7 | negative regulation of mononuclear cell migration |
| GO:0072679 | 0.00421 | 13.67973 | 0 | 3 | 7 | thymocyte migration |
| GO:0097646 | 0.00421 | 13.67973 | 0 | 3 | 7 | calcitonin family receptor signaling pathway |
| GO:2000425 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of apoptotic cell clearance |
| GO:2000553 | 0.00421 | 13.67973 | 0 | 3 | 7 | positive regulation of T-helper 2 cell cytokine production |
| GO:2001198 | 0.00421 | 13.67973 | 0 | 3 | 7 | regulation of dendritic cell differentiation |
| GO:0045184 | 0.00432 | 1.31181 | 97 | 122 | 1856 | establishment of protein localization |
| GO:0090596 | 0.00438 | 1.81132 | 16 | 27 | 301 | sensory organ morphogenesis |
| GO:0072009 | 0.00439 | 2.48019 | 6 | 13 | 109 | nephron epithelium development |
| GO:0006887 | 0.00439 | 1.71671 | 20 | 32 | 375 | exocytosis |
| GO:1901575 | 0.00439 | 1.31099 | 97 | 122 | 1857 | organic substance catabolic process |
| GO:0045892 | 0.00442 | 1.38914 | 61 | 82 | 1177 | negative regulation of transcription, DNA-templated |
| GO:0007422 | 0.00444 | 2.90427 | 4 | 10 | 73 | peripheral nervous system development |
| GO:0051851 | 0.00444 | 2.90427 | 4 | 10 | 73 | modification by host of symbiont morphology or physiology |
| GO:0051146 | 0.00445 | 1.78746 | 16 | 28 | 316 | striated muscle cell differentiation |
| GO:0051147 | 0.00446 | 2.16471 | 8 | 17 | 161 | regulation of muscle cell differentiation |
| GO:0030510 | 0.00452 | 2.58481 | 5 | 12 | 97 | regulation of BMP signaling pathway |
| GO:0048525 | 0.00452 | 2.58481 | 5 | 12 | 97 | negative regulation of viral process |
| GO:0070167 | 0.00452 | 2.58481 | 5 | 12 | 97 | regulation of biomineral tissue development |
| GO:0001974 | 0.00458 | 3.40151 | 3 | 8 | 51 | blood vessel remodeling |
| GO:0051954 | 0.00458 | 3.40151 | 3 | 8 | 51 | positive regulation of amine transport |
| GO:0043949 | 0.00461 | 3.10585 | 3 | 9 | 62 | regulation of cAMP-mediated signaling |
| GO:0045668 | 0.00461 | 3.10585 | 3 | 9 | 62 | negative regulation of osteoblast differentiation |
| GO:0070206 | 0.00461 | 3.10585 | 3 | 9 | 62 | protein trimerization |
| GO:0009896 | 0.00469 | 1.66504 | 22 | 35 | 422 | positive regulation of catabolic process |
| GO:0001893 | 0.00473 | 4.38424 | 2 | 6 | 31 | maternal placenta development |
| GO:0045920 | 0.00473 | 4.38424 | 2 | 6 | 31 | negative regulation of exocytosis |
| GO:0070670 | 0.00473 | 4.38424 | 2 | 6 | 31 | response to interleukin-4 |
| GO:0070741 | 0.00473 | 4.38424 | 2 | 6 | 31 | response to interleukin-6 |
| GO:0090022 | 0.00473 | 4.38424 | 2 | 6 | 31 | regulation of neutrophil chemotaxis |
| GO:0090075 | 0.00473 | 4.38424 | 2 | 6 | 31 | relaxation of muscle |
| GO:0090504 | 0.00473 | 4.38424 | 2 | 6 | 31 | epiboly |
| GO:0007156 | 0.00474 | 2.45450 | 6 | 13 | 110 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0002374 | 0.00476 | 5.37033 | 1 | 5 | 22 | cytokine secretion involved in immune response |
| GO:0010884 | 0.00476 | 5.37033 | 1 | 5 | 22 | positive regulation of lipid storage |
| GO:0014912 | 0.00476 | 5.37033 | 1 | 5 | 22 | negative regulation of smooth muscle cell migration |
| GO:0031649 | 0.00476 | 5.37033 | 1 | 5 | 22 | heat generation |
| GO:0033008 | 0.00476 | 5.37033 | 1 | 5 | 22 | positive regulation of mast cell activation involved in immune response |
| GO:0035634 | 0.00476 | 5.37033 | 1 | 5 | 22 | response to stilbenoid |
| GO:0043306 | 0.00476 | 5.37033 | 1 | 5 | 22 | positive regulation of mast cell degranulation |
| GO:0050857 | 0.00476 | 5.37033 | 1 | 5 | 22 | positive regulation of antigen receptor-mediated signaling pathway |
| GO:0072215 | 0.00476 | 5.37033 | 1 | 5 | 22 | regulation of metanephros development |
| GO:0010642 | 0.00482 | 7.29992 | 1 | 4 | 14 | negative regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010713 | 0.00482 | 7.29992 | 1 | 4 | 14 | negative regulation of collagen metabolic process |
| GO:0031340 | 0.00482 | 7.29992 | 1 | 4 | 14 | positive regulation of vesicle fusion |
| GO:0032604 | 0.00482 | 7.29992 | 1 | 4 | 14 | granulocyte macrophage colony-stimulating factor production |
| GO:0032645 | 0.00482 | 7.29992 | 1 | 4 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0032769 | 0.00482 | 7.29992 | 1 | 4 | 14 | negative regulation of monooxygenase activity |
| GO:0032966 | 0.00482 | 7.29992 | 1 | 4 | 14 | negative regulation of collagen biosynthetic process |
| GO:0035745 | 0.00482 | 7.29992 | 1 | 4 | 14 | T-helper 2 cell cytokine production |
| GO:0042271 | 0.00482 | 7.29992 | 1 | 4 | 14 | susceptibility to natural killer cell mediated cytotoxicity |
| GO:0045060 | 0.00482 | 7.29992 | 1 | 4 | 14 | negative thymic T cell selection |
| GO:0045188 | 0.00482 | 7.29992 | 1 | 4 | 14 | regulation of circadian sleep/wake cycle, non-REM sleep |
| GO:0045651 | 0.00482 | 7.29992 | 1 | 4 | 14 | positive regulation of macrophage differentiation |
| GO:0048484 | 0.00482 | 7.29992 | 1 | 4 | 14 | enteric nervous system development |
| GO:0061469 | 0.00482 | 7.29992 | 1 | 4 | 14 | regulation of type B pancreatic cell proliferation |
| GO:0070486 | 0.00482 | 7.29992 | 1 | 4 | 14 | leukocyte aggregation |
| GO:2000341 | 0.00482 | 7.29992 | 1 | 4 | 14 | regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:1903507 | 0.00482 | 1.38382 | 62 | 82 | 1181 | negative regulation of nucleic acid-templated transcription |
| GO:0002832 | 0.00485 | 3.76258 | 2 | 7 | 41 | negative regulation of response to biotic stimulus |
| GO:0007431 | 0.00485 | 3.76258 | 2 | 7 | 41 | salivary gland development |
| GO:0021955 | 0.00485 | 3.76258 | 2 | 7 | 41 | central nervous system neuron axonogenesis |
| GO:0046700 | 0.00487 | 1.62405 | 24 | 38 | 469 | heterocycle catabolic process |
| GO:0035148 | 0.00489 | 2.08937 | 9 | 18 | 176 | tube formation |
| GO:0044419 | 0.00490 | 1.67327 | 21 | 34 | 408 | interspecies interaction between organisms |
| GO:0043488 | 0.00491 | 2.55464 | 5 | 12 | 98 | regulation of mRNA stability |
| GO:0072080 | 0.00491 | 2.55464 | 5 | 12 | 98 | nephron tubule development |
| GO:1902679 | 0.00493 | 1.38250 | 62 | 82 | 1182 | negative regulation of RNA biosynthetic process |
| GO:0007517 | 0.00504 | 1.65632 | 22 | 35 | 424 | muscle organ development |
| GO:0030879 | 0.00505 | 2.13487 | 8 | 17 | 163 | mammary gland development |
| GO:1904064 | 0.00505 | 2.13487 | 8 | 17 | 163 | positive regulation of cation transmembrane transport |
| GO:0002712 | 0.00514 | 3.04819 | 3 | 9 | 63 | regulation of B cell mediated immunity |
| GO:0002889 | 0.00514 | 3.04819 | 3 | 9 | 63 | regulation of immunoglobulin mediated immune response |
| GO:0045454 | 0.00514 | 3.04819 | 3 | 9 | 63 | cell redox homeostasis |
| GO:0045661 | 0.00514 | 3.04819 | 3 | 9 | 63 | regulation of myoblast differentiation |
| GO:0006865 | 0.00516 | 2.18859 | 8 | 16 | 150 | amino acid transport |
| GO:0035924 | 0.00517 | 3.32405 | 3 | 8 | 52 | cellular response to vascular endothelial growth factor stimulus |
| GO:0097035 | 0.00517 | 3.32405 | 3 | 8 | 52 | regulation of membrane lipid distribution |
| GO:1903202 | 0.00517 | 3.32405 | 3 | 8 | 52 | negative regulation of oxidative stress-induced cell death |
| GO:0046677 | 0.00522 | 1.78493 | 16 | 27 | 305 | response to antibiotic |
| GO:0014902 | 0.00522 | 2.33149 | 6 | 14 | 124 | myotube differentiation |
| GO:0034764 | 0.00528 | 1.91402 | 12 | 22 | 233 | positive regulation of transmembrane transport |
| GO:0090092 | 0.00528 | 1.91402 | 12 | 22 | 233 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0033555 | 0.00533 | 2.52516 | 5 | 12 | 99 | multicellular organismal response to stress |
| GO:0060993 | 0.00533 | 2.52516 | 5 | 12 | 99 | kidney morphogenesis |
| GO:0008625 | 0.00539 | 2.81465 | 4 | 10 | 75 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032418 | 0.00539 | 2.81465 | 4 | 10 | 75 | lysosome localization |
| GO:0051193 | 0.00539 | 2.81465 | 4 | 10 | 75 | regulation of cofactor metabolic process |
| GO:0007589 | 0.00553 | 2.40470 | 6 | 13 | 112 | body fluid secretion |
| GO:0030516 | 0.00553 | 2.40470 | 6 | 13 | 112 | regulation of axon extension |
| GO:0006687 | 0.00557 | 3.65491 | 2 | 7 | 42 | glycosphingolipid metabolic process |
| GO:0048255 | 0.00557 | 3.65491 | 2 | 7 | 42 | mRNA stabilization |
| GO:0050691 | 0.00557 | 3.65491 | 2 | 7 | 42 | regulation of defense response to virus by host |
| GO:1900015 | 0.00557 | 3.65491 | 2 | 7 | 42 | regulation of cytokine production involved in inflammatory response |
| GO:0001964 | 0.00557 | 4.21542 | 2 | 6 | 32 | startle response |
| GO:0003016 | 0.00557 | 4.21542 | 2 | 6 | 32 | respiratory system process |
| GO:0040036 | 0.00557 | 4.21542 | 2 | 6 | 32 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0045577 | 0.00557 | 4.21542 | 2 | 6 | 32 | regulation of B cell differentiation |
| GO:0060669 | 0.00557 | 4.21542 | 2 | 6 | 32 | embryonic placenta morphogenesis |
| GO:0060706 | 0.00557 | 4.21542 | 2 | 6 | 32 | cell differentiation involved in embryonic placenta development |
| GO:0072538 | 0.00557 | 4.21542 | 2 | 6 | 32 | T-helper 17 type immune response |
| GO:0007611 | 0.00561 | 1.79584 | 15 | 26 | 292 | learning or memory |
| GO:0007179 | 0.00570 | 2.10582 | 9 | 17 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0042267 | 0.00571 | 2.99264 | 3 | 9 | 64 | natural killer cell mediated cytotoxicity |
| GO:0045778 | 0.00577 | 2.49635 | 5 | 12 | 100 | positive regulation of ossification |
| GO:0034113 | 0.00582 | 3.25003 | 3 | 8 | 53 | heterotypic cell-cell adhesion |
| GO:0042269 | 0.00582 | 3.25003 | 3 | 8 | 53 | regulation of natural killer cell mediated cytotoxicity |
| GO:0045933 | 0.00582 | 3.25003 | 3 | 8 | 53 | positive regulation of muscle contraction |
| GO:1900408 | 0.00582 | 3.25003 | 3 | 8 | 53 | negative regulation of cellular response to oxidative stress |
| GO:1904705 | 0.00582 | 3.25003 | 3 | 8 | 53 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.00582 | 3.25003 | 3 | 8 | 53 | vascular smooth muscle cell proliferation |
| GO:0034767 | 0.00583 | 2.05016 | 9 | 18 | 179 | positive regulation of ion transmembrane transport |
| GO:0046475 | 0.00583 | 5.07175 | 1 | 5 | 23 | glycerophospholipid catabolic process |
| GO:0048485 | 0.00583 | 5.07175 | 1 | 5 | 23 | sympathetic nervous system development |
| GO:0072202 | 0.00583 | 5.07175 | 1 | 5 | 23 | cell differentiation involved in metanephros development |
| GO:1903035 | 0.00593 | 2.61436 | 5 | 11 | 88 | negative regulation of response to wounding |
| GO:0021879 | 0.00593 | 2.77188 | 4 | 10 | 76 | forebrain neuron differentiation |
| GO:0002768 | 0.00601 | 1.72527 | 18 | 29 | 338 | immune response-regulating cell surface receptor signaling pathway |
| GO:0031623 | 0.00601 | 2.28964 | 7 | 14 | 126 | receptor internalization |
| GO:0045934 | 0.00609 | 1.34136 | 73 | 94 | 1395 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0033559 | 0.00625 | 2.46819 | 5 | 12 | 101 | unsaturated fatty acid metabolic process |
| GO:0002862 | 0.00630 | 6.63599 | 1 | 4 | 15 | negative regulation of inflammatory response to antigenic stimulus |
| GO:0014049 | 0.00630 | 6.63599 | 1 | 4 | 15 | positive regulation of glutamate secretion |
| GO:0033235 | 0.00630 | 6.63599 | 1 | 4 | 15 | positive regulation of protein sumoylation |
| GO:0042416 | 0.00630 | 6.63599 | 1 | 4 | 15 | dopamine biosynthetic process |
| GO:0042748 | 0.00630 | 6.63599 | 1 | 4 | 15 | circadian sleep/wake cycle, non-REM sleep |
| GO:0043383 | 0.00630 | 6.63599 | 1 | 4 | 15 | negative T cell selection |
| GO:0051712 | 0.00630 | 6.63599 | 1 | 4 | 15 | positive regulation of killing of cells of other organism |
| GO:0070234 | 0.00630 | 6.63599 | 1 | 4 | 15 | positive regulation of T cell apoptotic process |
| GO:0070254 | 0.00630 | 6.63599 | 1 | 4 | 15 | mucus secretion |
| GO:0072567 | 0.00630 | 6.63599 | 1 | 4 | 15 | chemokine (C-X-C motif) ligand 2 production |
| GO:0090197 | 0.00630 | 6.63599 | 1 | 4 | 15 | positive regulation of chemokine secretion |
| GO:1903978 | 0.00630 | 6.63599 | 1 | 4 | 15 | regulation of microglial cell activation |
| GO:2001267 | 0.00630 | 6.63599 | 1 | 4 | 15 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0060541 | 0.00632 | 1.85194 | 13 | 23 | 251 | respiratory system development |
| GO:0031128 | 0.00636 | 3.55322 | 2 | 7 | 43 | developmental induction |
| GO:0045823 | 0.00636 | 3.55322 | 2 | 7 | 43 | positive regulation of heart contraction |
| GO:0042472 | 0.00641 | 2.35687 | 6 | 13 | 114 | inner ear morphogenesis |
| GO:0019226 | 0.00645 | 2.58072 | 5 | 11 | 89 | transmission of nerve impulse |
| GO:0070301 | 0.00645 | 2.58072 | 5 | 11 | 89 | cellular response to hydrogen peroxide |
| GO:0002857 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of natural killer cell mediated immune response to tumor cell |
| GO:0021540 | 0.00648 | 10.94328 | 0 | 3 | 8 | corpus callosum morphogenesis |
| GO:0031665 | 0.00648 | 10.94328 | 0 | 3 | 8 | negative regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0032661 | 0.00648 | 10.94328 | 0 | 3 | 8 | regulation of interleukin-18 production |
| GO:0033007 | 0.00648 | 10.94328 | 0 | 3 | 8 | negative regulation of mast cell activation involved in immune response |
| GO:0034310 | 0.00648 | 10.94328 | 0 | 3 | 8 | primary alcohol catabolic process |
| GO:0035425 | 0.00648 | 10.94328 | 0 | 3 | 8 | autocrine signaling |
| GO:0048087 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of developmental pigmentation |
| GO:0051135 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of NK T cell activation |
| GO:0051136 | 0.00648 | 10.94328 | 0 | 3 | 8 | regulation of NK T cell differentiation |
| GO:0051581 | 0.00648 | 10.94328 | 0 | 3 | 8 | negative regulation of neurotransmitter uptake |
| GO:0060087 | 0.00648 | 10.94328 | 0 | 3 | 8 | relaxation of vascular smooth muscle |
| GO:0061687 | 0.00648 | 10.94328 | 0 | 3 | 8 | detoxification of inorganic compound |
| GO:0097501 | 0.00648 | 10.94328 | 0 | 3 | 8 | stress response to metal ion |
| GO:1901299 | 0.00648 | 10.94328 | 0 | 3 | 8 | negative regulation of hydrogen peroxide-mediated programmed cell death |
| GO:1902339 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of apoptotic process involved in morphogenesis |
| GO:1902866 | 0.00648 | 10.94328 | 0 | 3 | 8 | regulation of retina development in camera-type eye |
| GO:1903367 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of fear response |
| GO:1904415 | 0.00648 | 10.94328 | 0 | 3 | 8 | regulation of xenophagy |
| GO:1904417 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of xenophagy |
| GO:1904747 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of apoptotic process involved in development |
| GO:2000562 | 0.00648 | 10.94328 | 0 | 3 | 8 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000586 | 0.00648 | 10.94328 | 0 | 3 | 8 | regulation of platelet-derived growth factor receptor-beta signaling pathway |
| GO:2000987 | 0.00648 | 10.94328 | 0 | 3 | 8 | positive regulation of behavioral fear response |
| GO:0032088 | 0.00650 | 2.73038 | 4 | 10 | 77 | negative regulation of NF-kappaB transcription factor activity |
| GO:0051966 | 0.00650 | 2.73038 | 4 | 10 | 77 | regulation of synaptic transmission, glutamatergic |
| GO:0061180 | 0.00650 | 2.73038 | 4 | 10 | 77 | mammary gland epithelium development |
| GO:0071277 | 0.00650 | 2.73038 | 4 | 10 | 77 | cellular response to calcium ion |
| GO:0010543 | 0.00651 | 4.05911 | 2 | 6 | 33 | regulation of platelet activation |
| GO:0010837 | 0.00651 | 4.05911 | 2 | 6 | 33 | regulation of keratinocyte proliferation |
| GO:0002715 | 0.00652 | 3.17923 | 3 | 8 | 54 | regulation of natural killer cell mediated immunity |
| GO:0035272 | 0.00652 | 3.17923 | 3 | 8 | 54 | exocrine system development |
| GO:0045604 | 0.00652 | 3.17923 | 3 | 8 | 54 | regulation of epidermal cell differentiation |
| GO:0001838 | 0.00664 | 2.12476 | 8 | 16 | 154 | embryonic epithelial tube formation |
| GO:0044282 | 0.00673 | 1.74674 | 16 | 27 | 311 | small molecule catabolic process |
| GO:0050772 | 0.00676 | 2.44066 | 5 | 12 | 102 | positive regulation of axonogenesis |
| GO:0002429 | 0.00676 | 1.72668 | 17 | 28 | 326 | immune response-activating cell surface receptor signaling pathway |
| GO:0055088 | 0.00680 | 2.18104 | 7 | 15 | 141 | lipid homeostasis |
| GO:0002228 | 0.00699 | 2.88737 | 3 | 9 | 66 | natural killer cell mediated immunity |
| GO:0043535 | 0.00701 | 2.54794 | 5 | 11 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0006706 | 0.00705 | 4.80460 | 1 | 5 | 24 | steroid catabolic process |
| GO:0046685 | 0.00705 | 4.80460 | 1 | 5 | 24 | response to arsenic-containing substance |
| GO:0014706 | 0.00706 | 1.60423 | 23 | 36 | 449 | striated muscle tissue development |
| GO:0002260 | 0.00712 | 2.69011 | 4 | 10 | 78 | lymphocyte homeostasis |
| GO:2001242 | 0.00721 | 2.05003 | 9 | 17 | 169 | regulation of intrinsic apoptotic signaling pathway |
| GO:0034340 | 0.00723 | 3.45703 | 2 | 7 | 44 | response to type I interferon |
| GO:0061098 | 0.00723 | 3.45703 | 2 | 7 | 44 | positive regulation of protein tyrosine kinase activity |
| GO:0070830 | 0.00723 | 3.45703 | 2 | 7 | 44 | bicellular tight junction assembly |
| GO:0050830 | 0.00738 | 2.22961 | 7 | 14 | 129 | defense response to Gram-positive bacterium |
| GO:0010714 | 0.00757 | 3.91397 | 2 | 6 | 34 | positive regulation of collagen metabolic process |
| GO:0031338 | 0.00757 | 3.91397 | 2 | 6 | 34 | regulation of vesicle fusion |
| GO:0050869 | 0.00757 | 3.91397 | 2 | 6 | 34 | negative regulation of B cell activation |
| GO:0090322 | 0.00757 | 3.91397 | 2 | 6 | 34 | regulation of superoxide metabolic process |
| GO:1902624 | 0.00757 | 3.91397 | 2 | 6 | 34 | positive regulation of neutrophil migration |
| GO:2000406 | 0.00757 | 3.91397 | 2 | 6 | 34 | positive regulation of T cell migration |
| GO:0002028 | 0.00761 | 2.51597 | 5 | 11 | 91 | regulation of sodium ion transport |
| GO:0060401 | 0.00764 | 2.03654 | 9 | 17 | 170 | cytosolic calcium ion transport |
| GO:0048754 | 0.00770 | 1.98795 | 10 | 18 | 184 | branching morphogenesis of an epithelial tube |
| GO:0043903 | 0.00770 | 1.94647 | 10 | 19 | 198 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0000768 | 0.00772 | 2.83746 | 3 | 9 | 67 | syncytium formation by plasma membrane fusion |
| GO:0140253 | 0.00772 | 2.83746 | 3 | 9 | 67 | cell-cell fusion |
| GO:0019439 | 0.00776 | 1.57194 | 25 | 38 | 483 | aromatic compound catabolic process |
| GO:0051702 | 0.00778 | 2.65100 | 4 | 10 | 79 | interaction with symbiont |
| GO:0044248 | 0.00779 | 1.27619 | 104 | 128 | 1996 | cellular catabolic process |
| GO:0001550 | 0.00785 | 36.45402 | 0 | 2 | 3 | ovarian cumulus expansion |
| GO:0001983 | 0.00785 | 36.45402 | 0 | 2 | 3 | baroreceptor response to increased systemic arterial blood pressure |
| GO:0002432 | 0.00785 | 36.45402 | 0 | 2 | 3 | granuloma formation |
| GO:0002485 | 0.00785 | 36.45402 | 0 | 2 | 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent |
| GO:0003340 | 0.00785 | 36.45402 | 0 | 2 | 3 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0003347 | 0.00785 | 36.45402 | 0 | 2 | 3 | epicardial cell to mesenchymal cell transition |
| GO:0006714 | 0.00785 | 36.45402 | 0 | 2 | 3 | sesquiterpenoid metabolic process |
| GO:0016095 | 0.00785 | 36.45402 | 0 | 2 | 3 | polyprenol catabolic process |
| GO:0021538 | 0.00785 | 36.45402 | 0 | 2 | 3 | epithalamus development |
| GO:0021986 | 0.00785 | 36.45402 | 0 | 2 | 3 | habenula development |
| GO:0033693 | 0.00785 | 36.45402 | 0 | 2 | 3 | neurofilament bundle assembly |
| GO:0043366 | 0.00785 | 36.45402 | 0 | 2 | 3 | beta selection |
| GO:0045082 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of interleukin-10 biosynthetic process |
| GO:0045404 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of interleukin-4 biosynthetic process |
| GO:0045626 | 0.00785 | 36.45402 | 0 | 2 | 3 | negative regulation of T-helper 1 cell differentiation |
| GO:0045658 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0048165 | 0.00785 | 36.45402 | 0 | 2 | 3 | fused antrum stage |
| GO:0060168 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of adenosine receptor signaling pathway |
| GO:0060378 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of brood size |
| GO:0070494 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of thrombin-activated receptor signaling pathway |
| GO:0070495 | 0.00785 | 36.45402 | 0 | 2 | 3 | negative regulation of thrombin-activated receptor signaling pathway |
| GO:0071657 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0071725 | 0.00785 | 36.45402 | 0 | 2 | 3 | response to triacyl bacterial lipopeptide |
| GO:0071727 | 0.00785 | 36.45402 | 0 | 2 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0071798 | 0.00785 | 36.45402 | 0 | 2 | 3 | response to prostaglandin D |
| GO:0071799 | 0.00785 | 36.45402 | 0 | 2 | 3 | cellular response to prostaglandin D stimulus |
| GO:0090673 | 0.00785 | 36.45402 | 0 | 2 | 3 | endothelial cell-matrix adhesion |
| GO:0140199 | 0.00785 | 36.45402 | 0 | 2 | 3 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:1900623 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of monocyte aggregation |
| GO:1900625 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of monocyte aggregation |
| GO:1901258 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of macrophage colony-stimulating factor production |
| GO:1901492 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of lymphangiogenesis |
| GO:1901740 | 0.00785 | 36.45402 | 0 | 2 | 3 | negative regulation of myoblast fusion |
| GO:1902523 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of protein K63-linked ubiquitination |
| GO:1903279 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of calcium:sodium antiporter activity |
| GO:1903971 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of response to macrophage colony-stimulating factor |
| GO:1903974 | 0.00785 | 36.45402 | 0 | 2 | 3 | positive regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1904020 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of G protein-coupled receptor internalization |
| GO:1905863 | 0.00785 | 36.45402 | 0 | 2 | 3 | invadopodium organization |
| GO:2000468 | 0.00785 | 36.45402 | 0 | 2 | 3 | regulation of peroxidase activity |
| GO:0007498 | 0.00794 | 2.28857 | 6 | 13 | 117 | mesoderm development |
| GO:0033135 | 0.00795 | 2.07927 | 8 | 16 | 157 | regulation of peptidyl-serine phosphorylation |
| GO:0060402 | 0.00795 | 2.07927 | 8 | 16 | 157 | calcium ion transport into cytosol |
| GO:0002431 | 0.00806 | 6.08271 | 1 | 4 | 16 | Fc receptor mediated stimulatory signaling pathway |
| GO:0010310 | 0.00806 | 6.08271 | 1 | 4 | 16 | regulation of hydrogen peroxide metabolic process |
| GO:0010752 | 0.00806 | 6.08271 | 1 | 4 | 16 | regulation of cGMP-mediated signaling |
| GO:0034134 | 0.00806 | 6.08271 | 1 | 4 | 16 | toll-like receptor 2 signaling pathway |
| GO:0045059 | 0.00806 | 6.08271 | 1 | 4 | 16 | positive thymic T cell selection |
| GO:0051852 | 0.00806 | 6.08271 | 1 | 4 | 16 | disruption by host of symbiont cells |
| GO:0051873 | 0.00806 | 6.08271 | 1 | 4 | 16 | killing by host of symbiont cells |
| GO:0071379 | 0.00806 | 6.08271 | 1 | 4 | 16 | cellular response to prostaglandin stimulus |
| GO:0090196 | 0.00806 | 6.08271 | 1 | 4 | 16 | regulation of chemokine secretion |
| GO:1902337 | 0.00806 | 6.08271 | 1 | 4 | 16 | regulation of apoptotic process involved in morphogenesis |
| GO:0007612 | 0.00808 | 2.02322 | 9 | 17 | 171 | learning |
| GO:0006631 | 0.00810 | 1.65187 | 20 | 31 | 376 | fatty acid metabolic process |
| GO:0002704 | 0.00813 | 3.04649 | 3 | 8 | 56 | negative regulation of leukocyte mediated immunity |
| GO:0090303 | 0.00813 | 3.04649 | 3 | 8 | 56 | positive regulation of wound healing |
| GO:1902883 | 0.00813 | 3.04649 | 3 | 8 | 56 | negative regulation of response to oxidative stress |
| GO:0030890 | 0.00818 | 3.36590 | 2 | 7 | 45 | positive regulation of B cell proliferation |
| GO:0035136 | 0.00818 | 3.36590 | 2 | 7 | 45 | forelimb morphogenesis |
| GO:0050974 | 0.00818 | 3.36590 | 2 | 7 | 45 | detection of mechanical stimulus involved in sensory perception |
| GO:0071526 | 0.00818 | 3.36590 | 2 | 7 | 45 | semaphorin-plexin signaling pathway |
| GO:0090184 | 0.00818 | 3.36590 | 2 | 7 | 45 | positive regulation of kidney development |
| GO:0120192 | 0.00818 | 3.36590 | 2 | 7 | 45 | tight junction assembly |
| GO:0007613 | 0.00822 | 2.13003 | 8 | 15 | 144 | memory |
| GO:0060249 | 0.00830 | 1.63436 | 20 | 32 | 392 | anatomical structure homeostasis |
| GO:0042059 | 0.00845 | 4.56416 | 1 | 5 | 25 | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0060338 | 0.00845 | 4.56416 | 1 | 5 | 25 | regulation of type I interferon-mediated signaling pathway |
| GO:0071677 | 0.00845 | 4.56416 | 1 | 5 | 25 | positive regulation of mononuclear cell migration |
| GO:0098810 | 0.00845 | 4.56416 | 1 | 5 | 25 | neurotransmitter reuptake |
| GO:1901739 | 0.00845 | 4.56416 | 1 | 5 | 25 | regulation of myoblast fusion |
| GO:0002312 | 0.00849 | 2.61301 | 4 | 10 | 80 | B cell activation involved in immune response |
| GO:0021675 | 0.00849 | 2.61301 | 4 | 10 | 80 | nerve development |
| GO:0030500 | 0.00849 | 2.61301 | 4 | 10 | 80 | regulation of bone mineralization |
| GO:0070613 | 0.00849 | 2.61301 | 4 | 10 | 80 | regulation of protein processing |
| GO:0045669 | 0.00849 | 2.78924 | 4 | 9 | 68 | positive regulation of osteoblast differentiation |
| GO:0042476 | 0.00851 | 2.26667 | 6 | 13 | 118 | odontogenesis |
| GO:0032388 | 0.00854 | 1.92479 | 10 | 19 | 200 | positive regulation of intracellular transport |
| GO:2000113 | 0.00856 | 1.32562 | 72 | 92 | 1379 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0048609 | 0.00867 | 1.41367 | 45 | 61 | 858 | multicellular organismal reproductive process |
| GO:0031099 | 0.00874 | 2.11355 | 8 | 15 | 145 | regeneration |
| GO:0009072 | 0.00874 | 3.77883 | 2 | 6 | 35 | aromatic amino acid family metabolic process |
| GO:0038084 | 0.00874 | 3.77883 | 2 | 6 | 35 | vascular endothelial growth factor signaling pathway |
| GO:0042745 | 0.00874 | 3.77883 | 2 | 6 | 35 | circadian sleep/wake cycle |
| GO:0055090 | 0.00874 | 3.77883 | 2 | 6 | 35 | acylglycerol homeostasis |
| GO:0070328 | 0.00874 | 3.77883 | 2 | 6 | 35 | triglyceride homeostasis |
| GO:0036473 | 0.00893 | 2.45439 | 5 | 11 | 93 | cell death in response to oxidative stress |
| GO:0060537 | 0.00901 | 1.56514 | 25 | 37 | 472 | muscle tissue development |
| GO:0006879 | 0.00904 | 2.98418 | 3 | 8 | 57 | cellular iron ion homeostasis |
| GO:0048260 | 0.00904 | 2.98418 | 3 | 8 | 57 | positive regulation of receptor-mediated endocytosis |
| GO:0050854 | 0.00904 | 2.98418 | 3 | 8 | 57 | regulation of antigen receptor-mediated signaling pathway |
| GO:0030534 | 0.00904 | 1.95239 | 10 | 18 | 187 | adult behavior |
| GO:0001101 | 0.00912 | 1.65067 | 19 | 30 | 364 | response to acid chemical |
| GO:0048536 | 0.00923 | 3.27945 | 2 | 7 | 46 | spleen development |
| GO:0071384 | 0.00923 | 3.27945 | 2 | 7 | 46 | cellular response to corticosteroid stimulus |
| GO:2000404 | 0.00923 | 3.27945 | 2 | 7 | 46 | regulation of T cell migration |
| GO:0006766 | 0.00933 | 2.74262 | 4 | 9 | 69 | vitamin metabolic process |
| GO:0006949 | 0.00933 | 2.74262 | 4 | 9 | 69 | syncytium formation |
| GO:0007405 | 0.00933 | 2.74262 | 4 | 9 | 69 | neuroblast proliferation |
| GO:0001547 | 0.00935 | 9.11899 | 0 | 3 | 9 | antral ovarian follicle growth |
| GO:0002246 | 0.00935 | 9.11899 | 0 | 3 | 9 | wound healing involved in inflammatory response |
| GO:0002887 | 0.00935 | 9.11899 | 0 | 3 | 9 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0010624 | 0.00935 | 9.11899 | 0 | 3 | 9 | regulation of Schwann cell proliferation |
| GO:0014050 | 0.00935 | 9.11899 | 0 | 3 | 9 | negative regulation of glutamate secretion |
| GO:0016338 | 0.00935 | 9.11899 | 0 | 3 | 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0021891 | 0.00935 | 9.11899 | 0 | 3 | 9 | olfactory bulb interneuron development |
| GO:0021957 | 0.00935 | 9.11899 | 0 | 3 | 9 | corticospinal tract morphogenesis |
| GO:0030223 | 0.00935 | 9.11899 | 0 | 3 | 9 | neutrophil differentiation |
| GO:0033034 | 0.00935 | 9.11899 | 0 | 3 | 9 | positive regulation of myeloid cell apoptotic process |
| GO:0042118 | 0.00935 | 9.11899 | 0 | 3 | 9 | endothelial cell activation |
| GO:0045472 | 0.00935 | 9.11899 | 0 | 3 | 9 | response to ether |
| GO:0045657 | 0.00935 | 9.11899 | 0 | 3 | 9 | positive regulation of monocyte differentiation |
| GO:0045988 | 0.00935 | 9.11899 | 0 | 3 | 9 | negative regulation of striated muscle contraction |
| GO:0046113 | 0.00935 | 9.11899 | 0 | 3 | 9 | nucleobase catabolic process |
| GO:0050932 | 0.00935 | 9.11899 | 0 | 3 | 9 | regulation of pigment cell differentiation |
| GO:0051583 | 0.00935 | 9.11899 | 0 | 3 | 9 | dopamine uptake involved in synaptic transmission |
| GO:0051934 | 0.00935 | 9.11899 | 0 | 3 | 9 | catecholamine uptake involved in synaptic transmission |
| GO:0060040 | 0.00935 | 9.11899 | 0 | 3 | 9 | retinal bipolar neuron differentiation |
| GO:0060426 | 0.00935 | 9.11899 | 0 | 3 | 9 | lung vasculature development |
| GO:0060462 | 0.00935 | 9.11899 | 0 | 3 | 9 | lung lobe development |
| GO:0060463 | 0.00935 | 9.11899 | 0 | 3 | 9 | lung lobe morphogenesis |
| GO:0061032 | 0.00935 | 9.11899 | 0 | 3 | 9 | visceral serous pericardium development |
| GO:0090520 | 0.00935 | 9.11899 | 0 | 3 | 9 | sphingolipid mediated signaling pathway |
| GO:0099612 | 0.00935 | 9.11899 | 0 | 3 | 9 | protein localization to axon |
| GO:1903054 | 0.00935 | 9.11899 | 0 | 3 | 9 | negative regulation of extracellular matrix organization |
| GO:1903242 | 0.00935 | 9.11899 | 0 | 3 | 9 | regulation of cardiac muscle hypertrophy in response to stress |
| GO:1903589 | 0.00935 | 9.11899 | 0 | 3 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:2000121 | 0.00935 | 9.11899 | 0 | 3 | 9 | regulation of removal of superoxide radicals |
| GO:0043433 | 0.00946 | 2.03567 | 8 | 16 | 160 | negative regulation of DNA-binding transcription factor activity |
| GO:0048588 | 0.00949 | 1.78088 | 14 | 23 | 260 | developmental cell growth |
| GO:0048738 | 0.00949 | 1.78088 | 14 | 23 | 260 | cardiac muscle tissue development |
| GO:0009855 | 0.00956 | 2.15427 | 7 | 14 | 133 | determination of bilateral symmetry |
| GO:0007018 | 0.00959 | 1.75501 | 14 | 24 | 275 | microtubule-based movement |
| GO:0001570 | 0.00965 | 2.42470 | 5 | 11 | 94 | vasculogenesis |
| GO:0045069 | 0.00965 | 2.42470 | 5 | 11 | 94 | regulation of viral genome replication |
| GO:0090277 | 0.00975 | 2.22410 | 6 | 13 | 120 | positive regulation of peptide hormone secretion |
| GO:1901216 | 0.00975 | 2.22410 | 6 | 13 | 120 | positive regulation of neuron death |
| GO:0007043 | 0.00980 | 2.31167 | 6 | 12 | 107 | cell-cell junction assembly |
| GO:0042742 | 0.00989 | 1.58686 | 22 | 34 | 428 | defense response to bacterium |
| GO:0032535 | 0.00989 | 1.61160 | 21 | 32 | 397 | regulation of cellular component size |
| GO:0072175 | 0.01002 | 2.02154 | 8 | 16 | 161 | epithelial tube formation |
| GO:0007176 | 0.01002 | 4.34662 | 1 | 5 | 26 | regulation of epidermal growth factor-activated receptor activity |
| GO:0035809 | 0.01002 | 4.34662 | 1 | 5 | 26 | regulation of urine volume |
| GO:0045742 | 0.01002 | 4.34662 | 1 | 5 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0070168 | 0.01002 | 4.34662 | 1 | 5 | 26 | negative regulation of biomineral tissue development |
| GO:0001963 | 0.01004 | 3.65270 | 2 | 6 | 36 | synaptic transmission, dopaminergic |
| GO:0045987 | 0.01004 | 3.65270 | 2 | 6 | 36 | positive regulation of smooth muscle contraction |
| GO:1903317 | 0.01005 | 2.54020 | 4 | 10 | 82 | regulation of protein maturation |
| GO:1903901 | 0.01005 | 2.54020 | 4 | 10 | 82 | negative regulation of viral life cycle |
| GO:0043902 | 0.01007 | 1.97164 | 9 | 17 | 175 | positive regulation of multi-organism process |
| GO:0002883 | 0.01011 | 5.61455 | 1 | 4 | 17 | regulation of hypersensitivity |
| GO:0032740 | 0.01011 | 5.61455 | 1 | 4 | 17 | positive regulation of interleukin-17 production |
| GO:0035313 | 0.01011 | 5.61455 | 1 | 4 | 17 | wound healing, spreading of epidermal cells |
| GO:0045579 | 0.01011 | 5.61455 | 1 | 4 | 17 | positive regulation of B cell differentiation |
| GO:0045793 | 0.01011 | 5.61455 | 1 | 4 | 17 | positive regulation of cell size |
| GO:0050855 | 0.01011 | 5.61455 | 1 | 4 | 17 | regulation of B cell receptor signaling pathway |
| GO:0060253 | 0.01011 | 5.61455 | 1 | 4 | 17 | negative regulation of glial cell proliferation |
| GO:0060644 | 0.01011 | 5.61455 | 1 | 4 | 17 | mammary gland epithelial cell differentiation |
| GO:0061158 | 0.01011 | 5.61455 | 1 | 4 | 17 | 3'-UTR-mediated mRNA destabilization |
| GO:0099171 | 0.01011 | 5.61455 | 1 | 4 | 17 | presynaptic modulation of chemical synaptic transmission |
| GO:1900746 | 0.01011 | 5.61455 | 1 | 4 | 17 | regulation of vascular endothelial growth factor signaling pathway |
| GO:1902176 | 0.01011 | 5.61455 | 1 | 4 | 17 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| GO:1904748 | 0.01011 | 5.61455 | 1 | 4 | 17 | regulation of apoptotic process involved in development |
| GO:0044087 | 0.01016 | 1.38262 | 49 | 66 | 948 | regulation of cellular component biogenesis |
| GO:0006633 | 0.01018 | 2.13622 | 7 | 14 | 134 | fatty acid biosynthetic process |
| GO:0009799 | 0.01018 | 2.13622 | 7 | 14 | 134 | specification of symmetry |
| GO:0051928 | 0.01018 | 2.13622 | 7 | 14 | 134 | positive regulation of calcium ion transport |
| GO:1903322 | 0.01018 | 2.13622 | 7 | 14 | 134 | positive regulation of protein modification by small protein conjugation or removal |
| GO:1901796 | 0.01022 | 2.69754 | 4 | 9 | 70 | regulation of signal transduction by p53 class mediator |
| GO:0032309 | 0.01037 | 3.19732 | 2 | 7 | 47 | icosanoid secretion |
| GO:1902041 | 0.01037 | 3.19732 | 2 | 7 | 47 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0046888 | 0.01042 | 2.39573 | 5 | 11 | 95 | negative regulation of hormone secretion |
| GO:0055067 | 0.01046 | 2.06559 | 8 | 15 | 148 | monovalent inorganic cation homeostasis |
| GO:0030324 | 0.01075 | 1.84286 | 11 | 20 | 219 | lung development |
| GO:0019724 | 0.01080 | 1.75837 | 14 | 23 | 263 | B cell mediated immunity |
| GO:0072331 | 0.01084 | 2.11847 | 7 | 14 | 135 | signal transduction by p53 class mediator |
| GO:0006139 | 0.01100 | 1.17868 | 251 | 283 | 4813 | nucleobase-containing compound metabolic process |
| GO:0044270 | 0.01114 | 1.55063 | 24 | 36 | 463 | cellular nitrogen compound catabolic process |
| GO:0032504 | 0.01117 | 1.39370 | 45 | 61 | 869 | multicellular organism reproduction |
| GO:0009266 | 0.01120 | 1.99385 | 8 | 16 | 163 | response to temperature stimulus |
| GO:0120162 | 0.01123 | 2.36744 | 5 | 11 | 96 | positive regulation of cold-induced thermogenesis |
| GO:0008344 | 0.01127 | 2.26380 | 6 | 12 | 109 | adult locomotory behavior |
| GO:0031331 | 0.01146 | 1.63402 | 18 | 29 | 355 | positive regulation of cellular catabolic process |
| GO:0010955 | 0.01146 | 3.53471 | 2 | 6 | 37 | negative regulation of protein processing |
| GO:0045684 | 0.01146 | 3.53471 | 2 | 6 | 37 | positive regulation of epidermis development |
| GO:0071158 | 0.01146 | 3.53471 | 2 | 6 | 37 | positive regulation of cell cycle arrest |
| GO:1903318 | 0.01146 | 3.53471 | 2 | 6 | 37 | negative regulation of protein maturation |
| GO:0042471 | 0.01152 | 2.10101 | 7 | 14 | 136 | ear morphogenesis |
| GO:0097553 | 0.01152 | 2.10101 | 7 | 14 | 136 | calcium ion transmembrane import into cytosol |
| GO:0038066 | 0.01161 | 3.11919 | 3 | 7 | 48 | p38MAPK cascade |
| GO:0042755 | 0.01161 | 3.11919 | 3 | 7 | 48 | eating behavior |
| GO:0043489 | 0.01161 | 3.11919 | 3 | 7 | 48 | RNA stabilization |
| GO:0050873 | 0.01161 | 3.11919 | 3 | 7 | 48 | brown fat cell differentiation |
| GO:0002052 | 0.01178 | 4.14886 | 1 | 5 | 27 | positive regulation of neuroblast proliferation |
| GO:0010460 | 0.01178 | 4.14886 | 1 | 5 | 27 | positive regulation of heart rate |
| GO:0036037 | 0.01178 | 4.14886 | 1 | 5 | 27 | CD8-positive, alpha-beta T cell activation |
| GO:1901185 | 0.01178 | 4.14886 | 1 | 5 | 27 | negative regulation of ERBB signaling pathway |
| GO:2000272 | 0.01178 | 4.14886 | 1 | 5 | 27 | negative regulation of signaling receptor activity |
| GO:2001243 | 0.01209 | 2.33980 | 5 | 11 | 97 | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0060324 | 0.01221 | 2.81163 | 3 | 8 | 60 | face development |
| GO:1901605 | 0.01228 | 1.88494 | 10 | 18 | 193 | alpha-amino acid metabolic process |
| GO:0030323 | 0.01236 | 1.81524 | 12 | 20 | 222 | respiratory tube development |
| GO:0002524 | 0.01247 | 5.21328 | 1 | 4 | 18 | hypersensitivity |
| GO:0010832 | 0.01247 | 5.21328 | 1 | 4 | 18 | negative regulation of myotube differentiation |
| GO:0014061 | 0.01247 | 5.21328 | 1 | 4 | 18 | regulation of norepinephrine secretion |
| GO:0022038 | 0.01247 | 5.21328 | 1 | 4 | 18 | corpus callosum development |
| GO:0034587 | 0.01247 | 5.21328 | 1 | 4 | 18 | piRNA metabolic process |
| GO:0034695 | 0.01247 | 5.21328 | 1 | 4 | 18 | response to prostaglandin E |
| GO:0042447 | 0.01247 | 5.21328 | 1 | 4 | 18 | hormone catabolic process |
| GO:0048243 | 0.01247 | 5.21328 | 1 | 4 | 18 | norepinephrine secretion |
| GO:0060547 | 0.01247 | 5.21328 | 1 | 4 | 18 | negative regulation of necrotic cell death |
| GO:0060850 | 0.01247 | 5.21328 | 1 | 4 | 18 | regulation of transcription involved in cell fate commitment |
| GO:1902547 | 0.01247 | 5.21328 | 1 | 4 | 18 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:2000319 | 0.01247 | 5.21328 | 1 | 4 | 18 | regulation of T-helper 17 cell differentiation |
| GO:0060048 | 0.01264 | 2.14356 | 6 | 13 | 124 | cardiac muscle contraction |
| GO:0007623 | 0.01266 | 1.84264 | 11 | 19 | 208 | circadian rhythm |
| GO:0042632 | 0.01279 | 2.43825 | 4 | 10 | 85 | cholesterol homeostasis |
| GO:0002315 | 0.01284 | 7.81592 | 1 | 3 | 10 | marginal zone B cell differentiation |
| GO:0002645 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of tolerance induction |
| GO:0010612 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of cardiac muscle adaptation |
| GO:0030854 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of granulocyte differentiation |
| GO:0033085 | 0.01284 | 7.81592 | 1 | 3 | 10 | negative regulation of T cell differentiation in thymus |
| GO:0035744 | 0.01284 | 7.81592 | 1 | 3 | 10 | T-helper 1 cell cytokine production |
| GO:0043301 | 0.01284 | 7.81592 | 1 | 3 | 10 | negative regulation of leukocyte degranulation |
| GO:0043922 | 0.01284 | 7.81592 | 1 | 3 | 10 | negative regulation by host of viral transcription |
| GO:0048382 | 0.01284 | 7.81592 | 1 | 3 | 10 | mesendoderm development |
| GO:0051001 | 0.01284 | 7.81592 | 1 | 3 | 10 | negative regulation of nitric-oxide synthase activity |
| GO:0051133 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of NK T cell activation |
| GO:0071888 | 0.01284 | 7.81592 | 1 | 3 | 10 | macrophage apoptotic process |
| GO:0072070 | 0.01284 | 7.81592 | 1 | 3 | 10 | loop of Henle development |
| GO:0072610 | 0.01284 | 7.81592 | 1 | 3 | 10 | interleukin-12 secretion |
| GO:0099509 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of presynaptic cytosolic calcium ion concentration |
| GO:0140052 | 0.01284 | 7.81592 | 1 | 3 | 10 | cellular response to oxidised low-density lipoprotein particle stimulus |
| GO:1902074 | 0.01284 | 7.81592 | 1 | 3 | 10 | response to salt |
| GO:1902093 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of flagellated sperm motility |
| GO:2000109 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of macrophage apoptotic process |
| GO:2000302 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of synaptic vesicle exocytosis |
| GO:2000318 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of T-helper 17 type immune response |
| GO:2000389 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of neutrophil extravasation |
| GO:2000391 | 0.01284 | 7.81592 | 1 | 3 | 10 | positive regulation of neutrophil extravasation |
| GO:2000551 | 0.01284 | 7.81592 | 1 | 3 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0070229 | 0.01295 | 3.04479 | 3 | 7 | 49 | negative regulation of lymphocyte apoptotic process |
| GO:0016339 | 0.01303 | 3.42410 | 2 | 6 | 38 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0043368 | 0.01303 | 3.42410 | 2 | 6 | 38 | positive T cell selection |
| GO:0048265 | 0.01303 | 3.42410 | 2 | 6 | 38 | response to pain |
| GO:2001025 | 0.01303 | 3.42410 | 2 | 6 | 38 | positive regulation of response to drug |
| GO:0097305 | 0.01327 | 1.83286 | 11 | 19 | 209 | response to alcohol |
| GO:0031329 | 0.01337 | 1.42839 | 36 | 50 | 695 | regulation of cellular catabolic process |
| GO:0042698 | 0.01343 | 2.75846 | 3 | 8 | 61 | ovulation cycle |
| GO:0048512 | 0.01343 | 2.75846 | 3 | 8 | 61 | circadian behavior |
| GO:0007631 | 0.01346 | 2.12432 | 7 | 13 | 125 | feeding behavior |
| GO:0030036 | 0.01362 | 1.43768 | 35 | 48 | 663 | actin cytoskeleton organization |
| GO:0006066 | 0.01369 | 1.65697 | 16 | 26 | 314 | alcohol metabolic process |
| GO:0010001 | 0.01371 | 1.76630 | 12 | 21 | 239 | glial cell differentiation |
| GO:0002029 | 0.01374 | 3.96829 | 1 | 5 | 28 | desensitization of G protein-coupled receptor signaling pathway |
| GO:0022401 | 0.01374 | 3.96829 | 1 | 5 | 28 | negative adaptation of signaling pathway |
| GO:0035335 | 0.01374 | 3.96829 | 1 | 5 | 28 | peptidyl-tyrosine dephosphorylation |
| GO:0045187 | 0.01374 | 3.96829 | 1 | 5 | 28 | regulation of circadian sleep/wake cycle, sleep |
| GO:0051589 | 0.01374 | 3.96829 | 1 | 5 | 28 | negative regulation of neurotransmitter transport |
| GO:0060384 | 0.01374 | 3.96829 | 1 | 5 | 28 | innervation |
| GO:0080154 | 0.01374 | 3.96829 | 1 | 5 | 28 | regulation of fertilization |
| GO:0090200 | 0.01374 | 3.96829 | 1 | 5 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:1900745 | 0.01374 | 3.96829 | 1 | 5 | 28 | positive regulation of p38MAPK cascade |
| GO:1901186 | 0.01374 | 3.96829 | 1 | 5 | 28 | positive regulation of ERBB signaling pathway |
| GO:0006805 | 0.01380 | 2.19559 | 6 | 12 | 112 | xenobiotic metabolic process |
| GO:0007626 | 0.01382 | 1.73909 | 13 | 22 | 254 | locomotory behavior |
| GO:0055092 | 0.01382 | 2.40606 | 4 | 10 | 86 | sterol homeostasis |
| GO:0061333 | 0.01382 | 2.40606 | 4 | 10 | 86 | renal tubule morphogenesis |
| GO:0006641 | 0.01395 | 2.28641 | 5 | 11 | 99 | triglyceride metabolic process |
| GO:0097435 | 0.01419 | 1.42825 | 35 | 49 | 681 | supramolecular fiber organization |
| GO:0043393 | 0.01431 | 1.75815 | 13 | 21 | 240 | regulation of protein binding |
| GO:0032715 | 0.01440 | 2.97384 | 3 | 7 | 50 | negative regulation of interleukin-6 production |
| GO:0060043 | 0.01440 | 2.97384 | 3 | 7 | 50 | regulation of cardiac muscle cell proliferation |
| GO:0120193 | 0.01440 | 2.97384 | 3 | 7 | 50 | tight junction organization |
| GO:1902373 | 0.01440 | 2.97384 | 3 | 7 | 50 | negative regulation of mRNA catabolic process |
| GO:0007193 | 0.01446 | 2.53108 | 4 | 9 | 74 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0008543 | 0.01446 | 2.53108 | 4 | 9 | 74 | fibroblast growth factor receptor signaling pathway |
| GO:0097327 | 0.01446 | 2.53108 | 4 | 9 | 74 | response to antineoplastic agent |
| GO:0010976 | 0.01464 | 1.59916 | 19 | 29 | 362 | positive regulation of neuron projection development |
| GO:0098773 | 0.01473 | 2.17375 | 6 | 12 | 113 | skin epidermis development |
| GO:0007257 | 0.01474 | 3.32018 | 2 | 6 | 39 | activation of JUN kinase activity |
| GO:0021983 | 0.01474 | 3.32018 | 2 | 6 | 39 | pituitary gland development |
| GO:0090049 | 0.01474 | 3.32018 | 2 | 6 | 39 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0097009 | 0.01474 | 3.32018 | 2 | 6 | 39 | energy homeostasis |
| GO:0048008 | 0.01474 | 2.70725 | 3 | 8 | 62 | platelet-derived growth factor receptor signaling pathway |
| GO:0044255 | 0.01476 | 1.36087 | 49 | 64 | 932 | cellular lipid metabolic process |
| GO:0044283 | 0.01482 | 1.43532 | 34 | 47 | 650 | small molecule biosynthetic process |
| GO:0070252 | 0.01491 | 2.37471 | 5 | 10 | 87 | actin-mediated cell contraction |
| GO:0110020 | 0.01496 | 2.26062 | 5 | 11 | 100 | regulation of actomyosin structure organization |
| GO:0002043 | 0.01516 | 4.86550 | 1 | 4 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0006883 | 0.01516 | 4.86550 | 1 | 4 | 19 | cellular sodium ion homeostasis |
| GO:0009074 | 0.01516 | 4.86550 | 1 | 4 | 19 | aromatic amino acid family catabolic process |
| GO:0010818 | 0.01516 | 4.86550 | 1 | 4 | 19 | T cell chemotaxis |
| GO:0031664 | 0.01516 | 4.86550 | 1 | 4 | 19 | regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0032695 | 0.01516 | 4.86550 | 1 | 4 | 19 | negative regulation of interleukin-12 production |
| GO:0043046 | 0.01516 | 4.86550 | 1 | 4 | 19 | DNA methylation involved in gamete generation |
| GO:0050884 | 0.01516 | 4.86550 | 1 | 4 | 19 | neuromuscular process controlling posture |
| GO:0051546 | 0.01516 | 4.86550 | 1 | 4 | 19 | keratinocyte migration |
| GO:0051956 | 0.01516 | 4.86550 | 1 | 4 | 19 | negative regulation of amino acid transport |
| GO:0071605 | 0.01516 | 4.86550 | 1 | 4 | 19 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.01516 | 4.86550 | 1 | 4 | 19 | regulation of monocyte chemotactic protein-1 production |
| GO:0090036 | 0.01516 | 4.86550 | 1 | 4 | 19 | regulation of protein kinase C signaling |
| GO:1900424 | 0.01516 | 4.86550 | 1 | 4 | 19 | regulation of defense response to bacterium |
| GO:1902259 | 0.01516 | 4.86550 | 1 | 4 | 19 | regulation of delayed rectifier potassium channel activity |
| GO:0000239 | 0.01516 | 18.22618 | 0 | 2 | 4 | pachytene |
| GO:0001692 | 0.01516 | 18.22618 | 0 | 2 | 4 | histamine metabolic process |
| GO:0001905 | 0.01516 | 18.22618 | 0 | 2 | 4 | activation of membrane attack complex |
| GO:0001969 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of activation of membrane attack complex |
| GO:0001994 | 0.01516 | 18.22618 | 0 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0002215 | 0.01516 | 18.22618 | 0 | 2 | 4 | defense response to nematode |
| GO:0002434 | 0.01516 | 18.22618 | 0 | 2 | 4 | immune complex clearance |
| GO:0003332 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of extracellular matrix constituent secretion |
| GO:0006787 | 0.01516 | 18.22618 | 0 | 2 | 4 | porphyrin-containing compound catabolic process |
| GO:0008592 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of Toll signaling pathway |
| GO:0010040 | 0.01516 | 18.22618 | 0 | 2 | 4 | response to iron(II) ion |
| GO:0010911 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of isomerase activity |
| GO:0010912 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of isomerase activity |
| GO:0014016 | 0.01516 | 18.22618 | 0 | 2 | 4 | neuroblast differentiation |
| GO:0021557 | 0.01516 | 18.22618 | 0 | 2 | 4 | oculomotor nerve development |
| GO:0021773 | 0.01516 | 18.22618 | 0 | 2 | 4 | striatal medium spiny neuron differentiation |
| GO:0032264 | 0.01516 | 18.22618 | 0 | 2 | 4 | IMP salvage |
| GO:0032474 | 0.01516 | 18.22618 | 0 | 2 | 4 | otolith morphogenesis |
| GO:0032763 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of mast cell cytokine production |
| GO:0032971 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of muscle filament sliding |
| GO:0034635 | 0.01516 | 18.22618 | 0 | 2 | 4 | glutathione transport |
| GO:0035672 | 0.01516 | 18.22618 | 0 | 2 | 4 | oligopeptide transmembrane transport |
| GO:0035684 | 0.01516 | 18.22618 | 0 | 2 | 4 | helper T cell extravasation |
| GO:0035799 | 0.01516 | 18.22618 | 0 | 2 | 4 | ureter maturation |
| GO:0036301 | 0.01516 | 18.22618 | 0 | 2 | 4 | macrophage colony-stimulating factor production |
| GO:0038165 | 0.01516 | 18.22618 | 0 | 2 | 4 | oncostatin-M-mediated signaling pathway |
| GO:0040010 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of growth rate |
| GO:0042097 | 0.01516 | 18.22618 | 0 | 2 | 4 | interleukin-4 biosynthetic process |
| GO:0042167 | 0.01516 | 18.22618 | 0 | 2 | 4 | heme catabolic process |
| GO:0042253 | 0.01516 | 18.22618 | 0 | 2 | 4 | granulocyte macrophage colony-stimulating factor biosynthetic process |
| GO:0042939 | 0.01516 | 18.22618 | 0 | 2 | 4 | tripeptide transport |
| GO:0045402 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of interleukin-4 biosynthetic process |
| GO:0045423 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process |
| GO:0045917 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of complement activation |
| GO:0046149 | 0.01516 | 18.22618 | 0 | 2 | 4 | pigment catabolic process |
| GO:0048295 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
| GO:0048861 | 0.01516 | 18.22618 | 0 | 2 | 4 | leukemia inhibitory factor signaling pathway |
| GO:0051612 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of serotonin uptake |
| GO:0052564 | 0.01516 | 18.22618 | 0 | 2 | 4 | response to immune response of other organism involved in symbiotic interaction |
| GO:0052572 | 0.01516 | 18.22618 | 0 | 2 | 4 | response to host immune response |
| GO:0060066 | 0.01516 | 18.22618 | 0 | 2 | 4 | oviduct development |
| GO:0060167 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of adenosine receptor signaling pathway |
| GO:0060279 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of ovulation |
| GO:0070103 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of interleukin-6-mediated signaling pathway |
| GO:0070949 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of neutrophil mediated killing of symbiont cell |
| GO:0071543 | 0.01516 | 18.22618 | 0 | 2 | 4 | diphosphoinositol polyphosphate metabolic process |
| GO:0071611 | 0.01516 | 18.22618 | 0 | 2 | 4 | granulocyte colony-stimulating factor production |
| GO:0071655 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of granulocyte colony-stimulating factor production |
| GO:0071724 | 0.01516 | 18.22618 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.01516 | 18.22618 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0071878 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0072086 | 0.01516 | 18.22618 | 0 | 2 | 4 | specification of loop of Henle identity |
| GO:0072108 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0072268 | 0.01516 | 18.22618 | 0 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0140192 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:1901256 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of macrophage colony-stimulating factor production |
| GO:1901906 | 0.01516 | 18.22618 | 0 | 2 | 4 | diadenosine pentaphosphate metabolic process |
| GO:1901907 | 0.01516 | 18.22618 | 0 | 2 | 4 | diadenosine pentaphosphate catabolic process |
| GO:1901908 | 0.01516 | 18.22618 | 0 | 2 | 4 | diadenosine hexaphosphate metabolic process |
| GO:1901909 | 0.01516 | 18.22618 | 0 | 2 | 4 | diadenosine hexaphosphate catabolic process |
| GO:1901910 | 0.01516 | 18.22618 | 0 | 2 | 4 | adenosine 5'-(hexahydrogen pentaphosphate) metabolic process |
| GO:1901911 | 0.01516 | 18.22618 | 0 | 2 | 4 | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process |
| GO:1902202 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of hepatocyte growth factor receptor signaling pathway |
| GO:1902219 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:1902869 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of amacrine cell differentiation |
| GO:1903936 | 0.01516 | 18.22618 | 0 | 2 | 4 | cellular response to sodium arsenite |
| GO:1904714 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of chaperone-mediated autophagy |
| GO:1990410 | 0.01516 | 18.22618 | 0 | 2 | 4 | adrenomedullin receptor signaling pathway |
| GO:2000097 | 0.01516 | 18.22618 | 0 | 2 | 4 | regulation of smooth muscle cell-matrix adhesion |
| GO:2000259 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of protein activation cascade |
| GO:2000412 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of thymocyte migration |
| GO:2000503 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of natural killer cell chemotaxis |
| GO:2000525 | 0.01516 | 18.22618 | 0 | 2 | 4 | positive regulation of T cell costimulation |
| GO:2000587 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway |
| GO:2000660 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of interleukin-1-mediated signaling pathway |
| GO:2001199 | 0.01516 | 18.22618 | 0 | 2 | 4 | negative regulation of dendritic cell differentiation |
| GO:0048640 | 0.01521 | 2.08686 | 7 | 13 | 127 | negative regulation of developmental growth |
| GO:0051592 | 0.01521 | 2.08686 | 7 | 13 | 127 | response to calcium ion |
| GO:0043010 | 0.01541 | 1.60634 | 18 | 28 | 348 | camera-type eye development |
| GO:0062013 | 0.01550 | 1.96168 | 8 | 15 | 155 | positive regulation of small molecule metabolic process |
| GO:0060563 | 0.01570 | 2.49261 | 4 | 9 | 75 | neuroepithelial cell differentiation |
| GO:0022404 | 0.01571 | 2.15234 | 6 | 12 | 114 | molting cycle process |
| GO:0022405 | 0.01571 | 2.15234 | 6 | 12 | 114 | hair cycle process |
| GO:0048562 | 0.01585 | 1.63398 | 17 | 26 | 318 | embryonic organ morphogenesis |
| GO:0006536 | 0.01591 | 3.80278 | 2 | 5 | 29 | glutamate metabolic process |
| GO:0050802 | 0.01591 | 3.80278 | 2 | 5 | 29 | circadian sleep/wake cycle, sleep |
| GO:0071353 | 0.01591 | 3.80278 | 2 | 5 | 29 | cellular response to interleukin-4 |
| GO:0071354 | 0.01591 | 3.80278 | 2 | 5 | 29 | cellular response to interleukin-6 |
| GO:1902042 | 0.01591 | 3.80278 | 2 | 5 | 29 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032355 | 0.01596 | 2.90612 | 3 | 7 | 51 | response to estradiol |
| GO:0070265 | 0.01596 | 2.90612 | 3 | 7 | 51 | necrotic cell death |
| GO:0008104 | 0.01600 | 1.21639 | 134 | 158 | 2578 | protein localization |
| GO:0050848 | 0.01603 | 2.23540 | 5 | 11 | 101 | regulation of calcium-mediated signaling |
| GO:0051492 | 0.01607 | 2.34415 | 5 | 10 | 88 | regulation of stress fiber assembly |
| GO:0007622 | 0.01614 | 2.65791 | 3 | 8 | 63 | rhythmic behavior |
| GO:0015914 | 0.01614 | 2.65791 | 3 | 8 | 63 | phospholipid transport |
| GO:0030330 | 0.01614 | 2.65791 | 3 | 8 | 63 | DNA damage response, signal transduction by p53 class mediator |
| GO:0099601 | 0.01614 | 2.65791 | 3 | 8 | 63 | regulation of neurotransmitter receptor activity |
| GO:0050680 | 0.01635 | 2.00197 | 7 | 14 | 142 | negative regulation of epithelial cell proliferation |
| GO:0106106 | 0.01635 | 2.00197 | 7 | 14 | 142 | cold-induced thermogenesis |
| GO:0120161 | 0.01635 | 2.00197 | 7 | 14 | 142 | regulation of cold-induced thermogenesis |
| GO:0044242 | 0.01638 | 1.82195 | 10 | 18 | 199 | cellular lipid catabolic process |
| GO:0050806 | 0.01651 | 1.59622 | 18 | 28 | 350 | positive regulation of synaptic transmission |
| GO:0007339 | 0.01659 | 3.22239 | 2 | 6 | 40 | binding of sperm to zona pellucida |
| GO:0110111 | 0.01659 | 3.22239 | 2 | 6 | 40 | negative regulation of animal organ morphogenesis |
| GO:0032368 | 0.01674 | 2.13135 | 6 | 12 | 115 | regulation of lipid transport |
| GO:0051056 | 0.01695 | 1.70201 | 13 | 22 | 259 | regulation of small GTPase mediated signal transduction |
| GO:0001865 | 0.01698 | 6.83862 | 1 | 3 | 11 | NK T cell differentiation |
| GO:0002138 | 0.01698 | 6.83862 | 1 | 3 | 11 | retinoic acid biosynthetic process |
| GO:0002923 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0006527 | 0.01698 | 6.83862 | 1 | 3 | 11 | arginine catabolic process |
| GO:0010042 | 0.01698 | 6.83862 | 1 | 3 | 11 | response to manganese ion |
| GO:0010744 | 0.01698 | 6.83862 | 1 | 3 | 11 | positive regulation of macrophage derived foam cell differentiation |
| GO:0014010 | 0.01698 | 6.83862 | 1 | 3 | 11 | Schwann cell proliferation |
| GO:0016102 | 0.01698 | 6.83862 | 1 | 3 | 11 | diterpenoid biosynthetic process |
| GO:0031630 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of synaptic vesicle fusion to presynaptic active zone membrane |
| GO:0035739 | 0.01698 | 6.83862 | 1 | 3 | 11 | CD4-positive, alpha-beta T cell proliferation |
| GO:0035881 | 0.01698 | 6.83862 | 1 | 3 | 11 | amacrine cell differentiation |
| GO:0036005 | 0.01698 | 6.83862 | 1 | 3 | 11 | response to macrophage colony-stimulating factor |
| GO:0036006 | 0.01698 | 6.83862 | 1 | 3 | 11 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0044557 | 0.01698 | 6.83862 | 1 | 3 | 11 | relaxation of smooth muscle |
| GO:0045602 | 0.01698 | 6.83862 | 1 | 3 | 11 | negative regulation of endothelial cell differentiation |
| GO:0046040 | 0.01698 | 6.83862 | 1 | 3 | 11 | IMP metabolic process |
| GO:0048262 | 0.01698 | 6.83862 | 1 | 3 | 11 | determination of dorsal/ventral asymmetry |
| GO:0048263 | 0.01698 | 6.83862 | 1 | 3 | 11 | determination of dorsal identity |
| GO:0048934 | 0.01698 | 6.83862 | 1 | 3 | 11 | peripheral nervous system neuron differentiation |
| GO:0048935 | 0.01698 | 6.83862 | 1 | 3 | 11 | peripheral nervous system neuron development |
| GO:0051967 | 0.01698 | 6.83862 | 1 | 3 | 11 | negative regulation of synaptic transmission, glutamatergic |
| GO:0060056 | 0.01698 | 6.83862 | 1 | 3 | 11 | mammary gland involution |
| GO:0070278 | 0.01698 | 6.83862 | 1 | 3 | 11 | extracellular matrix constituent secretion |
| GO:0072182 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of nephron tubule epithelial cell differentiation |
| GO:0086103 | 0.01698 | 6.83862 | 1 | 3 | 11 | G protein-coupled receptor signaling pathway involved in heart process |
| GO:0090037 | 0.01698 | 6.83862 | 1 | 3 | 11 | positive regulation of protein kinase C signaling |
| GO:0098792 | 0.01698 | 6.83862 | 1 | 3 | 11 | xenophagy |
| GO:1901163 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of trophoblast cell migration |
| GO:1903365 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of fear response |
| GO:1903431 | 0.01698 | 6.83862 | 1 | 3 | 11 | positive regulation of cell maturation |
| GO:2000561 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:2000822 | 0.01698 | 6.83862 | 1 | 3 | 11 | regulation of behavioral fear response |
| GO:0030168 | 0.01701 | 2.45530 | 4 | 9 | 76 | platelet activation |
| GO:0070228 | 0.01701 | 2.45530 | 4 | 9 | 76 | regulation of lymphocyte apoptotic process |
| GO:0045834 | 0.01724 | 1.93388 | 8 | 15 | 157 | positive regulation of lipid metabolic process |
| GO:0021872 | 0.01728 | 2.31438 | 5 | 10 | 89 | forebrain generation of neurons |
| GO:0031016 | 0.01728 | 2.31438 | 5 | 10 | 89 | pancreas development |
| GO:0035265 | 0.01742 | 1.77626 | 11 | 19 | 215 | organ growth |
| GO:1901264 | 0.01763 | 2.61032 | 3 | 8 | 64 | carbohydrate derivative transport |
| GO:0032481 | 0.01764 | 2.84141 | 3 | 7 | 52 | positive regulation of type I interferon production |
| GO:0043268 | 0.01764 | 2.84141 | 3 | 7 | 52 | positive regulation of potassium ion transport |
| GO:1900271 | 0.01764 | 2.84141 | 3 | 7 | 52 | regulation of long-term synaptic potentiation |
| GO:2001222 | 0.01764 | 2.84141 | 3 | 7 | 52 | regulation of neuron migration |
| GO:0060341 | 0.01779 | 1.34302 | 50 | 65 | 958 | regulation of cellular localization |
| GO:0021543 | 0.01817 | 1.92027 | 8 | 15 | 158 | pallium development |
| GO:0002313 | 0.01818 | 4.56120 | 1 | 4 | 20 | mature B cell differentiation involved in immune response |
| GO:0002523 | 0.01818 | 4.56120 | 1 | 4 | 20 | leukocyte migration involved in inflammatory response |
| GO:0006688 | 0.01818 | 4.56120 | 1 | 4 | 20 | glycosphingolipid biosynthetic process |
| GO:0006691 | 0.01818 | 4.56120 | 1 | 4 | 20 | leukotriene metabolic process |
| GO:0032495 | 0.01818 | 4.56120 | 1 | 4 | 20 | response to muramyl dipeptide |
| GO:0033033 | 0.01818 | 4.56120 | 1 | 4 | 20 | negative regulation of myeloid cell apoptotic process |
| GO:0035584 | 0.01818 | 4.56120 | 1 | 4 | 20 | calcium-mediated signaling using intracellular calcium source |
| GO:0070498 | 0.01818 | 4.56120 | 1 | 4 | 20 | interleukin-1-mediated signaling pathway |
| GO:0072079 | 0.01818 | 4.56120 | 1 | 4 | 20 | nephron tubule formation |
| GO:1900409 | 0.01818 | 4.56120 | 1 | 4 | 20 | positive regulation of cellular response to oxidative stress |
| GO:0006829 | 0.01829 | 3.65050 | 2 | 5 | 30 | zinc ion transport |
| GO:0023058 | 0.01829 | 3.65050 | 2 | 5 | 30 | adaptation of signaling pathway |
| GO:0051085 | 0.01829 | 3.65050 | 2 | 5 | 30 | chaperone cofactor-dependent protein refolding |
| GO:0070266 | 0.01829 | 3.65050 | 2 | 5 | 30 | necroptotic process |
| GO:0070306 | 0.01829 | 3.65050 | 2 | 5 | 30 | lens fiber cell differentiation |
| GO:1900117 | 0.01829 | 3.65050 | 2 | 5 | 30 | regulation of execution phase of apoptosis |
| GO:0001708 | 0.01833 | 2.18661 | 5 | 11 | 103 | cell fate specification |
| GO:0032231 | 0.01833 | 2.18661 | 5 | 11 | 103 | regulation of actin filament bundle assembly |
| GO:0048635 | 0.01840 | 2.41908 | 4 | 9 | 77 | negative regulation of muscle organ development |
| GO:0051154 | 0.01861 | 3.13017 | 2 | 6 | 41 | negative regulation of striated muscle cell differentiation |
| GO:1900744 | 0.01861 | 3.13017 | 2 | 6 | 41 | regulation of p38MAPK cascade |
| GO:0009064 | 0.01921 | 2.56441 | 3 | 8 | 65 | glutamine family amino acid metabolic process |
| GO:0019748 | 0.01921 | 2.56441 | 3 | 8 | 65 | secondary metabolic process |
| GO:0033627 | 0.01921 | 2.56441 | 3 | 8 | 65 | cell adhesion mediated by integrin |
| GO:0042303 | 0.01924 | 2.01575 | 7 | 13 | 131 | molting cycle |
| GO:0042633 | 0.01924 | 2.01575 | 7 | 13 | 131 | hair cycle |
| GO:1903900 | 0.01928 | 1.95586 | 8 | 14 | 145 | regulation of viral life cycle |
| GO:0007010 | 0.01942 | 1.28813 | 68 | 85 | 1305 | cytoskeleton organization |
| GO:0014014 | 0.01944 | 2.77952 | 3 | 7 | 53 | negative regulation of gliogenesis |
| GO:0051932 | 0.01944 | 2.77952 | 3 | 7 | 53 | synaptic transmission, GABAergic |
| GO:0071407 | 0.01956 | 1.48326 | 25 | 36 | 482 | cellular response to organic cyclic compound |
| GO:0043507 | 0.01987 | 2.38391 | 4 | 9 | 78 | positive regulation of JUN kinase activity |
| GO:0045685 | 0.01992 | 2.25702 | 5 | 10 | 91 | regulation of glial cell differentiation |
| GO:0050808 | 0.02017 | 1.49774 | 23 | 34 | 451 | synapse organization |
| GO:0010765 | 0.02078 | 3.04309 | 2 | 6 | 42 | positive regulation of sodium ion transport |
| GO:1902742 | 0.02078 | 3.04309 | 2 | 6 | 42 | apoptotic process involved in development |
| GO:0035282 | 0.02086 | 2.13989 | 5 | 11 | 105 | segmentation |
| GO:0002026 | 0.02090 | 3.50993 | 2 | 5 | 31 | regulation of the force of heart contraction |
| GO:0006767 | 0.02090 | 3.50993 | 2 | 5 | 31 | water-soluble vitamin metabolic process |
| GO:0010614 | 0.02090 | 3.50993 | 2 | 5 | 31 | negative regulation of cardiac muscle hypertrophy |
| GO:0032967 | 0.02090 | 3.50993 | 2 | 5 | 31 | positive regulation of collagen biosynthetic process |
| GO:0042036 | 0.02090 | 3.50993 | 2 | 5 | 31 | negative regulation of cytokine biosynthetic process |
| GO:0042749 | 0.02090 | 3.50993 | 2 | 5 | 31 | regulation of circadian sleep/wake cycle |
| GO:0043302 | 0.02090 | 3.50993 | 2 | 5 | 31 | positive regulation of leukocyte degranulation |
| GO:0043537 | 0.02090 | 3.50993 | 2 | 5 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0045662 | 0.02090 | 3.50993 | 2 | 5 | 31 | negative regulation of myoblast differentiation |
| GO:0048535 | 0.02090 | 3.50993 | 2 | 5 | 31 | lymph node development |
| GO:0050999 | 0.02090 | 3.50993 | 2 | 5 | 31 | regulation of nitric-oxide synthase activity |
| GO:0003158 | 0.02136 | 2.05130 | 6 | 12 | 119 | endothelium development |
| GO:0043297 | 0.02136 | 2.72025 | 3 | 7 | 54 | apical junction assembly |
| GO:0046503 | 0.02136 | 2.72025 | 3 | 7 | 54 | glycerolipid catabolic process |
| GO:0061025 | 0.02153 | 1.98197 | 7 | 13 | 133 | membrane fusion |
| GO:0019953 | 0.02154 | 1.34374 | 46 | 60 | 883 | sexual reproduction |
| GO:0001976 | 0.02155 | 4.29270 | 1 | 4 | 21 | neurological system process involved in regulation of systemic arterial blood pressure |
| GO:0002863 | 0.02155 | 4.29270 | 1 | 4 | 21 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0010743 | 0.02155 | 4.29270 | 1 | 4 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0010759 | 0.02155 | 4.29270 | 1 | 4 | 21 | positive regulation of macrophage chemotaxis |
| GO:0022010 | 0.02155 | 4.29270 | 1 | 4 | 21 | central nervous system myelination |
| GO:0032291 | 0.02155 | 4.29270 | 1 | 4 | 21 | axon ensheathment in central nervous system |
| GO:0048486 | 0.02155 | 4.29270 | 1 | 4 | 21 | parasympathetic nervous system development |
| GO:0070230 | 0.02155 | 4.29270 | 1 | 4 | 21 | positive regulation of lymphocyte apoptotic process |
| GO:0071577 | 0.02155 | 4.29270 | 1 | 4 | 21 | zinc ion transmembrane transport |
| GO:1900017 | 0.02155 | 4.29270 | 1 | 4 | 21 | positive regulation of cytokine production involved in inflammatory response |
| GO:1901623 | 0.02155 | 4.29270 | 1 | 4 | 21 | regulation of lymphocyte chemotaxis |
| GO:0050954 | 0.02172 | 1.61794 | 15 | 24 | 296 | sensory perception of mechanical stimulus |
| GO:0002730 | 0.02178 | 6.07850 | 1 | 3 | 12 | regulation of dendritic cell cytokine production |
| GO:0002921 | 0.02178 | 6.07850 | 1 | 3 | 12 | negative regulation of humoral immune response |
| GO:0006957 | 0.02178 | 6.07850 | 1 | 3 | 12 | complement activation, alternative pathway |
| GO:0010838 | 0.02178 | 6.07850 | 1 | 3 | 12 | positive regulation of keratinocyte proliferation |
| GO:0019896 | 0.02178 | 6.07850 | 1 | 3 | 12 | axonal transport of mitochondrion |
| GO:0032026 | 0.02178 | 6.07850 | 1 | 3 | 12 | response to magnesium ion |
| GO:0032488 | 0.02178 | 6.07850 | 1 | 3 | 12 | Cdc42 protein signal transduction |
| GO:0032725 | 0.02178 | 6.07850 | 1 | 3 | 12 | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0033083 | 0.02178 | 6.07850 | 1 | 3 | 12 | regulation of immature T cell proliferation |
| GO:0060430 | 0.02178 | 6.07850 | 1 | 3 | 12 | lung saccule development |
| GO:0061450 | 0.02178 | 6.07850 | 1 | 3 | 12 | trophoblast cell migration |
| GO:0071281 | 0.02178 | 6.07850 | 1 | 3 | 12 | cellular response to iron ion |
| GO:0071294 | 0.02178 | 6.07850 | 1 | 3 | 12 | cellular response to zinc ion |
| GO:0071639 | 0.02178 | 6.07850 | 1 | 3 | 12 | positive regulation of monocyte chemotactic protein-1 production |
| GO:0072683 | 0.02178 | 6.07850 | 1 | 3 | 12 | T cell extravasation |
| GO:0090494 | 0.02178 | 6.07850 | 1 | 3 | 12 | dopamine uptake |
| GO:1901298 | 0.02178 | 6.07850 | 1 | 3 | 12 | regulation of hydrogen peroxide-mediated programmed cell death |
| GO:1902510 | 0.02178 | 6.07850 | 1 | 3 | 12 | regulation of apoptotic DNA fragmentation |
| GO:1902805 | 0.02178 | 6.07850 | 1 | 3 | 12 | positive regulation of synaptic vesicle transport |
| GO:0045446 | 0.02222 | 2.11727 | 6 | 11 | 106 | endothelial cell differentiation |
| GO:0007272 | 0.02225 | 1.86767 | 8 | 15 | 162 | ensheathment of neurons |
| GO:0008366 | 0.02225 | 1.86767 | 8 | 15 | 162 | axon ensheathment |
| GO:0034329 | 0.02242 | 1.75355 | 11 | 18 | 206 | cell junction assembly |
| GO:0003231 | 0.02259 | 1.91181 | 8 | 14 | 148 | cardiac ventricle development |
| GO:0097194 | 0.02269 | 2.47726 | 3 | 8 | 67 | execution phase of apoptosis |
| GO:2000378 | 0.02269 | 2.47726 | 3 | 8 | 67 | negative regulation of reactive oxygen species metabolic process |
| GO:0007215 | 0.02284 | 2.20244 | 5 | 10 | 93 | glutamate receptor signaling pathway |
| GO:0072078 | 0.02307 | 2.31655 | 4 | 9 | 80 | nephron tubule morphogenesis |
| GO:0032924 | 0.02312 | 2.96071 | 2 | 6 | 43 | activin receptor signaling pathway |
| GO:0070232 | 0.02312 | 2.96071 | 2 | 6 | 43 | regulation of T cell apoptotic process |
| GO:1990573 | 0.02312 | 2.96071 | 2 | 6 | 43 | potassium ion import across plasma membrane |
| GO:0002833 | 0.02342 | 2.66346 | 3 | 7 | 55 | positive regulation of response to biotic stimulus |
| GO:0003044 | 0.02342 | 2.66346 | 3 | 7 | 55 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0022410 | 0.02374 | 3.37978 | 2 | 5 | 32 | circadian sleep/wake cycle process |
| GO:0032743 | 0.02374 | 3.37978 | 2 | 5 | 32 | positive regulation of interleukin-2 production |
| GO:0045616 | 0.02374 | 3.37978 | 2 | 5 | 32 | regulation of keratinocyte differentiation |
| GO:0048668 | 0.02374 | 3.37978 | 2 | 5 | 32 | collateral sprouting |
| GO:0060561 | 0.02374 | 3.37978 | 2 | 5 | 32 | apoptotic process involved in morphogenesis |
| GO:1904646 | 0.02374 | 3.37978 | 2 | 5 | 32 | cellular response to amyloid-beta |
| GO:0001889 | 0.02400 | 2.01347 | 6 | 12 | 121 | liver development |
| GO:0048565 | 0.02400 | 2.01347 | 6 | 12 | 121 | digestive tract development |
| GO:1990138 | 0.02425 | 1.76854 | 10 | 17 | 193 | neuron projection extension |
| GO:0001978 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback |
| GO:0001992 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0002175 | 0.02440 | 12.15023 | 0 | 2 | 5 | protein localization to paranode region of axon |
| GO:0002220 | 0.02440 | 12.15023 | 0 | 2 | 5 | innate immune response activating cell surface receptor signaling pathway |
| GO:0002238 | 0.02440 | 12.15023 | 0 | 2 | 5 | response to molecule of fungal origin |
| GO:0002784 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of antimicrobial peptide production |
| GO:0002786 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of antibacterial peptide production |
| GO:0002901 | 0.02440 | 12.15023 | 0 | 2 | 5 | mature B cell apoptotic process |
| GO:0002905 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of mature B cell apoptotic process |
| GO:0002906 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of mature B cell apoptotic process |
| GO:0003241 | 0.02440 | 12.15023 | 0 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0009115 | 0.02440 | 12.15023 | 0 | 2 | 5 | xanthine catabolic process |
| GO:0010693 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of alkaline phosphatase activity |
| GO:0015727 | 0.02440 | 12.15023 | 0 | 2 | 5 | lactate transport |
| GO:0015961 | 0.02440 | 12.15023 | 0 | 2 | 5 | diadenosine polyphosphate catabolic process |
| GO:0016199 | 0.02440 | 12.15023 | 0 | 2 | 5 | axon midline choice point recognition |
| GO:0023041 | 0.02440 | 12.15023 | 0 | 2 | 5 | neuronal signal transduction |
| GO:0031284 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of guanylate cyclase activity |
| GO:0032227 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of synaptic transmission, dopaminergic |
| GO:0032364 | 0.02440 | 12.15023 | 0 | 2 | 5 | oxygen homeostasis |
| GO:0032632 | 0.02440 | 12.15023 | 0 | 2 | 5 | interleukin-3 production |
| GO:0033015 | 0.02440 | 12.15023 | 0 | 2 | 5 | tetrapyrrole catabolic process |
| GO:0033031 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of neutrophil apoptotic process |
| GO:0033239 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of cellular amine metabolic process |
| GO:0034136 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of toll-like receptor 2 signaling pathway |
| GO:0035666 | 0.02440 | 12.15023 | 0 | 2 | 5 | TRIF-dependent toll-like receptor signaling pathway |
| GO:0035747 | 0.02440 | 12.15023 | 0 | 2 | 5 | natural killer cell chemotaxis |
| GO:0035873 | 0.02440 | 12.15023 | 0 | 2 | 5 | lactate transmembrane transport |
| GO:0035879 | 0.02440 | 12.15023 | 0 | 2 | 5 | plasma membrane lactate transport |
| GO:0042091 | 0.02440 | 12.15023 | 0 | 2 | 5 | interleukin-10 biosynthetic process |
| GO:0042701 | 0.02440 | 12.15023 | 0 | 2 | 5 | progesterone secretion |
| GO:0045074 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of interleukin-10 biosynthetic process |
| GO:0046133 | 0.02440 | 12.15023 | 0 | 2 | 5 | pyrimidine ribonucleoside catabolic process |
| GO:0051342 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0060057 | 0.02440 | 12.15023 | 0 | 2 | 5 | apoptotic process involved in mammary gland involution |
| GO:0060058 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of apoptotic process involved in mammary gland involution |
| GO:0060278 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of ovulation |
| GO:0060591 | 0.02440 | 12.15023 | 0 | 2 | 5 | chondroblast differentiation |
| GO:0060665 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling |
| GO:0061743 | 0.02440 | 12.15023 | 0 | 2 | 5 | motor learning |
| GO:0070487 | 0.02440 | 12.15023 | 0 | 2 | 5 | monocyte aggregation |
| GO:0070669 | 0.02440 | 12.15023 | 0 | 2 | 5 | response to interleukin-2 |
| GO:0071205 | 0.02440 | 12.15023 | 0 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0071442 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of histone H3-K14 acetylation |
| GO:0072047 | 0.02440 | 12.15023 | 0 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
| GO:0072081 | 0.02440 | 12.15023 | 0 | 2 | 5 | specification of nephron tubule identity |
| GO:0097187 | 0.02440 | 12.15023 | 0 | 2 | 5 | dentinogenesis |
| GO:1900425 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of defense response to bacterium |
| GO:1901164 | 0.02440 | 12.15023 | 0 | 2 | 5 | negative regulation of trophoblast cell migration |
| GO:1902218 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:1902512 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of apoptotic DNA fragmentation |
| GO:1903519 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of mammary gland involution |
| GO:1903521 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of mammary gland involution |
| GO:1904636 | 0.02440 | 12.15023 | 0 | 2 | 5 | response to ionomycin |
| GO:1904637 | 0.02440 | 12.15023 | 0 | 2 | 5 | cellular response to ionomycin |
| GO:1905665 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of calcium ion import across plasma membrane |
| GO:2000196 | 0.02440 | 12.15023 | 0 | 2 | 5 | positive regulation of female gonad development |
| GO:2000410 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of thymocyte migration |
| GO:2000501 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of natural killer cell chemotaxis |
| GO:2000523 | 0.02440 | 12.15023 | 0 | 2 | 5 | regulation of T cell costimulation |
| GO:0034109 | 0.02458 | 2.43586 | 4 | 8 | 68 | homotypic cell-cell adhesion |
| GO:0031646 | 0.02479 | 2.28427 | 4 | 9 | 81 | positive regulation of neurological system process |
| GO:0032479 | 0.02479 | 2.28427 | 4 | 9 | 81 | regulation of type I interferon production |
| GO:0071772 | 0.02503 | 1.79682 | 9 | 16 | 179 | response to BMP |
| GO:0071773 | 0.02503 | 1.79682 | 9 | 16 | 179 | cellular response to BMP stimulus |
| GO:0030048 | 0.02513 | 2.07342 | 6 | 11 | 108 | actin filament-based movement |
| GO:0002834 | 0.02528 | 4.05403 | 1 | 4 | 22 | regulation of response to tumor cell |
| GO:0002837 | 0.02528 | 4.05403 | 1 | 4 | 22 | regulation of immune response to tumor cell |
| GO:0002864 | 0.02528 | 4.05403 | 1 | 4 | 22 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0021516 | 0.02528 | 4.05403 | 1 | 4 | 22 | dorsal spinal cord development |
| GO:0031643 | 0.02528 | 4.05403 | 1 | 4 | 22 | positive regulation of myelination |
| GO:0032303 | 0.02528 | 4.05403 | 1 | 4 | 22 | regulation of icosanoid secretion |
| GO:0032331 | 0.02528 | 4.05403 | 1 | 4 | 22 | negative regulation of chondrocyte differentiation |
| GO:0032897 | 0.02528 | 4.05403 | 1 | 4 | 22 | negative regulation of viral transcription |
| GO:0044851 | 0.02528 | 4.05403 | 1 | 4 | 22 | hair cycle phase |
| GO:0051043 | 0.02528 | 4.05403 | 1 | 4 | 22 | regulation of membrane protein ectodomain proteolysis |
| GO:0051654 | 0.02528 | 4.05403 | 1 | 4 | 22 | establishment of mitochondrion localization |
| GO:0060009 | 0.02528 | 4.05403 | 1 | 4 | 22 | Sertoli cell development |
| GO:0098581 | 0.02528 | 4.05403 | 1 | 4 | 22 | detection of external biotic stimulus |
| GO:2000353 | 0.02528 | 4.05403 | 1 | 4 | 22 | positive regulation of endothelial cell apoptotic process |
| GO:0017158 | 0.02534 | 1.93337 | 7 | 13 | 136 | regulation of calcium ion-dependent exocytosis |
| GO:0007586 | 0.02540 | 1.99508 | 6 | 12 | 122 | digestion |
| GO:0061013 | 0.02540 | 1.99508 | 6 | 12 | 122 | regulation of mRNA catabolic process |
| GO:0043536 | 0.02560 | 2.60899 | 3 | 7 | 56 | positive regulation of blood vessel endothelial cell migration |
| GO:0071385 | 0.02563 | 2.88266 | 2 | 6 | 44 | cellular response to glucocorticoid stimulus |
| GO:0048634 | 0.02620 | 1.78578 | 9 | 16 | 180 | regulation of muscle organ development |
| GO:0006897 | 0.02627 | 1.36024 | 39 | 51 | 741 | endocytosis |
| GO:0046777 | 0.02637 | 1.66534 | 13 | 20 | 240 | protein autophosphorylation |
| GO:0001541 | 0.02658 | 2.39582 | 4 | 8 | 69 | ovarian follicle development |
| GO:0015748 | 0.02661 | 2.25288 | 4 | 9 | 82 | organophosphate ester transport |
| GO:0048675 | 0.02671 | 1.91769 | 7 | 13 | 137 | axon extension |
| GO:0014741 | 0.02681 | 3.25893 | 2 | 5 | 33 | negative regulation of muscle hypertrophy |
| GO:0046596 | 0.02681 | 3.25893 | 2 | 5 | 33 | regulation of viral entry into host cell |
| GO:0048240 | 0.02681 | 3.25893 | 2 | 5 | 33 | sperm capacitation |
| GO:0050779 | 0.02681 | 3.25893 | 2 | 5 | 33 | RNA destabilization |
| GO:1901099 | 0.02681 | 3.25893 | 2 | 5 | 33 | negative regulation of signal transduction in absence of ligand |
| GO:1903205 | 0.02681 | 3.25893 | 2 | 5 | 33 | regulation of hydrogen peroxide-induced cell death |
| GO:2001240 | 0.02681 | 3.25893 | 2 | 5 | 33 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0001553 | 0.02723 | 5.47040 | 1 | 3 | 13 | luteinization |
| GO:0002087 | 0.02723 | 5.47040 | 1 | 3 | 13 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0002371 | 0.02723 | 5.47040 | 1 | 3 | 13 | dendritic cell cytokine production |
| GO:0002551 | 0.02723 | 5.47040 | 1 | 3 | 13 | mast cell chemotaxis |
| GO:0002638 | 0.02723 | 5.47040 | 1 | 3 | 13 | negative regulation of immunoglobulin production |
| GO:0002756 | 0.02723 | 5.47040 | 1 | 3 | 13 | MyD88-independent toll-like receptor signaling pathway |
| GO:0007320 | 0.02723 | 5.47040 | 1 | 3 | 13 | insemination |
| GO:0032926 | 0.02723 | 5.47040 | 1 | 3 | 13 | negative regulation of activin receptor signaling pathway |
| GO:0033079 | 0.02723 | 5.47040 | 1 | 3 | 13 | immature T cell proliferation |
| GO:0036376 | 0.02723 | 5.47040 | 1 | 3 | 13 | sodium ion export across plasma membrane |
| GO:0048012 | 0.02723 | 5.47040 | 1 | 3 | 13 | hepatocyte growth factor receptor signaling pathway |
| GO:0048742 | 0.02723 | 5.47040 | 1 | 3 | 13 | regulation of skeletal muscle fiber development |
| GO:0050746 | 0.02723 | 5.47040 | 1 | 3 | 13 | regulation of lipoprotein metabolic process |
| GO:0051132 | 0.02723 | 5.47040 | 1 | 3 | 13 | NK T cell activation |
| GO:0051549 | 0.02723 | 5.47040 | 1 | 3 | 13 | positive regulation of keratinocyte migration |
| GO:0055119 | 0.02723 | 5.47040 | 1 | 3 | 13 | relaxation of cardiac muscle |
| GO:0060339 | 0.02723 | 5.47040 | 1 | 3 | 13 | negative regulation of type I interferon-mediated signaling pathway |
| GO:0071285 | 0.02723 | 5.47040 | 1 | 3 | 13 | cellular response to lithium ion |
| GO:0072160 | 0.02723 | 5.47040 | 1 | 3 | 13 | nephron tubule epithelial cell differentiation |
| GO:0072216 | 0.02723 | 5.47040 | 1 | 3 | 13 | positive regulation of metanephros development |
| GO:0090493 | 0.02723 | 5.47040 | 1 | 3 | 13 | catecholamine uptake |
| GO:0090594 | 0.02723 | 5.47040 | 1 | 3 | 13 | inflammatory response to wounding |
| GO:0106072 | 0.02723 | 5.47040 | 1 | 3 | 13 | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:1902916 | 0.02723 | 5.47040 | 1 | 3 | 13 | positive regulation of protein polyubiquitination |
| GO:1903587 | 0.02723 | 5.47040 | 1 | 3 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0006790 | 0.02774 | 1.61254 | 14 | 22 | 272 | sulfur compound metabolic process |
| GO:0099565 | 0.02778 | 2.12532 | 5 | 10 | 96 | chemical synaptic transmission, postsynaptic |
| GO:0002067 | 0.02792 | 2.55669 | 3 | 7 | 57 | glandular epithelial cell differentiation |
| GO:0016079 | 0.02814 | 1.90226 | 7 | 13 | 138 | synaptic vesicle exocytosis |
| GO:0001843 | 0.02831 | 2.03135 | 6 | 11 | 110 | neural tube closure |
| GO:0019228 | 0.02831 | 2.80862 | 2 | 6 | 45 | neuronal action potential |
| GO:0031952 | 0.02831 | 2.80862 | 2 | 6 | 45 | regulation of protein autophosphorylation |
| GO:0060135 | 0.02831 | 2.80862 | 2 | 6 | 45 | maternal process involved in female pregnancy |
| GO:0006638 | 0.02839 | 1.95927 | 6 | 12 | 124 | neutral lipid metabolic process |
| GO:0061008 | 0.02839 | 1.95927 | 6 | 12 | 124 | hepaticobiliary system development |
| GO:0002719 | 0.02938 | 3.84049 | 1 | 4 | 23 | negative regulation of cytokine production involved in immune response |
| GO:0006144 | 0.02938 | 3.84049 | 1 | 4 | 23 | purine nucleobase metabolic process |
| GO:0006837 | 0.02938 | 3.84049 | 1 | 4 | 23 | serotonin transport |
| GO:0031954 | 0.02938 | 3.84049 | 1 | 4 | 23 | positive regulation of protein autophosphorylation |
| GO:0032461 | 0.02938 | 3.84049 | 1 | 4 | 23 | positive regulation of protein oligomerization |
| GO:0043371 | 0.02938 | 3.84049 | 1 | 4 | 23 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0050765 | 0.02938 | 3.84049 | 1 | 4 | 23 | negative regulation of phagocytosis |
| GO:0051969 | 0.02938 | 3.84049 | 1 | 4 | 23 | regulation of transmission of nerve impulse |
| GO:0090190 | 0.02938 | 3.84049 | 1 | 4 | 23 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:1902884 | 0.02938 | 3.84049 | 1 | 4 | 23 | positive regulation of response to oxidative stress |
| GO:1903306 | 0.02938 | 3.84049 | 1 | 4 | 23 | negative regulation of regulated secretory pathway |
| GO:2000316 | 0.02938 | 3.84049 | 1 | 4 | 23 | regulation of T-helper 17 type immune response |
| GO:0045638 | 0.02958 | 2.10079 | 5 | 10 | 97 | negative regulation of myeloid cell differentiation |
| GO:0048644 | 0.02958 | 2.10079 | 5 | 10 | 97 | muscle organ morphogenesis |
| GO:0030509 | 0.02961 | 1.79394 | 9 | 15 | 168 | BMP signaling pathway |
| GO:0061572 | 0.02961 | 1.79394 | 9 | 15 | 168 | actin filament bundle organization |
| GO:0050792 | 0.02994 | 1.75346 | 10 | 16 | 183 | regulation of viral process |
| GO:0001942 | 0.03001 | 2.01094 | 6 | 11 | 111 | hair follicle development |
| GO:0019079 | 0.03001 | 2.01094 | 6 | 11 | 111 | viral genome replication |
| GO:0060606 | 0.03001 | 2.01094 | 6 | 11 | 111 | tube closure |
| GO:0016054 | 0.03002 | 1.69006 | 11 | 18 | 213 | organic acid catabolic process |
| GO:0046395 | 0.03002 | 1.69006 | 11 | 18 | 213 | carboxylic acid catabolic process |
| GO:0001773 | 0.03013 | 3.14641 | 2 | 5 | 34 | myeloid dendritic cell activation |
| GO:0006739 | 0.03013 | 3.14641 | 2 | 5 | 34 | NADP metabolic process |
| GO:0097366 | 0.03013 | 3.14641 | 2 | 5 | 34 | response to bronchodilator |
| GO:0140115 | 0.03013 | 3.14641 | 2 | 5 | 34 | export across plasma membrane |
| GO:1903429 | 0.03013 | 3.14641 | 2 | 5 | 34 | regulation of cell maturation |
| GO:0016064 | 0.03027 | 1.61638 | 13 | 21 | 259 | immunoglobulin mediated immune response |
| GO:0021517 | 0.03037 | 2.50644 | 3 | 7 | 58 | ventral spinal cord development |
| GO:0060443 | 0.03037 | 2.50644 | 3 | 7 | 58 | mammary gland morphogenesis |
| GO:1902369 | 0.03037 | 2.50644 | 3 | 7 | 58 | negative regulation of RNA catabolic process |
| GO:0060420 | 0.03052 | 2.19260 | 4 | 9 | 84 | regulation of heart growth |
| GO:1901379 | 0.03052 | 2.19260 | 4 | 9 | 84 | regulation of potassium ion transmembrane transport |
| GO:0031346 | 0.03055 | 1.44473 | 24 | 34 | 466 | positive regulation of cell projection organization |
| GO:0014068 | 0.03091 | 2.31955 | 4 | 8 | 71 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0090304 | 0.03105 | 1.15114 | 223 | 248 | 4277 | nucleic acid metabolic process |
| GO:0006576 | 0.03118 | 2.73828 | 2 | 6 | 46 | cellular biogenic amine metabolic process |
| GO:0030517 | 0.03118 | 2.73828 | 2 | 6 | 46 | negative regulation of axon extension |
| GO:0035036 | 0.03118 | 2.73828 | 2 | 6 | 46 | sperm-egg recognition |
| GO:0030522 | 0.03134 | 1.70976 | 10 | 17 | 199 | intracellular receptor signaling pathway |
| GO:0045665 | 0.03138 | 1.60955 | 14 | 21 | 260 | negative regulation of neuron differentiation |
| GO:0021761 | 0.03147 | 2.07683 | 5 | 10 | 98 | limbic system development |
| GO:0042100 | 0.03177 | 1.99094 | 6 | 11 | 112 | B cell proliferation |
| GO:0044089 | 0.03251 | 1.40697 | 28 | 38 | 534 | positive regulation of cellular component biogenesis |
| GO:0006520 | 0.03252 | 1.60277 | 14 | 21 | 261 | cellular amino acid metabolic process |
| GO:0032606 | 0.03262 | 2.16365 | 4 | 9 | 85 | type I interferon production |
| GO:0048708 | 0.03262 | 2.16365 | 4 | 9 | 85 | astrocyte differentiation |
| GO:0050796 | 0.03264 | 1.73255 | 10 | 16 | 185 | regulation of insulin secretion |
| GO:0035637 | 0.03275 | 1.85742 | 7 | 13 | 141 | multicellular organismal signaling |
| GO:0051148 | 0.03297 | 2.45813 | 3 | 7 | 59 | negative regulation of muscle cell differentiation |
| GO:0031334 | 0.03304 | 1.62068 | 13 | 20 | 246 | positive regulation of protein complex assembly |
| GO:0002885 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of hypersensitivity |
| GO:0003334 | 0.03335 | 4.97286 | 1 | 3 | 14 | keratinocyte development |
| GO:0006924 | 0.03335 | 4.97286 | 1 | 3 | 14 | activation-induced cell death of T cells |
| GO:0007175 | 0.03335 | 4.97286 | 1 | 3 | 14 | negative regulation of epidermal growth factor-activated receptor activity |
| GO:0009310 | 0.03335 | 4.97286 | 1 | 3 | 14 | amine catabolic process |
| GO:0010226 | 0.03335 | 4.97286 | 1 | 3 | 14 | response to lithium ion |
| GO:0010421 | 0.03335 | 4.97286 | 1 | 3 | 14 | hydrogen peroxide-mediated programmed cell death |
| GO:0010644 | 0.03335 | 4.97286 | 1 | 3 | 14 | cell communication by electrical coupling |
| GO:0010804 | 0.03335 | 4.97286 | 1 | 3 | 14 | negative regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0014819 | 0.03335 | 4.97286 | 1 | 3 | 14 | regulation of skeletal muscle contraction |
| GO:0018119 | 0.03335 | 4.97286 | 1 | 3 | 14 | peptidyl-cysteine S-nitrosylation |
| GO:0019886 | 0.03335 | 4.97286 | 1 | 3 | 14 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
| GO:0030007 | 0.03335 | 4.97286 | 1 | 3 | 14 | cellular potassium ion homeostasis |
| GO:0034116 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of heterotypic cell-cell adhesion |
| GO:0035791 | 0.03335 | 4.97286 | 1 | 3 | 14 | platelet-derived growth factor receptor-beta signaling pathway |
| GO:0042532 | 0.03335 | 4.97286 | 1 | 3 | 14 | negative regulation of tyrosine phosphorylation of STAT protein |
| GO:0043116 | 0.03335 | 4.97286 | 1 | 3 | 14 | negative regulation of vascular permeability |
| GO:0043517 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0045938 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of circadian sleep/wake cycle, sleep |
| GO:0047484 | 0.03335 | 4.97286 | 1 | 3 | 14 | regulation of response to osmotic stress |
| GO:0048537 | 0.03335 | 4.97286 | 1 | 3 | 14 | mucosal-associated lymphoid tissue development |
| GO:0048541 | 0.03335 | 4.97286 | 1 | 3 | 14 | Peyer's patch development |
| GO:0048672 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of collateral sprouting |
| GO:0048711 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of astrocyte differentiation |
| GO:0097468 | 0.03335 | 4.97286 | 1 | 3 | 14 | programmed cell death in response to reactive oxygen species |
| GO:0097531 | 0.03335 | 4.97286 | 1 | 3 | 14 | mast cell migration |
| GO:0098712 | 0.03335 | 4.97286 | 1 | 3 | 14 | L-glutamate import across plasma membrane |
| GO:1901841 | 0.03335 | 4.97286 | 1 | 3 | 14 | regulation of high voltage-gated calcium channel activity |
| GO:1903624 | 0.03335 | 4.97286 | 1 | 3 | 14 | regulation of DNA catabolic process |
| GO:1905941 | 0.03335 | 4.97286 | 1 | 3 | 14 | positive regulation of gonad development |
| GO:0071383 | 0.03348 | 1.80344 | 8 | 14 | 156 | cellular response to steroid hormone stimulus |
| GO:1990845 | 0.03348 | 1.80344 | 8 | 14 | 156 | adaptive thermogenesis |
| GO:0090101 | 0.03361 | 1.97133 | 6 | 11 | 113 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0021846 | 0.03369 | 3.04139 | 2 | 5 | 35 | cell proliferation in forebrain |
| GO:0033238 | 0.03369 | 3.04139 | 2 | 5 | 35 | regulation of cellular amine metabolic process |
| GO:0034381 | 0.03369 | 3.04139 | 2 | 5 | 35 | plasma lipoprotein particle clearance |
| GO:0043516 | 0.03369 | 3.04139 | 2 | 5 | 35 | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0051084 | 0.03369 | 3.04139 | 2 | 5 | 35 | 'de novo' posttranslational protein folding |
| GO:0060142 | 0.03369 | 3.04139 | 2 | 5 | 35 | regulation of syncytium formation by plasma membrane fusion |
| GO:1904707 | 0.03369 | 3.04139 | 2 | 5 | 35 | positive regulation of vascular smooth muscle cell proliferation |
| GO:2001038 | 0.03369 | 3.04139 | 2 | 5 | 35 | regulation of cellular response to drug |
| GO:0055114 | 0.03372 | 1.31159 | 45 | 58 | 872 | oxidation-reduction process |
| GO:0001829 | 0.03385 | 3.64830 | 1 | 4 | 24 | trophectodermal cell differentiation |
| GO:0002418 | 0.03385 | 3.64830 | 1 | 4 | 24 | immune response to tumor cell |
| GO:0007205 | 0.03385 | 3.64830 | 1 | 4 | 24 | protein kinase C-activating G protein-coupled receptor signaling pathway |
| GO:0009065 | 0.03385 | 3.64830 | 1 | 4 | 24 | glutamine family amino acid catabolic process |
| GO:0021544 | 0.03385 | 3.64830 | 1 | 4 | 24 | subpallium development |
| GO:0021889 | 0.03385 | 3.64830 | 1 | 4 | 24 | olfactory bulb interneuron differentiation |
| GO:0032770 | 0.03385 | 3.64830 | 1 | 4 | 24 | positive regulation of monooxygenase activity |
| GO:0033233 | 0.03385 | 3.64830 | 1 | 4 | 24 | regulation of protein sumoylation |
| GO:0035455 | 0.03385 | 3.64830 | 1 | 4 | 24 | response to interferon-alpha |
| GO:0045723 | 0.03385 | 3.64830 | 1 | 4 | 24 | positive regulation of fatty acid biosynthetic process |
| GO:0048670 | 0.03385 | 3.64830 | 1 | 4 | 24 | regulation of collateral sprouting |
| GO:0050995 | 0.03385 | 3.64830 | 1 | 4 | 24 | negative regulation of lipid catabolic process |
| GO:0051580 | 0.03385 | 3.64830 | 1 | 4 | 24 | regulation of neurotransmitter uptake |
| GO:0051882 | 0.03385 | 3.64830 | 1 | 4 | 24 | mitochondrial depolarization |
| GO:0044085 | 0.03400 | 1.17026 | 158 | 180 | 3041 | cellular component biogenesis |
| GO:0003002 | 0.03414 | 1.48822 | 19 | 28 | 373 | regionalization |
| GO:0071229 | 0.03420 | 1.57431 | 14 | 22 | 278 | cellular response to acid chemical |
| GO:0071300 | 0.03422 | 2.67137 | 2 | 6 | 47 | cellular response to retinoic acid |
| GO:0031330 | 0.03427 | 1.61347 | 13 | 20 | 247 | negative regulation of cellular catabolic process |
| GO:0034101 | 0.03440 | 1.84294 | 7 | 13 | 142 | erythrocyte homeostasis |
| GO:0032386 | 0.03448 | 1.44611 | 23 | 32 | 438 | regulation of intracellular transport |
| GO:0060079 | 0.03482 | 2.13545 | 4 | 9 | 86 | excitatory postsynaptic potential |
| GO:0071466 | 0.03507 | 1.79075 | 8 | 14 | 157 | cellular response to xenobiotic stimulus |
| GO:0001705 | 0.03535 | 9.11226 | 0 | 2 | 6 | ectoderm formation |
| GO:0002925 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0003357 | 0.03535 | 9.11226 | 0 | 2 | 6 | noradrenergic neuron differentiation |
| GO:0008228 | 0.03535 | 9.11226 | 0 | 2 | 6 | opsonization |
| GO:0010701 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of norepinephrine secretion |
| GO:0010754 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of cGMP-mediated signaling |
| GO:0014055 | 0.03535 | 9.11226 | 0 | 2 | 6 | acetylcholine secretion, neurotransmission |
| GO:0014056 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of acetylcholine secretion, neurotransmission |
| GO:0016115 | 0.03535 | 9.11226 | 0 | 2 | 6 | terpenoid catabolic process |
| GO:0021523 | 0.03535 | 9.11226 | 0 | 2 | 6 | somatic motor neuron differentiation |
| GO:0031133 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of axon diameter |
| GO:0032261 | 0.03535 | 9.11226 | 0 | 2 | 6 | purine nucleotide salvage |
| GO:0032730 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of interleukin-1 alpha production |
| GO:0032741 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of interleukin-18 production |
| GO:0032762 | 0.03535 | 9.11226 | 0 | 2 | 6 | mast cell cytokine production |
| GO:0034242 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of syncytium formation by plasma membrane fusion |
| GO:0035434 | 0.03535 | 9.11226 | 0 | 2 | 6 | copper ion transmembrane transport |
| GO:0042427 | 0.03535 | 9.11226 | 0 | 2 | 6 | serotonin biosynthetic process |
| GO:0042536 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:0042713 | 0.03535 | 9.11226 | 0 | 2 | 6 | sperm ejaculation |
| GO:0045590 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of regulatory T cell differentiation |
| GO:0046110 | 0.03535 | 9.11226 | 0 | 2 | 6 | xanthine metabolic process |
| GO:0046654 | 0.03535 | 9.11226 | 0 | 2 | 6 | tetrahydrofolate biosynthetic process |
| GO:0050705 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of interleukin-1 alpha secretion |
| GO:0051005 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of lipoprotein lipase activity |
| GO:0051138 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of NK T cell differentiation |
| GO:0051584 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0051611 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of serotonin uptake |
| GO:0051771 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of nitric-oxide synthase biosynthetic process |
| GO:0051940 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of catecholamine uptake involved in synaptic transmission |
| GO:0052173 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to defenses of other organism involved in symbiotic interaction |
| GO:0052200 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to host defenses |
| GO:0055093 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to hyperoxia |
| GO:0060331 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of response to interferon-gamma |
| GO:0060336 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0061302 | 0.03535 | 9.11226 | 0 | 2 | 6 | smooth muscle cell-matrix adhesion |
| GO:0061643 | 0.03535 | 9.11226 | 0 | 2 | 6 | chemorepulsion of axon |
| GO:0070172 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of tooth mineralization |
| GO:0070245 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of thymocyte apoptotic process |
| GO:0070327 | 0.03535 | 9.11226 | 0 | 2 | 6 | thyroid hormone transport |
| GO:0070339 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to bacterial lipopeptide |
| GO:0070671 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to interleukin-12 |
| GO:0070948 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of neutrophil mediated cytotoxicity |
| GO:0071220 | 0.03535 | 9.11226 | 0 | 2 | 6 | cellular response to bacterial lipoprotein |
| GO:0071221 | 0.03535 | 9.11226 | 0 | 2 | 6 | cellular response to bacterial lipopeptide |
| GO:0071286 | 0.03535 | 9.11226 | 0 | 2 | 6 | cellular response to magnesium ion |
| GO:0071287 | 0.03535 | 9.11226 | 0 | 2 | 6 | cellular response to manganese ion |
| GO:0071640 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of macrophage inflammatory protein 1 alpha production |
| GO:0075136 | 0.03535 | 9.11226 | 0 | 2 | 6 | response to host |
| GO:0097070 | 0.03535 | 9.11226 | 0 | 2 | 6 | ductus arteriosus closure |
| GO:0097527 | 0.03535 | 9.11226 | 0 | 2 | 6 | necroptotic signaling pathway |
| GO:0099576 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
| GO:1900086 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of peptidyl-tyrosine autophosphorylation |
| GO:1901162 | 0.03535 | 9.11226 | 0 | 2 | 6 | primary amino compound biosynthetic process |
| GO:1902035 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of hematopoietic stem cell proliferation |
| GO:1902075 | 0.03535 | 9.11226 | 0 | 2 | 6 | cellular response to salt |
| GO:1903243 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of cardiac muscle hypertrophy in response to stress |
| GO:1903626 | 0.03535 | 9.11226 | 0 | 2 | 6 | positive regulation of DNA catabolic process |
| GO:2000110 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of macrophage apoptotic process |
| GO:2000416 | 0.03535 | 9.11226 | 0 | 2 | 6 | regulation of eosinophil migration |
| GO:2001268 | 0.03535 | 9.11226 | 0 | 2 | 6 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0060419 | 0.03552 | 1.95210 | 6 | 11 | 114 | heart growth |
| GO:0097479 | 0.03552 | 1.71213 | 10 | 16 | 187 | synaptic vesicle localization |
| GO:0060191 | 0.03571 | 2.24797 | 4 | 8 | 73 | regulation of lipase activity |
| GO:1903036 | 0.03571 | 2.24797 | 4 | 8 | 73 | positive regulation of response to wounding |
| GO:0050982 | 0.03571 | 2.41164 | 3 | 7 | 60 | detection of mechanical stimulus |
| GO:0050851 | 0.03574 | 1.54922 | 15 | 23 | 295 | antigen receptor-mediated signaling pathway |
| GO:0030326 | 0.03612 | 1.82868 | 7 | 13 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.03612 | 1.82868 | 7 | 13 | 143 | embryonic appendage morphogenesis |
| GO:0090288 | 0.03612 | 1.82868 | 7 | 13 | 143 | negative regulation of cellular response to growth factor stimulus |
| GO:0050864 | 0.03612 | 1.58276 | 14 | 21 | 264 | regulation of B cell activation |
| GO:0003008 | 0.03659 | 1.16958 | 153 | 174 | 2939 | system process |
| GO:0042475 | 0.03712 | 2.10798 | 5 | 9 | 87 | odontogenesis of dentin-containing tooth |
| GO:0042593 | 0.03739 | 1.57620 | 14 | 21 | 265 | glucose homeostasis |
| GO:0007520 | 0.03745 | 2.60765 | 3 | 6 | 48 | myoblast fusion |
| GO:0010107 | 0.03745 | 2.60765 | 3 | 6 | 48 | potassium ion import |
| GO:0044848 | 0.03745 | 2.60765 | 3 | 6 | 48 | biological phase |
| GO:0006458 | 0.03751 | 2.94315 | 2 | 5 | 36 | 'de novo' protein folding |
| GO:0070528 | 0.03751 | 2.94315 | 2 | 5 | 36 | protein kinase C signaling |
| GO:0071604 | 0.03751 | 2.94315 | 2 | 5 | 36 | transforming growth factor beta production |
| GO:0055024 | 0.03762 | 2.00808 | 5 | 10 | 101 | regulation of cardiac muscle tissue development |
| GO:2000300 | 0.03762 | 2.00808 | 5 | 10 | 101 | regulation of synaptic vesicle exocytosis |
| GO:0031032 | 0.03834 | 1.66367 | 11 | 17 | 204 | actomyosin structure organization |
| GO:0010812 | 0.03860 | 2.36687 | 3 | 7 | 61 | negative regulation of cell-substrate adhesion |
| GO:0021515 | 0.03860 | 2.36687 | 3 | 7 | 61 | cell differentiation in spinal cord |
| GO:0045840 | 0.03860 | 2.36687 | 3 | 7 | 61 | positive regulation of mitotic nuclear division |
| GO:0051591 | 0.03860 | 2.36687 | 3 | 7 | 61 | response to cAMP |
| GO:1902305 | 0.03860 | 2.36687 | 3 | 7 | 61 | regulation of sodium ion transmembrane transport |
| GO:0009595 | 0.03868 | 3.47441 | 1 | 4 | 25 | detection of biotic stimulus |
| GO:0010742 | 0.03868 | 3.47441 | 1 | 4 | 25 | macrophage derived foam cell differentiation |
| GO:0030194 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of blood coagulation |
| GO:0031100 | 0.03868 | 3.47441 | 1 | 4 | 25 | animal organ regeneration |
| GO:0032373 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of sterol transport |
| GO:0032376 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of cholesterol transport |
| GO:0034114 | 0.03868 | 3.47441 | 1 | 4 | 25 | regulation of heterotypic cell-cell adhesion |
| GO:0034123 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of toll-like receptor signaling pathway |
| GO:0042403 | 0.03868 | 3.47441 | 1 | 4 | 25 | thyroid hormone metabolic process |
| GO:0042573 | 0.03868 | 3.47441 | 1 | 4 | 25 | retinoic acid metabolic process |
| GO:0046426 | 0.03868 | 3.47441 | 1 | 4 | 25 | negative regulation of JAK-STAT cascade |
| GO:0055094 | 0.03868 | 3.47441 | 1 | 4 | 25 | response to lipoprotein particle |
| GO:0060004 | 0.03868 | 3.47441 | 1 | 4 | 25 | reflex |
| GO:0061213 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of mesonephros development |
| GO:0070050 | 0.03868 | 3.47441 | 1 | 4 | 25 | neuron cellular homeostasis |
| GO:0072606 | 0.03868 | 3.47441 | 1 | 4 | 25 | interleukin-8 secretion |
| GO:0090280 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of calcium ion import |
| GO:1900048 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of hemostasis |
| GO:1901032 | 0.03868 | 3.47441 | 1 | 4 | 25 | negative regulation of response to reactive oxygen species |
| GO:1901798 | 0.03868 | 3.47441 | 1 | 4 | 25 | positive regulation of signal transduction by p53 class mediator |
| GO:1903206 | 0.03868 | 3.47441 | 1 | 4 | 25 | negative regulation of hydrogen peroxide-induced cell death |
| GO:2001039 | 0.03868 | 3.47441 | 1 | 4 | 25 | negative regulation of cellular response to drug |
| GO:0033500 | 0.03869 | 1.56970 | 14 | 21 | 266 | carbohydrate homeostasis |
| GO:0051188 | 0.03950 | 1.58524 | 13 | 20 | 251 | cofactor biosynthetic process |
| GO:0010522 | 0.03985 | 1.98617 | 5 | 10 | 102 | regulation of calcium ion transport into cytosol |
| GO:0021510 | 0.03985 | 1.98617 | 5 | 10 | 102 | spinal cord development |
| GO:0050886 | 0.03985 | 1.98617 | 5 | 10 | 102 | endocrine process |
| GO:1905477 | 0.03985 | 1.98617 | 5 | 10 | 102 | positive regulation of protein localization to membrane |
| GO:0043112 | 0.03987 | 1.65474 | 11 | 17 | 205 | receptor metabolic process |
| GO:0006590 | 0.04011 | 4.55825 | 1 | 3 | 15 | thyroid hormone generation |
| GO:0007379 | 0.04011 | 4.55825 | 1 | 3 | 15 | segment specification |
| GO:0010819 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of T cell chemotaxis |
| GO:0010960 | 0.04011 | 4.55825 | 1 | 3 | 15 | magnesium ion homeostasis |
| GO:0016114 | 0.04011 | 4.55825 | 1 | 3 | 15 | terpenoid biosynthetic process |
| GO:0017014 | 0.04011 | 4.55825 | 1 | 3 | 15 | protein nitrosylation |
| GO:0032222 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of synaptic transmission, cholinergic |
| GO:0033089 | 0.04011 | 4.55825 | 1 | 3 | 15 | positive regulation of T cell differentiation in thymus |
| GO:0034393 | 0.04011 | 4.55825 | 1 | 3 | 15 | positive regulation of smooth muscle cell apoptotic process |
| GO:0034755 | 0.04011 | 4.55825 | 1 | 3 | 15 | iron ion transmembrane transport |
| GO:0042033 | 0.04011 | 4.55825 | 1 | 3 | 15 | chemokine biosynthetic process |
| GO:0043129 | 0.04011 | 4.55825 | 1 | 3 | 15 | surfactant homeostasis |
| GO:0045073 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of chemokine biosynthetic process |
| GO:0045342 | 0.04011 | 4.55825 | 1 | 3 | 15 | MHC class II biosynthetic process |
| GO:0046033 | 0.04011 | 4.55825 | 1 | 3 | 15 | AMP metabolic process |
| GO:0048385 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of retinoic acid receptor signaling pathway |
| GO:0051044 | 0.04011 | 4.55825 | 1 | 3 | 15 | positive regulation of membrane protein ectodomain proteolysis |
| GO:0051547 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of keratinocyte migration |
| GO:0051938 | 0.04011 | 4.55825 | 1 | 3 | 15 | L-glutamate import |
| GO:0060055 | 0.04011 | 4.55825 | 1 | 3 | 15 | angiogenesis involved in wound healing |
| GO:0060330 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of response to interferon-gamma |
| GO:0060334 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of interferon-gamma-mediated signaling pathway |
| GO:0060347 | 0.04011 | 4.55825 | 1 | 3 | 15 | heart trabecula formation |
| GO:0070102 | 0.04011 | 4.55825 | 1 | 3 | 15 | interleukin-6-mediated signaling pathway |
| GO:0071243 | 0.04011 | 4.55825 | 1 | 3 | 15 | cellular response to arsenic-containing substance |
| GO:1901317 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of flagellated sperm motility |
| GO:1902165 | 0.04011 | 4.55825 | 1 | 3 | 15 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:2001241 | 0.04011 | 4.55825 | 1 | 3 | 15 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0021545 | 0.04087 | 2.54689 | 3 | 6 | 49 | cranial nerve development |
| GO:0098586 | 0.04087 | 2.54689 | 3 | 6 | 49 | cellular response to virus |
| GO:1904036 | 0.04087 | 2.54689 | 3 | 6 | 49 | negative regulation of epithelial cell apoptotic process |
| GO:0000271 | 0.04098 | 2.18067 | 4 | 8 | 75 | polysaccharide biosynthetic process |
| GO:0030808 | 0.04098 | 2.18067 | 4 | 8 | 75 | regulation of nucleotide biosynthetic process |
| GO:0045843 | 0.04098 | 2.18067 | 4 | 8 | 75 | negative regulation of striated muscle tissue development |
| GO:0051705 | 0.04098 | 2.18067 | 4 | 8 | 75 | multi-organism behavior |
| GO:1900371 | 0.04098 | 2.18067 | 4 | 8 | 75 | regulation of purine nucleotide biosynthetic process |
| GO:0015695 | 0.04158 | 2.85104 | 2 | 5 | 37 | organic cation transport |
| GO:0019934 | 0.04158 | 2.85104 | 2 | 5 | 37 | cGMP-mediated signaling |
| GO:0021884 | 0.04158 | 2.85104 | 2 | 5 | 37 | forebrain neuron development |
| GO:0036474 | 0.04158 | 2.85104 | 2 | 5 | 37 | cell death in response to hydrogen peroxide |
| GO:0048846 | 0.04158 | 2.85104 | 2 | 5 | 37 | axon extension involved in axon guidance |
| GO:0060674 | 0.04158 | 2.85104 | 2 | 5 | 37 | placenta blood vessel development |
| GO:1901385 | 0.04158 | 2.85104 | 2 | 5 | 37 | regulation of voltage-gated calcium channel activity |
| GO:1902229 | 0.04158 | 2.85104 | 2 | 5 | 37 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1902284 | 0.04158 | 2.85104 | 2 | 5 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:1903792 | 0.04158 | 2.85104 | 2 | 5 | 37 | negative regulation of anion transport |
| GO:0014911 | 0.04164 | 2.32373 | 3 | 7 | 62 | positive regulation of smooth muscle cell migration |
| GO:0060038 | 0.04164 | 2.32373 | 3 | 7 | 62 | cardiac muscle cell proliferation |
| GO:0014020 | 0.04171 | 1.89660 | 6 | 11 | 117 | primary neural tube formation |
| GO:0007229 | 0.04202 | 2.05509 | 5 | 9 | 89 | integrin-mediated signaling pathway |
| GO:0016202 | 0.04203 | 1.70417 | 9 | 15 | 176 | regulation of striated muscle tissue development |
| GO:0048489 | 0.04203 | 1.70417 | 9 | 15 | 176 | synaptic vesicle transport |
| GO:0048592 | 0.04203 | 1.70417 | 9 | 15 | 176 | eye morphogenesis |
| GO:0097480 | 0.04203 | 1.70417 | 9 | 15 | 176 | establishment of synaptic vesicle localization |
| GO:0030038 | 0.04216 | 1.96472 | 5 | 10 | 103 | contractile actin filament bundle assembly |
| GO:0043149 | 0.04216 | 1.96472 | 5 | 10 | 103 | stress fiber assembly |
| GO:0048709 | 0.04216 | 1.96472 | 5 | 10 | 103 | oligodendrocyte differentiation |
| GO:0055008 | 0.04380 | 2.14850 | 4 | 8 | 76 | cardiac muscle tissue morphogenesis |
| GO:1901606 | 0.04380 | 2.14850 | 4 | 8 | 76 | alpha-amino acid catabolic process |
| GO:0007219 | 0.04381 | 1.69358 | 9 | 15 | 177 | Notch signaling pathway |
| GO:0050953 | 0.04384 | 1.72985 | 8 | 14 | 162 | sensory perception of light stimulus |
| GO:0003299 | 0.04389 | 3.31633 | 1 | 4 | 26 | muscle hypertrophy in response to stress |
| GO:0007620 | 0.04389 | 3.31633 | 1 | 4 | 26 | copulation |
| GO:0010863 | 0.04389 | 3.31633 | 1 | 4 | 26 | positive regulation of phospholipase C activity |
| GO:0014898 | 0.04389 | 3.31633 | 1 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0070233 | 0.04389 | 3.31633 | 1 | 4 | 26 | negative regulation of T cell apoptotic process |
| GO:0072574 | 0.04389 | 3.31633 | 1 | 4 | 26 | hepatocyte proliferation |
| GO:0072575 | 0.04389 | 3.31633 | 1 | 4 | 26 | epithelial cell proliferation involved in liver morphogenesis |
| GO:0090077 | 0.04389 | 3.31633 | 1 | 4 | 26 | foam cell differentiation |
| GO:0090189 | 0.04389 | 3.31633 | 1 | 4 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:1902175 | 0.04389 | 3.31633 | 1 | 4 | 26 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| GO:1904893 | 0.04389 | 3.31633 | 1 | 4 | 26 | negative regulation of STAT cascade |
| GO:1905523 | 0.04389 | 3.31633 | 1 | 4 | 26 | positive regulation of macrophage migration |
| GO:2000311 | 0.04389 | 3.31633 | 1 | 4 | 26 | regulation of AMPA receptor activity |
| GO:0046620 | 0.04393 | 1.87879 | 6 | 11 | 118 | regulation of organ growth |
| GO:0030073 | 0.04402 | 1.60688 | 12 | 18 | 223 | insulin secretion |
| GO:0009063 | 0.04462 | 2.02963 | 5 | 9 | 90 | cellular amino acid catabolic process |
| GO:0042770 | 0.04462 | 2.02963 | 5 | 9 | 90 | signal transduction in response to DNA damage |
| GO:0018105 | 0.04467 | 1.49536 | 17 | 24 | 318 | peptidyl-serine phosphorylation |
| GO:0043388 | 0.04483 | 2.28213 | 3 | 7 | 63 | positive regulation of DNA binding |
| GO:0050906 | 0.04502 | 1.81280 | 7 | 12 | 133 | detection of stimulus involved in sensory perception |
| GO:0060041 | 0.04577 | 1.71817 | 8 | 14 | 163 | retina development in camera-type eye |
| GO:0001953 | 0.04590 | 2.76452 | 2 | 5 | 38 | negative regulation of cell-matrix adhesion |
| GO:0014002 | 0.04590 | 2.76452 | 2 | 5 | 38 | astrocyte development |
| GO:0030851 | 0.04590 | 2.76452 | 2 | 5 | 38 | granulocyte differentiation |
| GO:0097300 | 0.04590 | 2.76452 | 2 | 5 | 38 | programmed necrotic cell death |
| GO:0051963 | 0.04623 | 1.86130 | 6 | 11 | 119 | regulation of synapse assembly |
| GO:0001756 | 0.04674 | 2.11727 | 4 | 8 | 77 | somitogenesis |
| GO:0014855 | 0.04674 | 2.11727 | 4 | 8 | 77 | striated muscle cell proliferation |
| GO:0015918 | 0.04674 | 2.11727 | 4 | 8 | 77 | sterol transport |
| GO:0030301 | 0.04674 | 2.11727 | 4 | 8 | 77 | cholesterol transport |
| GO:0050688 | 0.04674 | 2.11727 | 4 | 8 | 77 | regulation of defense response to virus |
| GO:0051785 | 0.04674 | 2.11727 | 4 | 8 | 77 | positive regulation of nuclear division |
| GO:0051965 | 0.04674 | 2.11727 | 4 | 8 | 77 | positive regulation of synapse assembly |
| GO:0035249 | 0.04706 | 1.92318 | 5 | 10 | 105 | synaptic transmission, glutamatergic |
| GO:0055123 | 0.04721 | 1.79786 | 7 | 12 | 134 | digestive system development |
| GO:0001886 | 0.04751 | 4.20742 | 1 | 3 | 16 | endothelial cell morphogenesis |
| GO:0002070 | 0.04751 | 4.20742 | 1 | 3 | 16 | epithelial cell maturation |
| GO:0002689 | 0.04751 | 4.20742 | 1 | 3 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0002866 | 0.04751 | 4.20742 | 1 | 3 | 16 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0006534 | 0.04751 | 4.20742 | 1 | 3 | 16 | cysteine metabolic process |
| GO:0007250 | 0.04751 | 4.20742 | 1 | 3 | 16 | activation of NF-kappaB-inducing kinase activity |
| GO:0007512 | 0.04751 | 4.20742 | 1 | 3 | 16 | adult heart development |
| GO:0021978 | 0.04751 | 4.20742 | 1 | 3 | 16 | telencephalon regionalization |
| GO:0030449 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of complement activation |
| GO:0042448 | 0.04751 | 4.20742 | 1 | 3 | 16 | progesterone metabolic process |
| GO:0042640 | 0.04751 | 4.20742 | 1 | 3 | 16 | anagen |
| GO:0043084 | 0.04751 | 4.20742 | 1 | 3 | 16 | penile erection |
| GO:0043374 | 0.04751 | 4.20742 | 1 | 3 | 16 | CD8-positive, alpha-beta T cell differentiation |
| GO:0044065 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of respiratory system process |
| GO:0044320 | 0.04751 | 4.20742 | 1 | 3 | 16 | cellular response to leptin stimulus |
| GO:0045655 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of monocyte differentiation |
| GO:0051386 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of neurotrophin TRK receptor signaling pathway |
| GO:0070885 | 0.04751 | 4.20742 | 1 | 3 | 16 | negative regulation of calcineurin-NFAT signaling cascade |
| GO:0071498 | 0.04751 | 4.20742 | 1 | 3 | 16 | cellular response to fluid shear stress |
| GO:0072672 | 0.04751 | 4.20742 | 1 | 3 | 16 | neutrophil extravasation |
| GO:0098703 | 0.04751 | 4.20742 | 1 | 3 | 16 | calcium ion import across plasma membrane |
| GO:0106057 | 0.04751 | 4.20742 | 1 | 3 | 16 | negative regulation of calcineurin-mediated signaling |
| GO:0106070 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:1900119 | 0.04751 | 4.20742 | 1 | 3 | 16 | positive regulation of execution phase of apoptosis |
| GO:2000479 | 0.04751 | 4.20742 | 1 | 3 | 16 | regulation of cAMP-dependent protein kinase activity |
| GO:2000651 | 0.04751 | 4.20742 | 1 | 3 | 16 | positive regulation of sodium ion transmembrane transporter activity |
| GO:1901861 | 0.04752 | 1.67277 | 9 | 15 | 179 | regulation of muscle tissue development |
| GO:0002072 | 0.04780 | 7.28948 | 0 | 2 | 7 | optic cup morphogenesis involved in camera-type eye development |
| GO:0002249 | 0.04780 | 7.28948 | 0 | 2 | 7 | lymphocyte anergy |
| GO:0002457 | 0.04780 | 7.28948 | 0 | 2 | 7 | T cell antigen processing and presentation |
| GO:0002666 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of T cell tolerance induction |
| GO:0002667 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of T cell anergy |
| GO:0002759 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of antimicrobial humoral response |
| GO:0002775 | 0.04780 | 7.28948 | 0 | 2 | 7 | antimicrobial peptide production |
| GO:0002778 | 0.04780 | 7.28948 | 0 | 2 | 7 | antibacterial peptide production |
| GO:0002870 | 0.04780 | 7.28948 | 0 | 2 | 7 | T cell anergy |
| GO:0002911 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of lymphocyte anergy |
| GO:0003321 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of blood pressure by epinephrine-norepinephrine |
| GO:0006729 | 0.04780 | 7.28948 | 0 | 2 | 7 | tetrahydrobiopterin biosynthetic process |
| GO:0008063 | 0.04780 | 7.28948 | 0 | 2 | 7 | Toll signaling pathway |
| GO:0008627 | 0.04780 | 7.28948 | 0 | 2 | 7 | intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:0010616 | 0.04780 | 7.28948 | 0 | 2 | 7 | negative regulation of cardiac muscle adaptation |
| GO:0014042 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of neuron maturation |
| GO:0014054 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of gamma-aminobutyric acid secretion |
| GO:0016198 | 0.04780 | 7.28948 | 0 | 2 | 7 | axon choice point recognition |
| GO:0019062 | 0.04780 | 7.28948 | 0 | 2 | 7 | virion attachment to host cell |
| GO:0030718 | 0.04780 | 7.28948 | 0 | 2 | 7 | germ-line stem cell population maintenance |
| GO:0030913 | 0.04780 | 7.28948 | 0 | 2 | 7 | paranodal junction assembly |
| GO:0031282 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of guanylate cyclase activity |
| GO:0032493 | 0.04780 | 7.28948 | 0 | 2 | 7 | response to bacterial lipoprotein |
| GO:0032811 | 0.04780 | 7.28948 | 0 | 2 | 7 | negative regulation of epinephrine secretion |
| GO:0032819 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:0033483 | 0.04780 | 7.28948 | 0 | 2 | 7 | gas homeostasis |
| GO:0034154 | 0.04780 | 7.28948 | 0 | 2 | 7 | toll-like receptor 7 signaling pathway |
| GO:0038001 | 0.04780 | 7.28948 | 0 | 2 | 7 | paracrine signaling |
| GO:0042321 | 0.04780 | 7.28948 | 0 | 2 | 7 | negative regulation of circadian sleep/wake cycle, sleep |
| GO:0042904 | 0.04780 | 7.28948 | 0 | 2 | 7 | 9-cis-retinoic acid biosynthetic process |
| GO:0042905 | 0.04780 | 7.28948 | 0 | 2 | 7 | 9-cis-retinoic acid metabolic process |
| GO:0045110 | 0.04780 | 7.28948 | 0 | 2 | 7 | intermediate filament bundle assembly |
| GO:0045359 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of interferon-beta biosynthetic process |
| GO:0045409 | 0.04780 | 7.28948 | 0 | 2 | 7 | negative regulation of interleukin-6 biosynthetic process |
| GO:0046135 | 0.04780 | 7.28948 | 0 | 2 | 7 | pyrimidine nucleoside catabolic process |
| GO:0048289 | 0.04780 | 7.28948 | 0 | 2 | 7 | isotype switching to IgE isotypes |
| GO:0048293 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of isotype switching to IgE isotypes |
| GO:0050703 | 0.04780 | 7.28948 | 0 | 2 | 7 | interleukin-1 alpha secretion |
| GO:0051461 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of corticotropin secretion |
| GO:0051610 | 0.04780 | 7.28948 | 0 | 2 | 7 | serotonin uptake |
| GO:0060054 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of epithelial cell proliferation involved in wound healing |
| GO:0060235 | 0.04780 | 7.28948 | 0 | 2 | 7 | lens induction in camera-type eye |
| GO:0060437 | 0.04780 | 7.28948 | 0 | 2 | 7 | lung growth |
| GO:0060664 | 0.04780 | 7.28948 | 0 | 2 | 7 | epithelial cell proliferation involved in salivary gland morphogenesis |
| GO:0060676 | 0.04780 | 7.28948 | 0 | 2 | 7 | ureteric bud formation |
| GO:0060754 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of mast cell chemotaxis |
| GO:0060763 | 0.04780 | 7.28948 | 0 | 2 | 7 | mammary duct terminal end bud growth |
| GO:0060839 | 0.04780 | 7.28948 | 0 | 2 | 7 | endothelial cell fate commitment |
| GO:0061526 | 0.04780 | 7.28948 | 0 | 2 | 7 | acetylcholine secretion |
| GO:0071362 | 0.04780 | 7.28948 | 0 | 2 | 7 | cellular response to ether |
| GO:0071440 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of histone H3-K14 acetylation |
| GO:0072675 | 0.04780 | 7.28948 | 0 | 2 | 7 | osteoclast fusion |
| GO:0086023 | 0.04780 | 7.28948 | 0 | 2 | 7 | adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:0098943 | 0.04780 | 7.28948 | 0 | 2 | 7 | neurotransmitter receptor transport, postsynaptic endosome to lysosome |
| GO:1900084 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of peptidyl-tyrosine autophosphorylation |
| GO:1900107 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of nodal signaling pathway |
| GO:1900747 | 0.04780 | 7.28948 | 0 | 2 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
| GO:1901490 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of lymphangiogenesis |
| GO:1903980 | 0.04780 | 7.28948 | 0 | 2 | 7 | positive regulation of microglial cell activation |
| GO:1905664 | 0.04780 | 7.28948 | 0 | 2 | 7 | regulation of calcium ion import across plasma membrane |
| GO:1990001 | 0.04780 | 7.28948 | 0 | 2 | 7 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043254 | 0.04811 | 1.40040 | 23 | 32 | 451 | regulation of protein complex assembly |
| GO:0001658 | 0.04817 | 2.24199 | 3 | 7 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0009988 | 0.04817 | 2.24199 | 3 | 7 | 64 | cell-cell recognition |
| GO:0051926 | 0.04817 | 2.24199 | 3 | 7 | 64 | negative regulation of calcium ion transport |
| GO:0033619 | 0.04828 | 2.43347 | 3 | 6 | 51 | membrane protein proteolysis |
| GO:0051353 | 0.04828 | 2.43347 | 3 | 6 | 51 | positive regulation of oxidoreductase activity |
| GO:2000649 | 0.04828 | 2.43347 | 3 | 6 | 51 | regulation of sodium ion transmembrane transporter activity |
| GO:0051208 | 0.04861 | 1.84414 | 6 | 11 | 120 | sequestering of calcium ion |
| GO:0030307 | 0.04890 | 1.63501 | 10 | 16 | 195 | positive regulation of cell growth |
| GO:0042180 | 0.04890 | 1.63501 | 10 | 16 | 195 | cellular ketone metabolic process |
| GO:0007264 | 0.04911 | 1.38265 | 25 | 34 | 485 | small GTPase mediated signal transduction |
| GO:0045598 | 0.04947 | 1.78316 | 7 | 12 | 135 | regulation of fat cell differentiation |
| GO:0002335 | 0.04948 | 3.17200 | 1 | 4 | 27 | mature B cell differentiation |
| GO:0002347 | 0.04948 | 3.17200 | 1 | 4 | 27 | response to tumor cell |
| GO:0014887 | 0.04948 | 3.17200 | 1 | 4 | 27 | cardiac muscle adaptation |
| GO:0021871 | 0.04948 | 3.17200 | 1 | 4 | 27 | forebrain regionalization |
| GO:0030212 | 0.04948 | 3.17200 | 1 | 4 | 27 | hyaluronan metabolic process |
| GO:0032925 | 0.04948 | 3.17200 | 1 | 4 | 27 | regulation of activin receptor signaling pathway |
| GO:0044550 | 0.04948 | 3.17200 | 1 | 4 | 27 | secondary metabolite biosynthetic process |
| GO:0045956 | 0.04948 | 3.17200 | 1 | 4 | 27 | positive regulation of calcium ion-dependent exocytosis |
| GO:0046639 | 0.04948 | 3.17200 | 1 | 4 | 27 | negative regulation of alpha-beta T cell differentiation |
| GO:0050849 | 0.04948 | 3.17200 | 1 | 4 | 27 | negative regulation of calcium-mediated signaling |
| GO:0060008 | 0.04948 | 3.17200 | 1 | 4 | 27 | Sertoli cell differentiation |
| GO:0060343 | 0.04948 | 3.17200 | 1 | 4 | 27 | trabecula formation |
| GO:0071402 | 0.04948 | 3.17200 | 1 | 4 | 27 | cellular response to lipoprotein particle stimulus |
| GO:0022600 | 0.04965 | 1.90306 | 6 | 10 | 106 | digestive system process |
| GO:1902803 | 0.04965 | 1.90306 | 6 | 10 | 106 | regulation of synaptic vesicle transport |
| GO:0051017 | 0.04979 | 1.69525 | 9 | 14 | 165 | actin filament bundle assembly |
| GO:0034637 | 0.04981 | 2.08693 | 4 | 8 | 78 | cellular carbohydrate biosynthetic process |
| GO:0045471 | 0.04981 | 2.08693 | 4 | 8 | 78 | response to ethanol |
| GO:1901862 | 0.04981 | 2.08693 | 4 | 8 | 78 | negative regulation of muscle tissue development |
| GO:0051098 | 0.04982 | 1.42115 | 21 | 29 | 403 | regulation of binding |